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ABSTRACT OF DISSERTATION
THE ROLE OF TOMBUSVIRUS REPLICASE PROTEINS AND RNA IN
REPLICASE ASSEMBLY, REPLICATION AND RECOMBINATION
Tombusviruses are single, positive strand RNA viruses of plants, often associated
with parasitic defective interfering (DI) RNAs. Two viral- coded gene products, namely
p33 and p92, are required for tombusvirus replication. The overlapping domains of p33
and p92 contain an arginine/proline-rich (RPR) RNA binding motif. In this study, the role
of RPR motif and viral RNA in tombusvirus replication and recombination, as well as
involvement of viral RNA in tombusvirus replicase assembly was examined.
Using site-directed mutagenesis I generated a series of RPR mutants of Cucumber
necrosis tombusvirus (CNV). Analysis of RPR mutants defined that wild type RPR motif,
especially two of the four arginines, were required for efficient RNA binding in vitro, for
replication of tombusviruses, their associated DI RNAs, subgenomic (sg)RNA synthesis
and DI RNA recombination in vivo. Experiments using a two-component tombusvirus
replication system showed that RPR motif is critical for functions of both p33 and p92 in
replication, but its role in these proteins might not be identical. Recombination studies
using a novel tombusvirus three-component system revealed that mutations in RPR motif
of p33 replicase protein resulted in an altered viral RNA recombination rate. Identified DI
RNA recombinants were mostly imprecise, with recombination sites clustered around a
replication enchancer and an additional putative cis-acting element that might facilitate
the template switching events by the tombusvirus replicase.
To study the role of RNA during the assembly of functional tombusvirus
replicase, recombinant CNV replicase that showed similar properties to plant-derived
CNV replicase was purified from Saccharomyces cerevisiae. When in addition to p33
and p92 proteins DI RNA was co-expressed in yeast cells, the isolated replicase activity
was increased ~40 fold. Further studies defined RNA motifs within two short DI RNA
regions that enhanced active CNV replicase formation.
In summary, this study showed that the conserved RNA binding motif of the
tombusvirus replicase proteins and viral RNA are involved in replicase assembly, viral
RNA replication, subgenomic RNA synthesis and RNA recombination. This data shed
new light on the complex roles of the viral elements in replication, and will help future
studies aimed at interfering with viral infections.
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Defective Interfering RNA; Replication enhancer; Replicase assembly
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1Chapter One
The overview of Tombusviruses
General properties
Tombusvirus   is   a   genus   of   plant   viruses   in   the Tombusviridae family.
Tombusviruses have a single positive stranded RNA genome component about 4.7kb long
(Russo et al., 1994). The virus genome is encapsidated by 180 subunits of 41kDa coat protein
that form a 32-34 nm icosahedral particle (Russo et al., 1994).
Tombusviruses can   infect   plants   from   different   groups  (woody, perrenial,
ornamentals) although the host range of each individual tombusvirus is relatively narrow. An
exception is the prototypical member of the family, Tomato bushy stunt virus (TBSV), which
causes diseases of plants from wide ranging species, including tomato and other solanaceous
plants, cherry, apple, plum, and grapevines (reviewed by T. J. Morris, 2001). Under experimental
conditions, TBSV can infect plants from more than 100 species that belong to 20 families
(Martelli et al., 1988)
Diseases   caused   by   tombusviruses   are   soil   borne, but   from   all   studied
tombusviruses only for Cucumber   necrosis virus  (CNV) has the vector, Chytrid fungus
Olpidium   bornovanus, been   identified ( Campbell,  1996 ). Most likely other tombusviruses
can spread by soil water or by infected woody plant stocks (reviewed by T.J. Morris, 2001).
Molecular  biology studies of tombusviruses have been done mainly using  four members
of the genus:TBSV, Cymbidium ringspot virus (CymRSV), Cucumber necrosis virus (CNV) and
Carnation Italian ringspot virus (CIRV).
Genome organization of Tombusviruses
The plus - stranded genome of tombusviruses, like many other plant viruses (Dreher,
T.W., 1999) lacks poly-A tail and 5’-cap (Russo et al., 1994),  yet  it  is  still  translation
competent  and  it  encodes  five  functional open reading    frames    ( ORFs )    (Figure 1.1)
between    conserved    5’-AGAAAU…  and …GCAGCCC-3’ sequences at the ends of
untranslated   regions   (UTRs)   ( Russo et al., 1994 ).   The   replicase proteins of tombusviruses
2p33 and p92 encoded by ORF1 and ORF2, respectively, are translated directly from gRNA
(Figure 1.1). Tombusviruses use ribosomal readthrough mechanism of amber translation
termination codon at the end of p33 to express p92 protein.  Due to this translation strategy the,
N-terminus of   p92 contains the entire p33 sequence (Scholthof et al., 1995d).
The coat protein (p41) of tombusvirus, encoded by ORF3, is located downstream from
the replicase protein genes  (Figure 1.1). At the 3’proximal end of genomic RNA are genes of
cell-to-cell movement protein (p22) and suppressor of gene silencing (p19) (Figure 1.1).  The
sequences of the latter two proteins are overlapping, but they have distinct ORFs  (ORF4 and
ORF5). The leaky scanning translation mechanism allows production of both proteins from the
same subgenomic (sg) RNA (Russo et al., 1994).
To express genes encoded by ORFs 3 through 5, tombusviruses use (sg) RNAs
(Figure1.1) :  sg RNA1(~2.1kb) for ORF3 (p41),  and sgRNA2 (~0.9kb)  for  ORF4 (p22) and
ORF5 (p19). The transcription of sgRNA2 occurs earlier in virus infection cycle than
transcription of sgRNA1(Johnston and Rochon, 1995; Qiu and Scholthof, 2001; Tavazza et al.,
1994;  Zhang et al., 1999),  suggesting  possible  regulation  of  protein  expression time.
Proteins encoded by tombusviruses
Translation strategies of tombusviruses
It has been shown that for translation initiation in  eukaryotic  cells, 5' cap  of mRNA
bound  by  eukaryotic  initiation  factor  eIF-4E  and  poly (A),  bound by poly-A binding protein
(PABP) are brought together via interaction with  eIF4G forming  "closed loop"  structure, which
promotes  translation initiation by attracting the 40S ribosome subunit (reviewed  in  Bushell
and Sarnow, 2002).  Small ribosome subunit with attached methionyl- initiation tRNA scans
mRNA in the 5' to 3' direction until it reaches an initiation codon, where 60S ribosome subunit
binds and ribosome starts translation elongation process (reviewed in Bushell and Sarnow,
2002).
The 5’cap or 3’polyA tail structures are not present in tombusviruses. Nevertheless, these
plant   viruses are  able  to  utilize  eukaryotic  cell  translation  machinery.  The   tombusvirus
translation was studied using 3’end deletion mutants of TBSV. These studies revealed that 3’cap
independent translation enchancer (3’CITE) was critical for the translation of tombusvirus
3proteins (Wu and White,  1999).  Interestingly, when mutant RNAs lacking 3’CITE were capped,
protein translation occurred, suggesting, that 3’CITE can have similar function as 5’cap. In
addition, it was found that for tombusvirus translation RNA-RNA interaction between 5’UTR
and 3’CITE is necessary (M. Fabian and K.A. White, unpublished). It is possible that
tombusvirus translation mechanism is similar to that reported for the luteovirus BYDV (Guo et
al., 2001), where 3’translation enchancer interacts with 5’UTR via “kissing loop” mechanism. It
was proposed that due to this interaction the circularization of viral RNA occurs that brings
translation initiation factors and/or ribosomal subunits bound to 3’translation enchancer to the
5’end and promotes translation initiation (Guo et al., 2001).
To express proteins that are encoded by internally located ORFs tombusvirus replicase
transcribes two sgRNAS. Several mechanisms for the synthesis of sgRNAs have been proposed
(Miller and Koev,  2000). These include 1) internal initiation, when replicase initiates (+) sgRNA
synthesis on the (-) strand gRNA; 2) premature termination, when replicase stops (-) strand
synthesis due to secondary structure formed on the gRNA. These shorter (-) strands then are used
to make (+) sgRNAs; 3) discontinuous transcription, which involves  replicase  jumping from
termination site to the 5’end of gRNA during (-) strand   synthesis. The findings that long
distance interactions between tombusvirus (+) gRNA sequences can form secondary structures
that might force the viral replicase to terminate (-) strand synthesis just upstream of sgRNA
initiation sites (Choi et al., 2001; Choi and White, 2002) support the premature termination
model.
To   express   p92   protein    tombusviruses   use    translational    readthrough   of UAG
termination codon. It is thought that a tyrosine is inserted at this position in p92 in vivo and
accordingly, in vitro gRNA transcript that has tyrosine codon substitution in place of stop codon,
has  been shown to be able to complement tombusvirus replication (Oster et al., 1998).
To produce p19 protein from sgRNA2, tombusviruses use leaky scanning mechanism
whereby some  ribosomes  do  not  initiate at the first start codon (for p22), but start at the second
ORF start codon. It has been shown that amount of p22 and p19 depend on the length of 5’UTR
in sgRNA2 and the sequence context around the start codon. When longer 5’UTR was
constructed, more p22 was made, but when sequence context was made less favorable for p22
translation, the level of p19 increased (Johnston and Rochon, 1996).
4p33 and p92 are replicase proteins of tombusviruses
The tombusvirus proteins p33 and p92, expressed directly from gRNA, are membrane
associated (Rubino and Russo, 1998; Scholthof et al., 1995d). The p92 is a fusion protein made
via ribosomal readthrough mechanism of p33 translation termination amber codon and it is 20
times less abundant than p33 in virus infected cells (Scholthof et al., 1995d). The tombusvirus
replication studies using mutants of viral proteins showed that p92 and p33 are required for virus
replication (Molinari et al., 1998; Oster et al., 1998; Scholthof et al., 1995d) and subgenomic
RNA synthesis in vivo (Rubino et al., 1995; Scholthof et al., 1995d).
Amino acid comparison revealed the presence of GDD motif in p92 that is conserved
among RNA polymerases (O'Reilly and Kao, 1998) , suggesting that p92 functions as an RNA
dependent RNA polymerase. The GDD motif is located in readthrough domain of p92.
Mutations in GDD motif of Artichoke mottle crinkle virus (AMCV) p92 proteins abolished viral
replication in protoplasts (Molinari et al., 1998) and supported the role of p92 as RNA-dependent
RNA polymerase.
Comperative sequence analysis of p33 has not revealed any known motifs and the role of
p33 in virus infection has not been defined, but it was shown that p33 was necessary for virus
replication in vivo (Dalmay et al., 1993a; Kollar and Burgyan, 1994; Molinari et al., 1998; Oster
et al., 1998;  Scholthof et al., 1995b). To confirm that p33 was required for virus replication in
vivo, the UAG (amber) stop codon at the end of p33 sequence was changed to UAC or UAU
(encoding tyrosine). After this modification, only p92 was expressed from gRNA and virus
replication was completely abolished in protoplasts (Oster et al., 1998; Scholthof et al., 1995d).
These experiments showed that expression of p92 was not sufficient for virus replication,
although p33 sequence is present in N terminus of p92. When p33 protein was expressed in trans
from a defective interfering (DI) RNA in addtion to p92, viral RNA was amplified (Oster et al.,
1998) These results suggested that p33 was a part of viral replicase and that separate p33
expression was required for virus replication in vivo. Tombusvirus replicase purification studies
supported the above data, showing that purified active replicase contained both proteins, p92 and
p33 (Pogany and Nagy, unpublished).
 The presence of membrane localization domain in the N terminus of p33 suggested that
one of the roles of p33 in virus replication is membrane targeting of virus replication complex
5and formation of Multivesicular bodies (MVB) where virus replication likely occurs. It has been
shown that p36 (CIRV) and p33 (CymRSV) proteins caused proliferation of mitochondrial or
peroxisomal membranes, respectively (Rubino et al., 2000; Rubino and Russo, 1998a; Rubino et
al., 2001; Weber-Lotfi, 2002). The role of p33 in RNA and possibly p92 targeting to the
replication sites is supported by recent findings of RNA binding motif in p33 (Rajendran and
Nagy, 2003) and p33:p92 interaction domain located at the C terminus of p33 (Rajendran and
Nagy, in press)
Coat protein, p41
Tombusvirus coat protein sequence is located downstream from the ORFs coding for
replicase proteins. Therefore, the coat protein is expressed from sgRNA1. A single coat protein
is about 41kDa. Tombusvirus capsid is T=3 icosahedron composed of 180 coat protein
molecules (Russo et al., 1994). It has been shown that tombusvirus coat protein is not required
for virus replication and cell-to cell movement (Dalmay et al., 1993a; McLean et al., 1994; Qiu
and Scholthof, 2001), although mutations in coat protein delayed long distance movement and
symptom development (Dalmay et al., 1992).
The studies of CNV coat protein revealed that it is important in virion binding to fungal
vector Olpidium bornovanus zoospores, and it is involved in virus transmission (Kakani et al.,
2003; Kakani et al., 2001; Robbins et al., 1997). When TBSV (closely related to CNV, but vector
has not been found) CP was replaced with CNV CP, the chimeric virus was transmitted by O.
bornovanus zoospores, while gCNV contained particles within TBSV CP were not (Robbins et
al., 1997). This experiment showed that CP determines specificity of CNV and O. bornovanus
interaction. Further experiments with CNV CP mutants determined the critical amino acid
residues that were involved in virus binding to zoospores (Kakani et al., 2001). The searches of
possible receptor on fungus zoospores revealed that binding of virus to the zoospores occurs via
oligosaccharides containing mannose and/or fucose (Kakani et al., 2003).
Movement protein, p22
Tombusvirus movement protein p22, which is membrane associated, is encoded by ORF4
that is expressed from sgRNA2 (Scholthof et al., 1995b). The role of this protein is to facilitate
virus cell-to-cell movement (Dalmay et al., 1993a; Scholthof et al., 1995b). It has been shown
6that CyRSV mutants lacking movement protein were not detected in inoculated and systemic
leaves (Dalmay et al., 1993a).When movement protein was deleted from TBSV genome, the
virus replication in protoplasts was delayed by 1-2h when compared to wild type virus, but it did
not abolished virus replication (Qiu and Scholthof, 2001). These findings suggest that p22
protein is not critical for replication, but is important for virus movement. The recent finding of a
host factor from tobacco named Hfi22 that binds to p22 suggests that viral MP might interact
with host proteins to ensure virus intercellular movement (Desvoyes et al., 2002).
Suppressor of RNA silencing, p19
The p19 protein is encoded by ORF 5, and is expressed from sgRNA2.  Translation of
this protein occurs via leaky scanning mechanism, allowing virus to use the same portion of the
genome to encode two different proteins (p22 and p19).
The first studies of tombusviruses defined p19 as cytoplasmic protein, and virus symptom
determinant (Chu et al., 2000; Dalmay et al., 1993b; Scholthof et al., 1995a; Scholthof et al.,
1995b), because virus mutants lacking p19 induced milder symptoms in the plants in
comaparison to wild type.
As studies of post-transcriptional gene silencing (PTGS) advanced, it has been proposed
that p19 functions as viral suppressor of gene silencing (Qiu et al., 2002; Qu and Morris, 2002;
Voinnet et al., 1999). Further experiments (Silhavy et al., 2002) showed that p19 binds to
siRNAs produced during RNA silencing process. These siRNAs work as RNA silencing
induction signal and by binding to them p19 prevents the spread of the signal to the neighboring
cells. The latest studies of viral RNA silencing suppressors from TBSV (Ye et al., 2003) and
CIRV (Vargason et al., 2003) revealed the crystal structure of p19 protein bound to the 21nt long
siRNA. The studies confirmed that p19 binds with the highest affinity to the 20-22nt long RNAs,
but does not have sequence specificity. It has been proposed that the 21-22nt siRNAs are
involved in gene silencing by triggering degradation of mRNA with complementary sequence
(Vance and Vaucheret, 2001; Waterhouse et al., 2001). The viral protein’s ability to bind these
RNAs supports p19 role in preventing degradation of viral RNA without interfering with cell
processes that are regulated by longer microRNAs (Papp et al., 2003).
7Defective interfering (DI) RNAs
DI RNAs are small RNA molecules derived from genomic RNA (White and Morris,
1999) (Figure 1.2). DI RNAs do not encode replicase proteins, but have cis acting RNA elements
that are needed for replication. To be able to replicate they have to use the helper virus coded
replicase in trans (White and Morris, 1999). It has been shown that DI RNAs are associated with
several tombusviruses: TBSV(Hillman et al., 1987), CyRSV(Burgyan et al., 1991), CIRV
(Rubino et al., 1995) and CNV (Rochon, 1991). De novo generation of tombusvirus DI RNAs
accumulation was detected after passages at high multiplicity of infection (Burgyan et al., 1991;
Knorr et al., 1991; Rochon, 1991). Using reverse transcriptase PCR, DI RNAs were detected in
TBSV infected plants without passages (Law and Morris, 1994), suggesting that during passages
DI RNAs are amplified. But in naturally occurring field infections DI RNAs have not yet been
found (Celix et al., 1997).
It has been proposed that generation of DI RNAs occurs during virus replication via
series of deletions made by viral replicase (White and Morris, 1994b). DI RNAs are able to
replicate to high levels if introduced to the plant together with the helper virus. It was shown that
many DI RNAs reduce accumulation of helper virus significantly and lead to attenuation of
symptoms (Kollar et al., 1993; Rubio et al., 1999; Scholthof et al., 1995c).
DI RNAs associated with tombusviruses are about 400-600nt long RNA molecules
(White and Morris, 1994b).Prototypical tombusvirus DI RNA, termed DI-72 is composed of four
non-contigious regions (I to IV) derived from genomic RNA (White and Morris, 1994b; White
and Morris, 1999) (Figure 1.2). Regions I and IV are derived from 5’ and 3’ untranslated viral
genome sequences, respectively. Region I also includes start codon for p33 and p92. Region II
encompasses viral sequence just downstream from p33 stop codon within the p92 ORF. Region
III represents sequences from the upstream portion of 3’ UTR plus 3’end of p22 and p19 (White
and Morris, 1994b). The studies on the significance of each region showed that deletions of
regions II and IV abolished DI RNA replication in protoplasts (Chang et al., 1995), deletions of
region I reduced DI RNA accumulation about 90% (Wu and White, 1998). Although region III is
not essential for TBSV DI RNA replication (Chang et al., 1995), deletion of this region reduced
DI RNA accumulation about 10 fold (Ray and White, 1999). These studies suggested that cis
acting elements in different regions of DI RNA might have different roles in DI RNA replication.
8Studies on replication of DI RNAs revealed that promoter for (+) strand synthesis was
localized to 3’end of RI (-). In addition, structural domains of RNA, named T-shaped domain
(TDS) and downstream domain (DSD), separated by stem-loop (SL) 5 were defined within RI
(+) (Ray et al., 2003). These RNA structures likely function in (+) strand and are important for
DI RNA replication (Ray et al., 2003; Wu et al., 2001). When RI is deleted, DI RNA replication
is not abolished most likely due to sequences in 5’of RII that resemble (+) strand promoter
allowing low level of DI RNA replication (Wu and White, 1998). The role of RI (+) in virus
replication has not been defined but it could be that this region is involved in protection of DI
RNA (+) 5’end, interaction with viral and/or host proteins leading to replicase assembly, and/or
initiation of (+) strand synthesis.
Sequence analysis of RII revealed that it could form an extended hairpin structure, which
is critical for replication (Chang et al., 1995). The role of RII has not been determined, but it was
shown that duplication of this region increases the level of DI RNA accumulation in protoplasts
(White and Morris, 1994b). Recent studies indicate that RII (+) hairpin is involved in viral
replicase binding, possibly leading to viral RNA recruitment and replicase complex assembly
(Pogany and Nagy, unpublished).
The studies of RIII (-) revealed that it has two stem-loop structures separated by a single
stranded region (Ray and White, 2003), can function in both orientations, preferably as a single
copy, and that DI RNAs without RIII tend to form head –to- tail dimers (Ray and White, 1999).
The extensive RIII studies in vivo (Ray and White, 1999; Ray and White, 2003) and in vitro
(Panavas and Nagy, 2003a) suggested that RIII functions as replication enchancer on the minus
strand. In addition it was shown that this region could be used by CNV replicase in
recombination as donor or acceptor in in vitro assay (Cheng and Nagy, 2003).
The role of RIV in viral replication has been extensively studied in vivo and in vitro. It
has been shown that region IV(+) of DI RNA has promoter (termed gPR) at the  3’end that is
critical for (-) strand synthesis (Fabian et al., 2003; Panavas et al., 2002a). Solution structure
mapping of secondary structures within RIV(+) revealed three stem- loop structures (SL1, SL2,
SL3) and ssRNA region (Fabian et al., 2003). Further analysis in vivo and in vitro revealed that
SL3 is critical for replication, and it contains a sequence that can interact with gPR and inhibit (-)
strand synthesis (Pogany et al., 2003). The 5nt sequence in SL3 complementary to gPR, was
named replication silencer (Pogany et al., 2003).While gPR includes SL1, which is important for
9(-) strand initiation, the role of SL2 has not been defined, but mutational analysis in vivo
suggested that it is important for virus replication (Fabian et al., 2003).
Overall, the ability of DI RNAs to replicate very efficiently, via utilizing helper virus
replication machinery, makes them a very useful tool for studying viral RNA elements involved
in replication and recombination.
Satelite (sat) RNAs
In addition to DI RNAs, tombusviruses can be associated with other type of subviral
RNAs, termed satellite (sat) RNAs (Celix et al., 1997; Rubino et al., 1990), which are RNA
molecules that require helper virus for their replication. In contrast to DI RNAs, satRNAs do not
have significant sequence homology with the helper virus gRNA (reviewed by A.E. Simon,
1999). The first of a tombusvirus satellite RNA was found in association with CymRSV (Rubino
et al., 1990), followed by identification of satRNA B1 (822nt) and B10 (612nt) in Nicotiana
clevelandii after serial passages at high multiplicity of TBSV field isolates (Celix et al., 1997). It
was shown that B10 satRNA attenuated symptom appearance in infected plants, while plants
infected with B1 satRNA showed the same symptoms as infected with TBSV alone (Celix et al.,
1997). Sequence comparison of satRNAs revealed that satRNAs associated with CymRSV and
TBSV do not share significant sequence identity between each other (Celix et al., 1997), but
there is an internal segment about 50nt long that is identical with the 3’portion of helper virus 5’
UTR. RNA structure mapping showed that 5’ends of sat RNAs can form structures similar to
TSD found in RI (+) of DI RNAs and helper virus genomes (Wu et al., 2001). These features
imply that these identical sequences and similar structures could be critical for viral RNA
accumulation.
What the thesis will show
The objectives of this work were to study the roles of a previously defined RNA binding
motif of the replicase proteins of tombusvirus (CNV) and regions within DI RNA in replication
and recombination of tombusviruses, as well as viral components necessary for active CNV
replicase formation.
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Chapter 2 will provide background information on tombusvirus replication, followed by
experimental results defining the role of an RNA binding motif of CNV replicase proteins in
RNA binding, virus replication and subgenomic RNA synthesis. Chapter 3 will describe
recombination studies in protoplasts, which were used for revealing the role of the RNA binding
motif in recombination of tombusvirus RNA. Chapter 4 will introduce tombusvirus replication
system in yeast, a model host, followed by description of functional CNV replicase isolation
procedure that was used to define viral elements required for enchancement of replicase activity.
At the end of the thesis (chapter 5), I will discuss the possible impact of these studies on
revealing the roles of replicase proteins and the viral RNA in tombusvirus replication,
recombination and active replicase assembly.
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Figure 1.1: Genome organization of Tomato bushy stunt virus (TBSV). Coding sequencies are
shown as boxes. Expressed ORFs are represented as white boxes with protein (p) molecular mass
(in kDa) and functions written in the box (RdRp- RNA dependent RNA polymerase; CP-coat
protein; RSS- RNA silencing suppressor; MP- movement protein); non-expressed ORFs are
shown as black boxes. Bellow genomic (g)RNA are shown TBSV subgenomic (sg)RNAs. The
length of all three RNAs is in kilobases (kb).
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Figure 1.2: Genome representation of TBSV genomic (g)RNA and DI RNA. The boxes in the
gRNA represent coding sequences; the lines –non- coding RNA sequences. The sequences of
gRNA present in DI RNA (regions RI through RIV) are enlarged and shown as boxes in DI RNA
scheme.
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Chapter Two
The overlapping RNA-binding domains of p33 and p92 replicase proteins are
essential for tombusvirus replication
Introduction
Replication of RNA viruses in infected cells is performed by the viral replicase in a
multi-step process. During the first step viral replicase proteins are translated from genomic
RNA.  Then replicase complex has to form to allow efficient viral RNA amplification. The
replicase complex includes the viral-coded RNA-dependent RNA polymerase (RdRp),
additional viral replicase protein(s) and host factors (Ahlquist et al., 2003; Buck, 1996; Buck,
1999; Diez et al., 2000; Lai, 1998; Noueiry et al., 2000; Quadt et al., 1993). Viral replicase
complex has to be recruited to the site of replication, possibly forming membranous
multivesicular bodies (MVB). In addition, the viral genomic RNA must also be recruited to the
viral replicase complex (Ahlquist, 2002; Buck, 1996; Buck, 1999). After the assembly of the
replicase complex and the recruitment of the viral genomic RNA, a complementary (minus-
strand) RNA is made. This is followed by the synthesis of many plus-strand RNAs utilizing the
minus-strand intermediates with (+) strands accumulation reaching up to 100 times higher level
than (-) strand (Panavas T., PoganyJ. and P.D. Nagy, unpublished).
Interestingly, tombusviruses are frequently associated with defective interfering (DI)
RNAs that are derived entirely from the genomic RNA. The most frequently occurring DI RNAs
contain three or four short noncontiguous segments of the genomic RNA (Burgyan et al., 1991;
Chang et al., 1995; Finnen and Rochon, 1993; Hillman et al., 1987; White and Morris, 1999)
(Figure 1.2). DI RNAs replicate efficiently with the help of the tombusvirus replicase, therefore
they are useful to study replication in vivo and in vitro (Nagy and Pogany, 2000a; Panavas et al.,
2002a; White and Morris, 1999).
The replication of tombusviruses is a very efficient process that requires interaction
between replicase proteins p33 and p92, as well as viral RNA and most likely host proteins. The
finding that both p33 and p92 are required for virus replication suggests that these proteins
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might interact between themselves. In addition, the ability of replicase proteins to replicate viral
RNA implies that these proteins have to bind the RNA as well.
Recently it has been shown using purified recombinant TBSV replicase proteins in
surface plasmon resonance (SPR) assay that p33 can interact with p92 as well as with other p33
molecules, but not with maltose binding protein (MBP) (Rajendran and Nagy, in press). More
detailed studies revealed that protein- protein interaction domain is localized in the C-terminus
of p33 (Rajendran and Nagy, in press). The analysis of the partially purified CNV replicase from
plants supports this data, because in purified active replicase both p33 and p92 proteins were
detected (Pogany and Nagy, unpublished)
The ability of the replicase proteins to bind to tombusvirus RNA was studied using gel
mobility-shift assay and SPR (Rajendran and Nagy, 2003). These experiments revealed that: 1)
both p33 and p92 could bind to tombusvirus RNAs in vitro; 2) p33 binds RNA in a cooperative
manner (Rajendran and Nagy, 2003). Further studies performed with deletion derivatives of p33
expressed in E. coli as MBP fusion revealed that an arginine/proline-rich (the sequence in
RPRRRP) motif (termed RPR motif), which is conserved among tombusviruses and related
carmoviruses, is critical for efficient RNA binding (Rajendran and Nagy, 2003). The
corresponding region in the overlapping domain of p92 may also bind to RNA, although this has
not been confirmed yet. This is because p92 has two more RNA-binding domains within its
unique C-terminal region (Rajendran and Nagy, 2003) therefore mutations within the RPR motif
in p92 did not abolish RNA binding.
In this chapter I demonstrate that the RPR motif is essential for tombusvirus replication
in vivo. Detailed site-specific mutagenesis of the RPR motif revealed that two of the four
arginines within the RPR are critical for virus replication in protoplasts and for RNA binding in
vitro.I also demonstrate that the RPR motif is essential for the replication function of both p33
and p92. This was achieved by using a two-component system, in which p92 was expressed
from the viral genomic RNA and p33 was expressed from a DI RNA (Oster et al., 1998). I found
that mutations within the RPR in either p33 or p92 inhibited replication in the above two-
component system. The non-replicating DI RNAs carrying mutated p33 could be rendered
replication-competent in the presence of the wild type (WT) tombusvirus RNA, excluding the
possibility that the mutations debilitated the ability of the DI RNA to replicate. Overall, these
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experiments supply direct evidence that functional RPR motif in both p33 and p92 is essential
for replication.
Materials and methods
Site directed mutagenesis of CNV (pK2M5)
A full-length cDNA clone of CNV, named pK2M5 (Rochon and Johnston, 1991), was
used to generate the RPR motif mutants of p33/p92 listed in Figure 2.2.A. Mutagenesis was
performed by PCR using the QuickChange XL Site-Directed Mutagenesis Kit (Stratagene). The
PCR reactions included the Pfu Turbo DNA polymerase, different set of primer pairs designed
for each mutant (see Table 2.1) and 40 ng of pK2M5 DNA as a template. PCR products were
digested with DpnI, to remove template DNA before transformation into E. coli (DH5a). The
presence of the desired mutations was confirmed by sequencing with primer 27 (5’-
GTATTTCACACCAAGGGAC-3’).
The series of p92Y constructs, containing mutated or WT RPR motif (Figure 2.7), were
obtained by replacing the EagI to NsiI (positions 998 and 1650 in the p92 ORF) fragment with
the corresponding mutated fragment of Mal/p92 (Rajendran and Nagy, 2003), containing a stop
codon to tyrosine codon mutation at the end of the p33 gene. The presence of tyrosine mutation
was confirmed in each clone by sequencing, using primer 631 (5’-
GAGGAATTCAAGGTAATTGCGTCCACA-3’). For the construction of DI-p33 series of
mutants (Figure 2.6), we used construct DI-83CNV (a generous gift of Andy White) (Oster et
al., 1998). Each full-length RPR-motif mutant of CNV was digested with StuI and SphI and the
DNA fragment containing the p33 sequence was used to replace the corresponding sequence in
DI-83CNV.
For the gel shift experiments, we used either full-length or a truncated version of the p33
protein that were fused to MBP (vector pMal-c2X, New England Biolabs). To make the p33
expression constructs, containing WT or each of the mutated RPR motif shown in Figure 2.2.A,
we amplified a 90 nt-long fragment of the p33 gene (positions 616-705 in the p92 ORF) that
represent a 30 amino acid long region including the RPR-motif by PCR using primers 631 (5’-
GAGGAATTCAAGGTAATTGCGTCCACA-3’)  and  632  (5’ -GAGTCTA
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GACTACTTCAGGTAACCCACCTT-3’) with Deep Vent polymerase (New England Biolabs).
The templates for the PCR were WT or mutated pK2M5 DNA (see above). The PCR fragments
were digested with EcoRI and XbaI, gel isolated and ligated into the similarly treated pMal-c2X
vector.
To generate constructs expressing full-length p33 fused with MBP (Figure 2.1 and 2.3), the
WT or mutant p33 sequences were PCR amplified with primers #25 (5’-GGA GTC TAG AGA
T A C  C A T  C A A  G A G  G A T  G - 3 ’ )  a n d  # 9 9 2 B   ( 5 ’ -
GAGCTGCAGCTATTTCACACCAAGGGA-3’) using Deep Vent polymerase (see above). The
PCR products were digested with XbaI and PstI and cloned into pMAL-c2 vector to generate in
frame MBP-p33 fusion.  To obtain the expression construct DRPR (Figure 2.1), we amplified the
5’ portion and the 3’ portion of the CNV p33 gene separately using either primer pairs #25
(above) and #994B  (5’-CCGCGCTAGCTCCTGTGGACGCAATTACCT-3’) or #993B (5’-
GCGGGCTAGCTATGCAGCTAAGATTGCACA-3’) and #992 (above). The PCR product
representing the 5' portion of the p33 gene was digested with XbaI and NheI, while the PCR
product representing the 3’ portion of the p33 gene was digested with NheI and PstI. Both PCR
products were cloned into pMAL-c2, which had been digested with PstI and XbaI, in a three-
piece ligation reaction. The clones were sequenced to validate their correctness. 
Preparation of RNA transcripts
RNA transcripts were obtained using SmaI linearized WT pK2M5, mutated pK2M5, DI-
72, DI-73 and DI-p33 (original name is DI-83CNV, (Oster et al., 1998) clones in a standard
transcription reaction with T7 RNA polymerase (Nagy et al., 1999). Template DNA was
removed by DNase I, followed by purification of the RNA transcript with phenol/chloroform
extraction and 95% ethanol precipitation. The pellet was washed three times with 70% ethanol
to remove residual salts. The RNA transcripts were quantified by UV spectrophotometer
(Beckman), followed by 1% agarose gel electrophoresis.
Purification of full-length and truncated p33-MBP fusion protein from E. coli
The protein expression for each p33 RPR-motif mutant as an MBP fusion protein (Figure
2.2.A) was induced at 37 0C by IPTG in Epicurian BL21-Codon plus (DE3)-RIL cells
(Stratagene) as recommended by the supplier. After 2 hours of induction, the cells were
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harvested and processed as described by (Rajendran et al., 2002). Briefly, the bacterial cells
were resuspended in column buffer (20mM Tris-HCl, pH8.0; 25mM NaCl; 1mM EDTA, pH8.0;
10mM b-mercaptoethanol), sonicated and after centrifugation the supernatant was applied to
equilibrated amylose column (New England Biolabs). Following the wash with column buffer,
the proteins were eluted from the amylose column with column buffer containing 10mM
maltose. All steps were carried out on ice or in the cold room. The quality of the proteins
obtained was checked by 10% SDS-PAGE analysis and their amounts were measured as
described by (Rajendran et al., 2002). The RNA-binding studies (see below) were done with the
fusion proteins.
In vitro RNA binding studies
The RNA probe in the gel shift experiments was the 169 nt region I (+) of DI-72 (White
and Morris, 1994), which was labeled with 32P UTP using T7 RNA polymerase in vitro reaction.
The amount of 32P UTP was 100 fold less than unlabeled UTP (Rajendran et al., 2002). The gel
shift experiments were performed according to Rajendran et al., (2002). Briefly, ~2 ng of 32P
UTP labeled RNA was mixed with 1 mg of the p33-MBP preparation for 15 min at 25 0C in the
presence of 50 mM Tris-HCl, pH 8.2, 10 mM MgCl2, and 10 mM DTT, 10% glycerol, 2.4U
RNase inhibitor and 100ng tRNA. The samples were analyzed by electrophoresis on native 4%
polyacrylamide gels run at 200V for 50 min at 4 0C in TAE buffer. Dried gels were analyzed
using a phosphorimager.
Preparation of protoplasts
N. benthamiana protoplasts were prepared from callus cells by treatment with 0.5 g
cellulysin and 0.1g macerase (Calbiochem) in 50 ml protoplast incubation media (Kong et al.,
1997; Nagy et al., 1999; Nagy et al., 2001) for 4.5h with gentle shaking at 25 0C. After
incubation, the protoplasts were filtrated through sieve set and a sterile nylon cloth. The
protoplasts were washed twice with 0.5M mannitol and once with the electroporation buffer (10
mM HEPES, 10 mM NaCl, 120 mM KCl, 4 mM CaCl2, 200 mM mannitol). 5¥10
5 protoplasts
were electroporated with either 2µg in vitro transcribed gCNV RNA or the combination of 2µg
gCNV RNA and 1µg DI-72 RNA. In the two-component studies (Figs. 2.6-2.7), we used 4µg of
p92Y and  2µg of DI-p33 RNA transcripts. Electroporation was done using Gene pulser II
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(Biorad, the settings were at 0.2kV voltage and 0.5µF capacity). After electroporation, samples
were kept on ice for 30 min, followed by adding 1.8 ml protoplast culture medium (Kong et al.,
1997) to each sample. Protoplasts were incubated in 35¥10 mm petri dishes in the dark for 24-
48h at 22 0C.
Total RNA extraction from protoplasts and RNA analysis
Total RNA was extracted using the phenol/chloroform-based method of Kong et al.,
(1997) and Nagy et al., (2001). For Northern blot analysis, the total RNA was treated with
formamide at 850C, followed by agarose gel electrophoresis (0.8% for gCNV RNA and 1.2% for
DI RNA). After electrophoresis, the RNA was transferred by electrotransfer to Hybond-XL
membrane (Amersham-Pharmacia) and hybridized with gCNV- or DI-72 specific probes in
ULTRAhyb hybridization buffer at 680C using the conditions recommended by the supplier
(Ambion). The probes were prepared by T7 RNA polymerase in an in vitro transcription
reaction in the presence of [a-32P] UTP using PCR amplified DNA templates that were obtained
by using primers 16 (5’-GTAATA CGACTCACTATAGGGCTGCATTTCTGCAATGTTC-3’)
and 312 (5’-GCTGTCAGTCTAGTGGA-3’) for the gCNV and primers 15 (5’-GTAATACG
ACTCACTATAGGGCATGTCGCTTGTTTGTTG-3’) and 20 (5’-GGAAATT
CTCCAGGATTTCTC-3’) for DI-72 RNA. These probes are complementary to the 3’-terminal
200  nt of gCNV RNA and the 5’ 169 nt of DI-72 RNA, respectively.
RT-PCR analysis of gCNV RNA from protoplasts
We tested the stability of the RPR-motif mutants of gCNV during virus replication in
protoplasts by sequencing the RT-PCR products obtained from total RNA samples using primers
27 (5’-GTATTTCACACCAAGGGAC-3’) for RT and primers 213 (5’-
GAGGATGAAAGGGAATTCACGGATT GTTTGG-3’) and 27 for the PCR reaction. The RT-
PCR products were gel purified before sequencing, which was performed by using primer 27
(see above).
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Results
Essential role for the arginines of the arginine/prolin-rich motif in RNA-binding in vitro.
The RPR motif present in both p33 and p92 of Tomato bushy stunt virus (TBSV) and
Cucumber necrosis virus (CNV) (Figure 2.1A) contains two prolines and four arginines that are
the primary candidates to bind to the negatively charged viral RNA (the actual sequence of the
RPR motif is R637P640R643R646R649P652, (Rajendran and Nagy, 2003)). Accordingly, deletion of
the entire RPR motif from the full-length p33 of CNV (see construct DRPR, Figure 2.1)
inhibited the in vitro RNA binding activity of DRPR (expressed and purified from E. coli, see
below) by ~80% when compared to the full-length WT p33 protein (Figure 2.1C). Since the
level of expression of the WT p33 is low in E. coli and it also shows poor solubility (not shown),
we expressed a 30 amino acid-long region of p33 (which was fused to the maltose-binding
protein, MBP), including the RPR motif in E. coli. This 30 amino acid-long region of p33 was
demonstrated earlier to bind RNA efficiently (Figure 2.2 and (Rajendran and Nagy, 2003)). To
test which amino acids within the RPR motif play an important role in RNA-binding, we have
generated 19 mutants of the CNV p33 that had one or more altered amino acids within the RPR
motif (see Figure 2.2A). One set of mutants contained one, two or three alanine mutations
replacing either arginines or prolines. The second set of mutants contained arginine to lysine
mutations, which maintained the positive charge of the RPR motif. The third set of mutants had
one, two or three of the arginines deleted. The fourth set of mutants contained one or two extra
arginines that increased the overall positive charge of the RPR domain. The purified truncated
p33-MBP fusion proteins carrying one of the 19 mutations or the WT sequence within the RPR
motif were used in similar amounts in gel mobility-shift assays in combination with the 5’ 169
nt segment of DI-72 RNA, a prototypical DI RNA (White and Morris, 1994b). These
experiments demonstrated that replacing the first proline (P640 in construct P640-A, lane 2, Figure
2.2A) or the second proline (P652 in construct P652-A, lane 3, Figure 2.2A) with alanines did not
alter the ability of the truncated p33 to bind RNA by more than 10% when compared to the
truncated p33 carrying the WT RPR motif (construct WT, Figure 2.2B-C). Substitution of
alanines for both prolines (P640 and P652 in construct P640-652-A, lane 4, Figure 2.2A), however,
decreased RNA-binding by ~30%. In contrast, replacing either or both of the prolines with
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arginine(s) increased RNA-binding by 2.5 to 3-fold when compared to WT (constructs P640-R,
P652-R and P640-652-R, lanes 5-7, Figure 2.2A-C).
Separate substitutions of each arginine with alanines in the RPR motif resulted in 30-
50% decrease in RNA-binding when compared to WT (constructs R637-A, R643-A, R646-A and
R649-A, lanes 1, 8, 10, 12 in Figure 2.2A). Combined replacement of three of the arginines
(second, third and the fourth arginines in the RPR motif, i.e., R643, R646, and R649) with alanines
decreased RNA-binding by 42% (construct R643-649-A, lane 19 in Figure 2.2A-C). Similarly,
deletion of one, two or three of the arginines reduced RNA-binding significantly (by ~40 to
60%, see constructs DR, D2R and D3R, lanes 16-18 in Figure 2.2A-C). On the contrary, single
lysine substitutions for the second or fourth arginines within the RPR motif (mutants R643-K and
R649-K, lanes 9 and 13 in Figure 2.2A-C) increased RNA-binding by 32 and 280%, while similar
substitution at the third arginine (mutant R646-K, lane 11 in Figure 2.2A-C) actually decreased
RNA-binding by ~40%. This suggests that the third arginine (R646) within the RPR motif is
important for RNA-binding and even the positively charged lysine is detrimental in that
location. Insertion of one or two arginines into the RPR motif did not increase RNA-binding by
more than 10-20% (mutants R643+R and R643+2R, lanes 14 and 15 in Figure 2.2A-C). Overall,
these in vitro experiments suggest that the arginines in the RPR motif play important roles in
RNA-binding.
Since the above RNA binding studies included a 30 amino acid fragment of p33, it is
possible that the RPR motif mutations (Figure 2.2A-C) may have different roles and/or
structures when present in the full-length p33. Therefore, I expressed three RPR motif mutants,
namely P652-A, R649-K and R643-649-A (see constructs # 3, 13 and 19 in Figure 2.2A), as full-
length p33 proteins fused to the MBP domain (Figure 2.3). Due to the difficulty of obtaining
large amounts of purified full-length proteins (unlike in the case of the truncated p33), I used
reduced but comparable amounts of these proteins and the WT p33 in the gel shift experiments
(Figure 2.3). Quantification of the bound RNA to the full-length p33 revealed that mutation P652-
A showed activity that was comparable to that of the full-length WT p33, while R649-K bound
65% better and R643-649-A bound only at 45% reduced level of the WT p33 (Figure 2.3A-B).
Comparison of the data obtained with the RPR motif mutations present either in the full-length
or the truncated p33 showed a similar trend in the overall effect on the RNA binding activities of
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these RPR motif mutations (Figure 2.2 and 2.3). Therefore, I suggest that the sequences within
the RPR motif in p33 play major roles in RNA binding.
The arginine/proline-rich RNA-binding motif is essential for tombusvirus replication in
protoplast.
To test whether the RPR motif plays an essential role during tombusvirus replication, I
introduced the above RPR motif mutations into the full-length genomic CNV (gCNV) RNA (see
Materials and Methods). Note that due to the expression strategy of CNV, both p33 and p92
should carry the same RPR motif mutation during infection (see below). First, tombusvirus
replication was tested in cis (i.e., the mutations were present on the replicating gCNV RNA) in
Nicotiana benthamiana protoplasts after electroproration of the in vitro transcribed full-length
gCNV RNA transcripts. Second, I also tested the ability of the RPR motif mutants of CNV to
support trans-replication (i.e., the replication of DI-72 RNA that must use p33/p92 in trans for
its replication) by using co-electroporation of the mutated gCNV RNA transcript and the WT
DI-72 RNA. It is well established that the TBSV-associated DI-72 RNA can use the replicase
proteins generated by the CNV helper virus for replication (Oster et al., 1998; White and Morris,
1994b). The accumulation of gCNV RNA and DI-72 RNA in protoplasts was studied using
Northern blot with CNV-specific and DI RNA-specific probes, respectively. The amounts of
total RNA loaded on gels were adjusted based on the host ribosomal RNA (Figures 2.4-2.5A).
The protoplasts experiments revealed that seven of the nineteen RPR mutants supported
gCNV RNA accumulation in cis and DI RNA replication in trans at 50 to 95% of the WT level
(constructs R637-A, P640-A, P652-A, P640-652-A, P640-R, R649-A and R649-K, lanes 1-5 and 12-13,
Figures 2.4A-C and 2.5). Interestingly, several of the above mutants supported trans-replication
of the DI RNA with 10-to 20% higher efficiency than the level of cis-replication of the
corresponding mutant gCNV. These data suggest that none of these four amino acids (i.e., R637,
P640, R649
 and P652) within the RPR motif is essential for cis- or t rans-replication of
tombusviruses in protoplast. In contrast, replacing the third arginines (R646) with alanine reduced
gCNV and DI-72 RNA replication by over 90% (mutant R646-A, lane 10 in Figures 2.4A-C and
2.5), suggesting that this arginine is important for tombusvirus replication. Replacement of the
second arginine (R643) with alanine reduced gCNV RNA replication by 80%, but affected DI
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RNA replication by 10% only (mutant R643-A, lane 8 in Figures 2.4A-C and 2.5), suggesting that
the second arginine is more important for cis-replication than for trans-replication.
The essential role for the arginines within the RPR motif for tombusvirus replication was
further supported by the observation that combined replacement of three of the arginines (the
second, third and the fourth, i.e., R643, R646 and R649, see mutant R643-649-A, lane 19 in Fig. 4A-C
and 5) with alanines completely abolished tombusvirus and DI RNA replication. Interestingly,
replacing separately the two important arginines (the second and third arginines, mutants R643-K
and R646-K, lanes 9 and 11, Figures 2.4A-C and 2.5) with lysines decreased tombusvirus or DI
RNA replication by 95 to 98%. This is somewhat surprising since both lysine and arginine are
positively charged. In contrast, the lysine for arginine substitution at the fourth arginine position
in the RPR motif had smaller effect on virus replication (50% of that of WT, see construct R649-
K, lane 13, Figure 2.4A-C), further indicating that this arginine may not be essential for
tombusvirus and DI RNA replication.
To test if the number of arginines within the RPR motif is important for tombusvirus
replication, first I used insertion mutants that contained one or two extra arginines between the
two prolines in the RPR motif (see mutants R643+R and R643+2R in Figure 2.2A). Mutant R643+R
with one extra arginine supported gCNV and DI-72 RNA replication only at a reduced
efficiency (~5%, lane 14, Figures 2.4A-C and 2.5), while addition of two extra arginines in
mutant R643+2R abolished tombusvirus or DI RNA accumulation completely (Figures 2.4A-C
and 2.5, lanes 14 and 15). The second set of constructs had deletion of one, two or three
arginines in the RPR motif that resulted in complete inhibition of tombusvirus replication
(Figures 2.4A-C and 2.5, mutants DR, D2R and D3R, lanes 16-18,). The third set of mutants
carried proline to arginine mutations that did not alter the length of the RPR motif (see mutants
P640-R, P652-R and P640-652-R, Figure 2.2A). Interestingly, one of the mutants supported gCNV
replication at 60% of WT level, although the replication of DI-72 RNA was somewhat less
efficient (Figures 2.4A-B and 2.5A-B, lane 5, 20% of WT level). The two other mutants
replicated poorly in protoplast (5-10%)(Figures 2.4 and 2.5A-B, lanes 6-7). The data obtained
with these deletion, insertion and replacement mutants indicate that, in general, the number of
arginines in the WT RPR motif is optimal for tombusvirus replication.
I also tested if the relative accumulation of subgenomic (sg)RNAs (i.e., the ratio between
the sg1 and sg2 RNAs versus gCNV) was different with all the above mutants in comparison
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with the WT in protoplast. Four mutants, including R643-A, R643-K, R646-K and R643+R,
supported the relative accumulation sg2 RNA at 4 to 20-fold higher level than the WT did
(Figure 2.4C, lanes 8, 9, 11, 14). The increase in the relative accumulation of sg1 was much less
pronounced (between 2 to 4-fold, Figure 2.4C, lanes 8, 9, 11, 14) with these four mutants. In
contrast, mutant P640-652-A generated sg2 RNA less efficiently (drop of 40% in relative
accumulation) than the WT did (Figure 2.4A-C, lane 4). The difference in the ratio of sg2/gCNV
between P640-652-A and WT is significant after both 24 and 48 hours incubation and we
confirmed this by repeating the experiment two times (not shown). Overall, this observation
suggests that mutations within the RPR motif can affect subgenomic RNA
synthesis/accumulation.
It is possible that unwanted mutations are introduced during the in vitro mutagenesis, in
spite of the use of the high fidelity Pfu Turbo DNA polymerase to introduce the site-directed
mutations (see Materials and Methods). However, sequencing of a 500-600 nt region around the
targeted RPR motif mutations did not reveal any mutated positions, except the target ones (not
shown). Also, we used two independently generated clones for P652-R, R643-649-A and D3R in the
protoplast experiments, which in each case, gave results comparable to that shown in Figure
2.4A (lanes 6, 18 and 19), i.e. poor accumulation for P652-R, and undetectable level of
accumulation in case of R643-649-A and D3R (not shown). Since it is very unlikely that the proven
mutagenesis method used in this work (see Materials and Methods) would introduce the same
second-site mutation for two separate clones, we conclude that the effect on the reduction of
CNV RNA accumulation is due to specific targeted mutations introduced into the RPR motif.
Since RNA viruses can accumulate mutations quickly during infection, we have tested
stability of the mutated gCNV RNA for the twelve constructs that supported gCNV replication
at detectable levels. This was done by RT-PCR, followed by sequencing (in the vicinity of the
RPR motif) of the progeny gCNV RNA obtained from protoplasts 48 hours after
electroporation. These experiments confirmed that the original mutations in the RPR motif were
stably maintained during the course of infection (not shown). This observation suggests that the
original mutated p33/p92 proteins and not putative revertants or WT contaminants were
responsible for supporting tombusvirus replication in protoplast (Figures 2.4A-C and 2.5).
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Essential role for the RPR motif in p33 during tombusvirus replication in protoplast.
Although the above experiments demonstrated that the RPR motif plays an essential role
in tombusvirus replication, due to the overlapping domains in p33 and p92, they could not
answer whether the RPR motif is important for the function(s) of p33, p92 or both. To test this
question, we used a two-component, complementation-based tombusvirus replication system
developed by Oster et al., (1998). Briefly, in the two-component system, the p92 is expressed
from the gCNV RNA that carries a tyrosine mutation eliminating the p33 termination codon
(Figure 2.6A, construct p92Y). Since it cannot express p33, construct p92Y alone is not able to
replicate in protoplast, confirming that p33 is not expressed (Figure 2.6B, lane 20, and Oster et
al., 1998). The function of the second RNA, which is based on DI RNA, is to supply the p33 in
the two-component system (Figure 2.6A). This RNA, which we name DI-p33 RNA, is not able
to replicate in protoplast when present alone (Figure 2.6B, lane 21, and Oster et al., 1998). Co-
infection of p92Y and DI-p33 RNA into protoplast, however, leads to replication of DI-p33
RNA, while construct p92Y can only replicate poorly (at a level close to the detection limit,
Figure 2.6B, lane WT, and Oster et al., 1998), but apparently it can supply enough p92 to
support the efficient replication of DI-p33 RNA in trans.
To test the role of the RPR motif in p33 in tombusvirus replication, we made a series of
DI-p33 RNA mutants that included nine of the above RPR mutants (Figure 2.2A and Figure
2.6B). After co-electroporation of N. benthamiana protoplasts with construct p92Y and each of
the DI-p33 RNA mutants, we tested the level of accumulation of DI-p33 RNA by Northern
blotting (Figure 2.6B). The accumulation of three of the DI-p33 RNA mutants was not detected
in this assay. These were the mutants with the third arginine being replaced with either alanine
or lysine (Figure 2.6B, lanes 11-12 and 17-18, mutants R646-A and R646-K,) and the combined
replacement mutant that carried three alanines in the place of arginines (Figure 2.6B, lanes 13-
14, construct R643-649-A). The DI-p33 RNA mutant with the two prolines within the RPR motif
being replaced with alanines (Figure 2.6B, lanes 7-8, construct P640-652-A) accumulated poorly
(10% of WT level) in protoplast. In contrast, mutants R637-A, P652-A, P640-R and P640-A (Figure
2.6B-C, lanes 1-4, 9-10 and 15-16) accumulated to ~50% of WT level, while mutant R649-K
(Figure 2.6B-C, lanes 5-6) reached accumulation level comparable to WT (Figure 2.6B-C, lanes
25
WT). Overall, these experiments strongly support that the RPR motif in p33 is essential for
replication of tombusviruses.
To rule out that the above RPR motif mutants in DI-p33 have a defect in RNA
replication due to the altered RNA sequence within the RPR motif, we conducted
complementation studies in protoplasts after co-electroporation of the mutated DI-p33 RNA and
the full-length gCNV helper, which expressed both WT p33 and WT p92. For the
complementation studies, we selected mutants, P640-652-A, R646-A, R646-K and R643-649-A, which
did not replicate or replicated poorly and mutant R649-K that replicated efficiently in the DI-
p33/p92Y-based two-component system (Figure 2.6B-C). Northern blot analysis of the total
RNA extract of the co-inoculated protoplasts revealed that all the 5 tested DI-p33 mutants
replicated at comparable levels to the WT DI-p33 in the presence of the WT gCNV helper virus
after 48 hours of incubation in protoplast (compare lanes 1-10 versus lane WT in Figure 2.6D).
These data demonstrate that the DI-p33 mutants can be complemented in trans by the WT p33
expressed from the gCNV RNA. Therefore, it is unlikely that the RNA genomes of the DI-p33
mutants tested in this work have a cis-acting replication defect due to the altered sequence in the
RPR motif.
The RPR motif of p92 affects trans-replication of DI RNA in protoplast.
To test the role of the RPR motif in p92 in tombusvirus replication, we also used the
p92Y/DI-p33 complementation system (Figure 2.7A). For these experiments, we made a series
of p92Y RNA mutants (Figure 2.7B), similar to the ones tested for p33 in DI-p33 (Figure 2.6B).
After co-electroporation of N. benthamiana protoplasts with each of the p92Y RPR motif
mutants and the WT DI-p33 RNA, we tested the level of accumulation of DI-p33 RNA by
Northern blotting (Figure 2.7B). These experiments revealed that one of the RPR mutants of
p92Y, namely construct R643-649-A with three arginine-to-alanine changes (Figure 2.7B-C, lanes
13-14), did not support the replication of DI-p33 RNA at a detectable level. Another mutant,
namely construct P640-652-A with the two prolines being replaced with alanines (Figure 2.7B-C,
lanes 7-8), supported tombusvirus accumulation at a very low level (2.5 % of WT). Substitution
of alanine for arginine in construct R646-A also reduced tombusvirus accumulation by 70%
(Figure 2.7B-C, lanes 11-12). The other six mutants of p92Y tested supported tombusvirus
accumulation efficiently (75-85% of WT, Figure 2.7B-C). Overall, the observation that one of
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the tested p92Y mutants did not support tombusvirus replication confirms that the RPR motif in
p92 is essential for tombusvirus replication. The data also suggest that the role of the RPR motif
is different in p33 than in p92, since two p33 mutants carrying either alanine or lysine
substitutions at position R646
 (namely DI-p33/R646-A and R646-K) did not support tombusvirus
replication at detectable levels (Figure 2.6B-C, lanes 11-12 and 17-18), while the corresponding
p92Y mutants did support DI-p33 replication  (Figure 2.7B-C, lanes 11-12 and 17-18).
Discussion
The replication process of tombusviruses is currently not yet fully understood. The p92
protein that is expressed from the genomic RNA by a ribosomal readthrough mechanism due to
leaky termination at the end of the p33 ORF (Scholthof et al., 1995d), contains the signature
motifs of viral RdRp within its unique C-terminal region. In contrast, the role of the essential
p33 protein in tombusvirus replication is currently unknown. We have recently demonstrated
that the C-terminal portion of p33 and the corresponding region of p92 contain an RPR motif
that is involved in RNA-binding in vitro (Figure 2.1; (Rajendran and Nagy, 2003)). In this paper,
we further delineated the role of particular amino acids within the RPR motif in RNA-binding in
vitro and tombusvirus and DI RNA replication in protoplast.
The in vitro RNA-binding studies revealed that none of the changes within the RPR
motif that included one, two and three amino acid alterations, deletions or insertions abolished
completely the ability of p33 to bind to tombusvirus RNA (Figure 2.2A-C). In contrast, deletion
of the entire RPR motif did result in 80% loss in RNA-binding (Fig. 1,  (Rajendran and Nagy,
2003), suggesting that the entire RPR motif contributes to the strength of RNA-binding. Among
the individual amino acids in the RPR motif (the sequence is R637P640R643R646R649P652, the third
arginine is underlined), the third arginine (R646), and to a less extent, the second arginine (R643)
play the most significant roles in RNA-binding in vitro. Replacing these amino acids with
alanine resulted in 40 to 50% reduction in RNA-binding in vitro (Figure 2.2A-C). Replacing the
third arginine with lysine, a positively charged amino acid, also reduced RNA-binding by 44%
in vitro. Interestingly, similar replacement of either the second or the fourth arginines with
lysines increased the efficiency of RNA-binding. These data suggest that positively charged
amino acids should be present at the positions of the second and the fourth arginines, while the
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function of the third arginine (R646) depends not only on its charge, but possibly on its structure
as well.
Combined deletion of the second, third and fourth arginines in the RPR motif reduced
RNA-binding by 62%, but the fact that it did not reduce RNA-binding in vitro as much as the
deletion of the motif (Figure 2.1, mutant DRPR) suggests that the first arginine also plays a role
in RNA-binding. This is also supported by the observation that alanine substitution for the first
arginine (R637) reduced RNA-binding by 33%. In contrast to the arginines, the direct role of the
two prolines in RNA-binding is less significant in vitro. For example, replacing either of the
prolines with alanines resulted in RNA-binding similar to WT level (Figure 2.2A-C, construct
P640-A and P652-A). On the contrary, replacing both prolines with alanines resulted in 30%
reduction in RNA-binding (Figure 2.2A-C, construct P640-652-A). This suggests that the prolines
likely play a structural role that may facilitate the correct positioning of arginines for RNA
binding. Interestingly, replacing one or both prolines with arginines (Figure 2.2A-C constructs
P640-R, P652-R and P640-652-R) increased RNA-binding by 2.5-3-fold, indicating that the WT RPR
motif is not the most efficient sequence in RNA-binding. Importantly, however, these mutants
supported cis- or trans-replication inefficiently (Figures 2.4 and 2.5A-B), suggesting that the
ability of p33 and/or p92 to bind strongly to RNA is actually detrimental for replication.
Detailed testing of the RPR motif mutants in protoplasts revealed that this motif is
essential for tombusvirus replication. For example, 10 of the 19 RPR mutants tested replicated
poorly in protoplast (Figure 2.4A-B). These mutants also supported trans-replication of DI-72
RNA poorly (Figure 2.5A-B), suggesting that the reduction in the level of tombusvirus RNA
replication is likely due to the mutations that render p33 and/or p92 trans-acting factors less
efficient.
The use of a complementation-based two-component system, which included the
tombusvirus genomic RNA expressing only p92 (but not the p33 protein due to the elimination
of the leaky stop codon in the p33 ORF) and a DI RNA producing p33, defined that mutations
within the RPR motif of both p33 and p92 can debilitate tombusvirus replication. These data
(Figures 2.6-2.7) confirmed that the RPR motif, and therefore likely the ability to bind RNA, is
important for the function of both p33 and p92 during tombusvirus infection. Interestingly,
however, we observed significant differences among particular mutations depending whether
they were located in p33 or p92. For example, mutating the third arginine in the RPR motif in
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p33 to alanine or lysine (constructs R646-A and R646-K) reduced tombusvirus replication below
the level of detection. The same mutations when present in p92, however, only reduced the level
of RNA accumulation to 30 to 90% of the WT level (Figures 2.6 and 2.7A-B). The ability of the
same mutants of p33 and p92 to support tombusvirus replication at different levels suggests that
the function/structure of the RPR motif is different when present in p33 or p92. It is also
possible that the above differences may reflect quantitative differences between p33 and p92
during infection. Indeed, p33 is expressed approximately 20-fold higher levels in plants than p92
(Scholthof et al., 1995d), suggesting that more p33 may be needed for replication than p92.
Therefore, reducing the ability of p33 to bind RNA may affect replication more than that of p92
that has a second RNA-binding region (Rajendran and Nagy, 2003). Alternatively, the RPR
motif may overlap with another, yet unknown, domain in either p33 or p92 that is also involved
in tombusvirus replication. If this is the case, then mutations within the RPR motif may also
affect the function of the second putative domain in either p33 or p92, resulting in differences in
RNA replication in the two-component system.
 Comparison of the ability of p33 to bind RNA in vitro and the efficiency of tombusvirus
replication in protoplast revealed three groups of mutants. The first group includes seven RPR
motif mutants that bound to RNA by less than 60% of WT level in vitro. Six of these mutants
supported dramatically decreased level of gCNV accumulation (10% or less than the WT level)
in protoplast (Figures 2.2 and 2.4-2.5, constructs R646-A, R646-K, DR, D2R, D3R, and R643-649-
A,). These observations are valid for both cis-replication (i.e., for gCNV RNA accumulation)
and trans-replication (i.e., for DI-72 RNA accumulation). The only somewhat unusual mutant in
this group is R643-A that supported gCNV accumulation at 20% of the WT level, but DI-72 RNA
was replicated by over 80% of WT level. Overall, the results obtained with this group of mutants
suggest that the ability to bind to RNA efficiently (more than 60% of WT level) may be
important for the function of p33 and/or p92.
The second group of mutants includes four members (R637-A, P652-A, P640-652-A and R649-
A) that are similar to the first group (i) in their ability to bind RNA less efficiently in vitro than
WT (between 5 to 30% reduction) and (ii) they also support tombusvirus replication less
efficiently than WT (between 5-60% reduction), but they are different from the first group
because the effects on RNA binding and replication are not as dramatic as in the case of the first
group.
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The third group of mutants includes eight members that are able to bind RNA more
efficiently than the WT protein (increase between 10 to 200%, Figure 2.2). Five of these mutants
support tombusvirus replication at a very low level (10% or less) (Figures 2.4-2.5, mutants P652-
R, P640-652-R, R643-K, R643+R and R643+2R). The remaining three of these mutants also show
reduced level of replication, but the reduction is less pronounced (between 25-50%, see
constructs P640-A, P640-R and R649-K). Overall, these results suggest that the ability to bind RNA
stronger than WT, like the ability to bind weakly, is also detrimental for tombusvirus replication.
This suggests that the WT p33 and p92 replicase proteins of tombusviruses contain the sequence
that may be optimal for both binding and release of RNA templates during replication. In
contrast, it is possible that those mutants that can bind RNA either too weekly or too strongly are
deficient in replication.
Comparison of the RPR mutants for their abilities to support viral replication revealed
that the third arginine (R646), and to a less extent, the second arginine (R643) affected
tombusvirus replication to the largest extent among the single alanine mutants. Importantly,
these mutations also inhibited in vitro RNA binding to the highest extent (Figure 2.2).
Replacement of the first and the fourth arginines with alanines affected tombusvirus replication
and RNA-binding to a lesser extent than the second and the third arginines did. Deletion of one,
two or three of the arginines in the RPR motif reduced cis-replication below the level of
detection, while the accumulation of the DI RNA (in the trans-replication system) was also
reduced to 0 to 1% of WT level in vivo. Similarly, replacing three of the arginines with alanines
resulted in tombusvirus accumulation below the level of detection.  These data confirm that the
arginines of the RPR motif are essential for tombusvirus replication. In contrast to the arginine
mutations, replacement of the first, the second or both prolines with alanines affected the level
of tombusvirus accumulation only by 30 to 60% in protoplast. Overall, the fact that several
alanine mutants can support tombusvirus replication rather efficiently suggest that p33 and/or
p92 may tolerate some loss in the effectiveness of RNA-binding without major detrimental
effects on their functions under the conditions used in vivo. The possibility may exist that these
mutants may have lost fitness that would only be obvious under competitive conditions (e. g., in
the presence of WT p33/p92).
The interpretation of in vitro RNA binding data and the in vivo RNA replication data
obtained with p33/p92 mutants carrying arginine or lysine substitutions or insertions is certainly
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more complex than the corresponding alanine mutants. For example, separate replacement of the
second and third arginines with lysines resulted in 130% and 55% RNA-binding, respectively,
while both mutants replicated only at ~5% level of the WT. Lysine substitution for the fourth
arginine in the RPR motif increased RNA-binding to 285%, and it reduced the level of
replication to 50% when compared to WT. Similar to the above lysine mutants, the
interpretation of data obtained with the proline to arginine mutants and for mutants carrying
extra arginines within the RPR motif is not straightforward. For example, addition of one or two
extra arginines increased the ability of p33 to bind RNA 20 to 30% more efficiently, but it
inhibited replication dramatically (down to 0 to 10% of WT). In addition, our data show that the
two prolines in the RPR motif can be replaced with small neutral amino acids (such as alanine),
but not with the large positively charged arginine(s) without debilitating cis- or trans-replication
of tombusviruses. To explain all these data, we propose that for the proper functions of p33 and
p92, it may not only be important to bind RNA, but it is also critical to form the “right” structure
with the viral RNA. For example, it is possible that the RPR motif in p33 and/or p92 is needed
for proper presentation of the RNA in the viral replicase complex during replication. Mutations
within the RPR motif might change the positioning of the RNA within p33 and/or p92 that could
affect the efficiency of replication. In addition to the proper presentation of the RNA, it is also
likely that the release of the RNA after replication is important and those features of the p33/p92
proteins are expected to affect the in vivo replication results but these features have not been
measured with the gel mobility shift assay. Overall, the observed differences between the in
vitro RNA binding and the in vivo replication results may reflect the multiple functions of the
RNA binding domain in p33/p92, such as binding, positioning and releasing the RNA, all of
which might be critical for RNA replication in the infected cells.
Interestingly, most of the RPR mutants tested supported cis-replication of gCNV and
trans-replication of DI-72 RNA at somewhat similar relative levels when compared to WT
gCNV and WT DI-72 RNA. The two notable exceptions are (i) P640-R that supported gCNV
replication efficiently (60% of WT, Figure 2.4B) and DI-72 RNA replication inefficiently (20%
of WT, Figure 2.5B); and (ii) R643-A that supported gCNV replication inefficiently (20% of
WT), while it supported DI-72 RNA replication at 85% of the WT level (Figure 2.5B). Although
the reason for the above differences is not yet known, they do suggest that the function(s) of the
RPR motif in p33 and/or p92 is not completely the same in cis- versus in trans-replication.
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Another interesting finding in this work is the altered ratio between genomic and
subgenomic RNAs for several mutants when compared to WT. For example, the ratio between
sg2 and gCNV was ~7-fold higher in case of R643+R than for WT CNV, while P640-652-A
generated sg2 RNA 40% less efficiently than WT CNV did (Figure 2.4C). The currently popular
model of subgenomic RNA synthesis for tombusviruses predicts that the viral replicase
terminates prematurely during the minus-strand synthesis in the vicinity of the subgenomic
promoter (Choi et al., 2001). The truncated minus-stranded RNA then serves as a template for
the synthesis of plus-stranded subgenomic RNAs from the subgenomic promoter. It is possible
that the above RPR mutants may have either higher (for example, R643+R) or lower (P640-652-A)
termination rates in the vicinity of the subgenomic promoter than WT, which then could lead to
altered sg2 and, to a lesser extent, sg1 RNA synthesis. Further in vitro experiments with purified
p33/p92 mutants will be needed to address this question.
(Reprinted from “Virology”, Vol.308, Zivile Panaviene, Jannine Baker, and Peter D. Nagy “The overlapping RNA-
binding domains of p33 and p92 replicase proteins are essential for tombusvirus replication”, pages 191-205, 2003,
with permission from Elsevier).
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Table 2.1: List of primer used for site directed mutagenesis of CNV(pK2M5)
_____________________________________________________________________________________
Mutant Primer pair       Sequencea           Positionb
_____________________________________________________________________________________
R637-A 554 ATTGCGTCCACAGGAGCGCCTCGCAGAAGACC 622-653
555 AGGTCTTCTGCGAGGCGCTCCTGTGGACGCAAT 654-622
P640-A 556 GCGTCCACAGGACGCGCGCGCAGAAGACCTTATG 625-658
557 CATAAGGTCTTCTGCGCGCGCGTCCTGTGGACGC 658-625
R643-A 558 TCCACAGGACGCCCTGCGAGAAGACCTTATGCA 628-660
559 TGCATAAGGTCTTCTCGCAGGGCGTCCTGTGGA 660-628
R646-A 560 ACAGGACGCCCTCGCGCGAGACCTTATGCAGCT 631-663
561 AGCTGCATAAGGTCTCGCGCGAGGGCGTCCTGT 663-631
R649-A 562 GGACGCCCTCGCAGAGCGCCTTATGCAGCTAAG 634-666
563 CTTAGCTGCATAAGGCGCTCTGCGAGGGCGTCC 666-634
P652-A 564 CGCCCTCGCAGAAGAGCGTATGCAGCTAAGATTG 637-670
565 CAATCTTAGCTGCATACGCTCTTCTGCGAGGGCG 670-637
R643-K 566 TCCACAGGACGCCCTAAGAGAAGACCTTATGCA 628-660
567 TGCATAAGGTCTTCTCTTAGGGCGTCCTGTGGA 660-628
R646-K 568 ACAGGACGCCCTCGCAAGAGACCTTATGCAGCT 631-663
569 AGCTGCATAAGGTCTCTTGCGAGGGCGTCCTGT 663-631
R649-K 570 GGACGCCCTCGCAGAAAGCCTTATGCAGCTAAG 634-666
571 CTTAGCTGCATAAGGCTTTCTGCGAGGGCGTCC 666-634
R643+R 577 TCCACAGGACGCCCTAGACGCAGAAGACCTTATG 628-658
578 CATAAGGTCTTCTGCGTCTAGGGCGTCCTGTGGA 658-628
R643+2R 579 TCCACAGGACGCCCTAGAAGACGCAGAAGACCTTATG 628-658
     580 CATAAGGTCTTCTGCGTCTTCTAGGGCGTCCTGTGGA 658-628
∆R 581 TCCACAGGACGCCCT-AGAAGACCTTATGCA 628-660
582 TGCATAAGG-TCTTCTAGGGCGTCCTGTGGA 660-628
∆2R 583 TCCACAGGACGCCCT--AGACCTTATGCAGCT 628-663
       584 AGCTGCATAAGG--TCTAGGGCGTCCTGTGGA 663-628
∆3R 585 TCCACAGGACGCCCT---CCTTATGCAGCTAAG 628-666
      586 CTTAGCTGCATAAGG---AGGGCGTCCTGTGGA 666-628
P640-652-A            587         GCGTCCACAGGACGCGCGCGCAGAAGAGCGTAT-
GCAGCTAAGATTG 625-670
588 CAATCTTAGCTGCATACGCTCTTCTGCGCGCGCG-
TCCTGTGGACGC 670-625
P640-652-R 589 GCGTCCACAGGACGCAGACGCAGAAGAAGATAT-
GCAGCTAAGATTG 625-670
590 CAATCTTAGCTGCATATCTTCTTCTGCGTCTGCGT-
CCTGTGGACGC  670-625
R643-649-A 591 TCCACAGGACGCCCTGCGGCGGCGCCTTATGCAGCTAAG 628-666
       592 CTTAGCTGCATAAGGCGCCGCCGCAGGGCGTCCTGTGGA 666-628
P640-R 594 GCGTCCACAGGACGCAGACGCAGAAGACCTTATG 625-658
595 CATAAGGTCTTCTGCGTCTGCGTCCTGTGGACGC 658-625
P652-R 596 CGCCCTCGCAGAAGAAGATATGCAGCTAAGATTG 637-670
597 CAATCTTAGCTGCATATCTTCTTCTGCGAGGGCG                        670-637
aThe  mutated sequences are underlined. aThe nucleotide positions within p92 ORF are indicated (Rochon and
Johnson, 1991)
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Figure 2.1: The RPR motif in the CNV p33 is essential for RNA binding in vitro. (A) Schematic
representation of the gCNV RNA (shown in 5’ to 3’ orientation). Among the five genes, p33 and
p92, which are essential for tombusvirus replication, are directly expressed from the genomic
RNA via a translational readthrough mechanism. The other three genes are the coat protein, the
movement protein and the suppressor of gene silencing (shown with black boxes) that are
expressed from two subgenomic RNAs (not shown). The previously defined RPR-motif in the
overlapping region of p33 and p92 (Rajendran and Nagy, 2003) is shown with a gray box and the
actual amino acids are specified. We used the following symbols for the amino acids: P for
proline, R for arginine, A for alanine and S for serine. The deleted sequence in construct DRPR is
shown with (-). (B) A representative gel-shift analysis of protein/RNA complexes. The RNA
probe (lane p, containing the probe only) was the 5’ 169 nt segment of DI-72(+) RNA, which
was 32P-labeled using in vitro transcription. The same amount of RNA probe (2 ng) was added to
each lane in the gel, while the WT and DRPR proteins were added (0.5 mg each) to the lanes as
indicated below the gel. (C) The relative RNA binding efficiencies of the p33DRPR mutant is
shown compared to WT (100%) from three separate experiments. The amounts of free probes in
each lane were measured using a phosphorimager.
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Figure 2.2: Defining the amino acids within the RPR motif in CNV p33 that are essential for
RNA binding in vitro. (A) The name and amino acid sequences of the 19 RPR motif mutants
tested in this work. The mutated amino acids are bold-faced, while the deleted sequences are
shown with (-). We used the following symbols for the amino acids: A for alanine, P for proline,
R for arginine and K for lysine. (B) A representative gel-shift analysis of protein/RNA
complexes. The RNA probe (lane p, containing the probe only) was prepared as described in the
legend to Figure 2.1. The same amount of RNA probe (2 ng) was added to each lane in the gel,
while the proteins (1 µg each) were different as indicated below the gel. Lane mb indicates the
sample containing the maltose-binding protein, while lane WT depicts the truncated p33 with
the WT RPR-motif, which was expressed and purified from E. coli as a 30 amino acid fragment
of p33 fused to MBP. Lanes 1-19 depict the truncated p33 with the RPR-motif in the order as
shown in panel A. The migration of the free probe and the RNA/protein complex is indicated on
the left. Note that the migration of the RNA/protein complex can be different in case of
particular p33 mutants when compared to WT, probably due to the changes in the charge of the
protein. (C) The relative RNA binding efficiencies of the given truncated p33 mutants are shown
compared to WT (100%) from three separate experiments. The amounts of free probes in each
lane were measured using a phosphorimager. Light gray bars represent those mutants that
showed decreased efficiencies in RNA binding.
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Figure 2.3: Effects of amino acid changes within the RPR motif on RNA binding in vitro when
present in the full-length p33. (A) The names of the RPR motif mutants and the corresponding
amino acid changes are the same as in Figure 2.2. Two separate representative gel-shift analyses
of protein/RNA complexes are shown. The RNA probe was prepared as described in the legend
to Figure 2.1. The same amount of RNA probe (2 ng) was added to each lane in the gels, while
the proteins (0.5 µg each) were different as indicated below the gels. (B) The relative RNA
binding efficiencies of the particular p33 mutants are shown in comparison with WT (100%).
The amounts of free probes in each lane were measured using a phosphorimager.
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Figure 2.4: Relative in vivo accumulation of gCNV RNA carrying mutations within the RPR-
motif. (A) The full-length, infectious gCNV RNA (2 µg) carrying a given mutation (the numbers
of constructs corresepond to the mutations in Figure 2.2 (A)) within the RPR-motif was
electroporated into N. benthamiana protoplasts (5x105 cells per experiment). Total RNA was
isolated, electrophoresed and blotted onto a membrane, followed by probing with 32P-labeled
RNA specific for gCNV (see Materials and Methods). The same amount of total RNA was used
for loading onto the gels based on the estimation of the host ribosomal RNA in ethidium
bromide-stained gels (not shown, see Figure 2.6 as example). The positions of the gCNV (g),
subgenomic RNA1 (sg1) and subgenomic RNA2 (sg2) are depicted on the left. The samples
were taken 24 (top) and 48 hours (bottom) after electroporation. The experiment was repeated
three times. (B) The relative accumulation of gCNV RNA for the WT and the p33/p92 mutants
are shown (WT was chosen as 100%). The amounts of gCNV in each lane were measured in the
samples taken after 48 hours of incubation using a phosphorimager. (C) The percentage of sg1
RNA (dark bar) and sg2 RNA (gray bar on the right) accumulation was calculated based on the
accumulation of the corresponding gCNV RNA for the WT and the p33/p92 mutants. The data
represent the samples taken after 48 hours of incubation.
39
a
DI
A
0
20
40
60
80
100
120B
WT  1    2    3    4    5    6    7    8    9   10  11  12  13  14  15  16  17  18  19
WT 1    2     3    4    5    6    7    8    9   10  11  12  13  14  15  16  17  18  19
DI
WT  1    2    3    4    5    6    7    8    9   10  11  12  13  14  15  16  17  18  19
RPR mutant number
Figure 2.5: Relative trans-replication efficiency of DI-72 RNA by the gCNV helper carrying
mutations within the RPR-motif. (A) The full-length DI-72 RNA (1 µg) (White and Morris,
1994a) was co-electroporated with the infectious gCNV RNA (2 µg) carrying a given mutation
within the RPR-motif (the numbers of constructs corresepond to the mutations in Figure 2.2 (A))
into N. benthamiana protoplasts (5x105 cells per experiment). Sample preparation and Northern-
blotting was done as described in the legend to Figure 2.4, except the probing was done with
32P-labeled RNA specific for DI-72 RNA (see Materials and Methods). The position of the DI-
72 RNA is depicted on the left. The samples were taken 24 (top) and 48 hours after
electroporation. The experiment was repeated three times. (B) The relative trans-replication of
DI-72 RNA in the presence of the WT helper or one of the p33/p92 mutants are shown (WT was
chosen as 100%). The amounts of DI-72 RNA in each lane were measured in the samples taken
after 24 hours (left bars) and 48 hours (right bars) of incubation using a phosphorimager.
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Figure 2.6: Testing the role of the RPR-motif in p33 in tombusvirus replication using a two-
component system. (A). Schematic representation of the two constructs used. The stop codon at
the end of the p33 gene was mutated to a tyrosine codon (represented by letter Y in the resulting
construct, p92Y) in gCNV RNA to prevent the production of p33 from this RNA. The second
RNA (DI-p33) was derived from a DI RNA that carried a translation competent p33 gene (Oster
et al., 1998). The RPR-motif within the p33, shown with a gray box in DI-p33, was mutated
(marked with an asterisk). (B) Northern blot analysis of replication of DI-p33 mutants in the
two-component system. The p92Y RNA  (2 mg) (Oster et al., 1998) was co-electroporated with
DI-p33 (2 mg) carrying a given mutation within the RPR-motif into N. benthamiana protoplasts
(5x105 cells per experiment). Sample preparation and Northern-blotting was done as described
in the legend to Fig. 4, except the probing was done with 32P-labeled RNA specific for DI-p33
RNA (see Materials and Methods). The same amount of total RNA was used for loading onto
the gels based on the estimation of the host ribosomal RNA in ethidium bromide-stained gels
(see the gel at the bottom of panel B). The positions of the DI-p33 and p92Y RNAs are depicted
on the left. Note that p92Y replicates poorly in protoplast (undetectable with this probe), while
the control gCNV replicates to high level and the gCNV RNA can be detected with this probe
(due to weak cross-hybridization). The names of the DI-p33 mutants are shown on the top. The
samples were taken 48 hours after electroporation. The experiment was repeated three times. (C)
The relative replication efficiency of DI-p33 RNA in the presence of the p92Y helper (WT was
chosen as 100%). See legend to Figure 2.4 for details. (D) Complementation of replication of
DI-p33 mutants by the WT gCNV helper RNA. The Northern blot was performed as described
in panel B.
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Figure 2.7: Testing the role of the RPR-motif in p92 in tombusvirus replication using a two-
component system. (A). Schematic representation of the two constructs used. See legend to
Figure 2.6 for further details. The RPR-motif within the p92, shown with a gray box, was
mutated (marked with an asterisk). (B) Northern blot analysis of replication of WT DI-p33 in the
two-component system. The DI-p33 RNA (2 mg) was co-electroporated with p92Y RNA (4 mg)
carrying a given mutation within the RPR-motif into N. benthamiana protoplasts (5x105 cells per
experiment). Sample preparation and Northern-blotting was done as described in the legend to
Figure 2.4, except the probing was done with 32P-labeled RNA specific for DI-p33 RNA. The
names of the p92Y mutants are shown on the top. The samples were taken 48 hours after
electroporation. The experiment was repeated three times. See Figure 2.4 for further details. (C)
The relative replication efficiency of WT DI-p33 RNA in the presence of the WT or mutated
p92Y helper. See legend to Figure 2.4 for details.
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Chapter Three
Mutations in the RNA-binding domains of tombusvirus replicase proteins affect
RNA recombination in vivo
Introduction
Errors have been proposed to occur during viral RNA replication often leading to RNA
recombination, which is a process that joins RNA sequences that were either present on separate
molecules or they were noncontiguous when present on the same molecule (Jarvis and
Kirkegaard, 1991; Lai, 1992; Nagy and Simon, 1997). RNA recombination has been documented
for a growing number of bacterial (Mindich et al., 1992; Palasingam and Shaklee, 1992), fungal
(Shapira et al., 1991), plant (Allison et al., 1990; Ayllon et al., 1999; Borja et al., 1999; Cascone
et al., 1993; Nagy and Bujarski, 1993; Rao and Hall, 1993; White and Morris, 1999), animal and
human viruses (Banner et al., 1990; Becher et al., 1999; Furuya et al., 1993; Hajjou et al., 1996;
Keck et al., 1988; Khatchikian et al., 1989; King et al., 1982; Kirkegaard and Baltimore, 1986;
Li and Ball, 1993; Molenkamp et al., 2001; Suzuki et al., 1998; Vezza et al., 1980; Walter et al.,
2001; Weiss and Schlesinger, 1991; Worobey et al., 1999; Wu et al., 1999).
Depending on the sequences brought into proximity by RNA recombination, the changes
in the viral genomes can be dramatic or minor. Due to the formation of viral genomes with novel
traits, RNA recombination has been proposed to be a major driving force in viral evolution
(Aranda et al., 1997; Fernandez-Cuartero et al., 1994; Gibbs, 1987; Lai, 1992; Strauss and
Strauss, 1988; Worobey and Holmes, 1999). In addition, it has been shown that recombination
process is involved in viral genome repair (White and Morris, 1994b) and DI RNA formation
(White, 1996; White and Morris, 1994a).
There were proposed three models of viral RNA recombination (Nagy and Simon, 1997):
1) replicase driven template switching; 2) breakage and ligation and 3) breakage induced
template switching (breakage in RNA molecule leads to template switching process).
The model most supported by recombination studies is the template switching model,
which proposes that viral replicase (due to yet incompletely understood reasons) makes
significant errors during the replication process, leading to template switching during
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complementary RNA synthesis (Jarvis and Kirkegaard, 1991; Lai, 1992; Nagy and Simon,
1997). After the switch from the donor to the acceptor RNA, the viral replicase can resume RNA
synthesis using the nascent RNA (made on the donor template) as a primer on the acceptor RNA.
This model assumes relationship between viral replication and recombination processes in
infected cells.
The breakage and ligation model has been proposed for recombinant Qb bacteriophage
RNA formation  and  was  based  on  findings  that  changes in 3’ end OH group of  5’ template
influenced  recombination  (Chetverin, 1997).  The fact that the recombination process occurred
only in the presence of viral replicase does not allow to rule out the possibility that
recombination  might have occurred via template switching mechanism (Nagy and Simon, 1997).
Breakage - induced template switching model suggests that the breakage in RNA can
stop replicase,  and  that would  facilitate template switch. It has been shown that modifying
5’end of donor RNA to mimic cleaved RNA can lead to increased recombination in
tombusviruses (White and Morris, 1995). Involvement   of RNA cleavage in recombination was
reported for HIV-1 reverse transcriptase (Peliska and Benkovic, 1992; Peliska and Benkovic,
1994).
The most of the tombusvirus recombination studies favor template  switching mechanism
that  can  be   divided  into  three  steps: 1)  the  pausing  of  replicase  on  the donor  template, 2)
release  of  donor  RNA  and  binding  to the acceptor RNA molecule, 3) resumption  of  nascent
RNA synthesis by replicase on the acceptor RNA (Nagy and Simon, 1997). The major
components   facilitating this process  are   viral  RNAs  and replicase proteins, possibly with
host proteins involvement.
There were extensive studies done to find out what RNA features are influencing
recombination. It was shown that the first recombination step, replicase pausing, can occur due
to donor template 5’end degradation (White and Morris, 1995) or shorter 5’ends caused by
internal replication initiation (Panavas et al., 2002b), strong secondary structure formation
(hairpins ) (Carpenter et al., 1995; Cascone et al., 1990; Cascone et al., 1993; White and Morris,
1995) or heteroduplexes (Nagy and Bujarski, 1993; Nagy et al., 1995)), or AU rich regions in
donor template (Nagy and Bujarski, 1995; Nagy and Bujarski, 1996; Shapka and Nagy, 2004).
It has been suggested that acceptor RNA template is important for replicase binding and
facilitating 3’end extension on the nascent strand. The studies with Turnip crinkle virus (TCV)
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revealed that the motif1-hairpin of satC RNA (-) of acceptor template was important for replicase
binding, while the sequence around the replicase binding site was critical for nascent strand
binding and for primer extension (Nagy et al., 1998). In addition to its role in recombination, the
motif1-hairpin also functions as an enchancer for satC replication. Interestingly, it has been
shown that RIII (-) functions as replication enchancer in tombusvirus DI-72 (Panavas and Nagy,
2003a; Ray and White, 1999; Ray and White, 2003) and it can bind to the replicase efficiently
(Panavas and Nagy, unpublished) and promote recombination in in vitro assay using partially
purified CNV replicase (Cheng and Nagy, 2003).
For the late step in recombination (nascent strand extension) complementarity between
these two RNAs is important (Li and Ball, 1993b; Nagy and Bujarski, 1995; Olsthoorn and
vanDuin, 1996; Pogany et al., 1995; Qiao et al., 1997; Raffo and Dawson, 1991; White and
Morris, 1994a; White and Morris, 1994b; White and Morris, 1995). Further studies of primer
extension in in vitro system using partially purified CNV replicase, revealed that the most
effective primer extension occurred with primers (primers in this study resemble nascent strand)
allowing 4-5nt base-pairing with the acceptor template (Cheng et al., 2002).
In summary, previous studies on the role of RNA in recombination revealed that
abnormal 5’ends of donor template as well as strong secondary structures could trigger replicase
pausing and release from donor strand. This step is followed by replicase binding to acceptor
RNA, facilitated by certain RNA structures on the acceptor RNA, and then by nascent strand
extention supported by complementarity between nascent and acceptor RNAs.
The requirement of replicase activity during recombination implies that replicase proteins
play an important role in this process as well. The above mentioned studies of the  ability of
replicase to bind RNA regions involved in recombination support this idea. In addition, the
detection of recombinant RNAs in in vitro experiments using TCV replicase purified from E.coli
and CNV replicase partially purified from N.benthamiana plants strongly suggest a critical role
for replicase in viral RNA recombination. Taking all these findings together, it is clear that
recombination and replication are closely interconnected processes.
To understand the relationship between replication and recombination, I was studying
tombusviruses, which are single-component plus-stranded RNA viruses of plants. Two closely
related tombusviruses, namely Tomato bushy stunt virus (TBSV) and Cucumber necrosis virus
(CNV) are known to support RNA recombination at high frequencies (Borja et al., 1999; White
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and Morris, 1994a; 1994b; 1995; Rochon, 1991). In addition to the genomic RNAs of
tombusviruses, defective interfering (DI) RNAs associated with these viruses are also frequently
used templates for RNA recombination. The major advantages of using DI RNAs for both
replication and recombination studies are that (i) DI RNAs are involved in RNA recombination
with high frequencies (White and Morris, 1999), (ii) they do not contribute essential protein
factors to replication, and thus having higher genetic plasticity than the viral genomic RNA; and
(iii) they use the same replication/recombination machinery as the genomic RNAs. The
tombusvirus DI RNAs are mosaic types that are derived from the genomic RNA via two or three
large sequence deletions (White and Morris, 1999; Figure 3.1A). The sequence deletions during
the DI RNA formation are thought to be the consequence of viral replicase jumping on the
template and the deletions may occur in a step-wise manner (White and Morris, 1999).
The TBSV and CNV replicases contain two essential viral proteins (i.e., p33 and p92)
and possibly host factors (Scholthof et al., 1995; Oster et al., 1998; Nagy and Pogany, 2000). The
p92 protein contains the signature motifs of RNA-dependent RNA polymerases (RdRp), while
the function of p33 is currently not known. Both proteins bind to single-stranded RNA, including
the plus-stranded DI RNA (Rajendran and Nagy, 2003). Due to the overlapping expression
strategy for these proteins, p33 and p92 contain the same RNA-binding region that includes an
arginine/proline-rich sequence (termed the RPR motif, Rajendran and Nagy, 2003; Panaviene et
al., 2003). Many mutations within the RPR motif of p33 and p92 were detrimental to virus and
DI RNA replication. Several mutations in the RPR motif affected the function of p33 differently
than that of p92, suggesting that the RPR motif plays somewhat different roles in these proteins
(Panaviene et al., 2003). Interestingly, few mutations in the RPR motif of p33 could also affect
the level of subgenomic RNA relative to genomic RNA synthesis (Panaviene et al., 2003). These
observations demonstrated that p33 and p92 and their RPR motifs play major roles in
tombusvirus RNA replication. Therefore, due to the proposed interrelationship between
replication and recombination, many of the mutations might also affect RNA recombination as
well. This assumption was tested in this work using a single cell (protoplasts) system, which
supports efficient recombination of DI RNAs when the wild type (wt) p33 and p92 proteins are
present. I found that mutations in the RPR motif in p33/p92 proteins resulted in either “fast”, wt-
like, or “slow” recombinant formation. The altered recombination efficiency in these RPR motif
mutants was mapped to the p33 protein. I also found that wt or selected replicase mutants with
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altered recombination frequencies supported the relative accumulation of new recombinants
versus the parental DI RNAs to similar extent, suggesting that post-recombinational selection is
unlikely the reason for the observed differences among the mutants and the wt virus. Overall,
this chapter provides evidence that the replicase proteins of a tombusvirus, particularly the RNA-
binding region, are involved in RNA recombination.     
Materials and methods
Plasmid construction
For construction of cDNA clones of DI-33 and DI-333 DI RNA, we PCR-amplified RIII
of DI-72 using primers #355 (5’-GGACGCTGCAGGGCCCAGAAAGCGAGTAA GACAG-3’)
and #356 (5’-GACGCTGCAGACGCGTGGGGCGAGATCTCCAGAA CCCAAC-3’) and
template DI-72XPXN (Shapka and Nagy, unpublished). DI-72XPXN, which contains Xho I and
Nco I sites between RIII and RIV, is a derivative of DI-72SXP obtained from Andy White
(White and Morris, 1994a). The PCR product was digested with Pst I, gel purified and cloned
into DI-72XPXN linearized with Pst I. We selected the appropriate DI-33 and DI-333 clones,
which contained either one RIII copy or two RIII copies, respectively, in 5’-3’ orientation by
sequencing.
For construction of DI-2233 clone, RII of DI-72SXP was amplified by PCR using
primers #386 (5’-GGACGGGGCCCATCGATAGAAACGGGAAGCTCGC-3’) and #387 (5’-
GGACGGGGCCCGATATCCTGCTTTTACGAAGGTAG-3’) and DI-72SXP template. The
PCR product was digested with ApaI, gel purified and ligated into DI-33 cDNA treated with
ApaI. Additional copy of RII was inserted between the original RII and RIII in 5’-3’ orientation.
To make DI-2323 clone, RII of DI-72 was PCR-amplified using primers #388 (5’-
GGACGAGATCTGGGTGGATCGATAGAAACGGGAAGCTCGC-3’) and #389 (5’-
GGACGACGCGTGGGTGGGATATCCTGCTTTTACGAAGGTA-3’), and template DI-72SXP
RNA. The PCR fragment was digested with BglII and MluI, followed by gel purification and
ligation into DI-33 treated with BglII and MluI.
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Construction of RPR motif mutants
Site directed mutagenesis within the RPR motif of gCNV (Panaviene et al., 2003;
Rajendran and Nagy, 2003) was performed with Quick Change XL Site Directed Mutagenesis
Kit (Stratagene). The primer pairs used for each mutant are shown in the Table 3.1, while the
template was pK2M5 (Rochon and Johnston, 1991), encoding a full-length cDNA clone for
CNV. Before transformation into E.coli (DH5a), the PCR products were digested with DpnI.
The clones for each mutant were confirmed by sequencing using primer #27 (5’-
GTATTTCACACCAAGGGAC-3’).
We made derivatives of gCNV-Y (expressing protein p92-Y) and DI-p33, carrying
selected mutations in the RPR motif (Table 3.2) as described in Panaviene et al., 2003(Chapter
2). To confirm the presence of the RPR mutation and that the termination codon was replaced
with tyrosine codon in derivatives of gCNV-Y, each clone was sequenced using primer #631 (5’-
GAGGAATTCAAGGTAATTGCGTCCACA-3’).
Cloning recombinant DI RNAs
To obtain cDNA clones for a representative number of recombinant DI RNAs, we
performed reverse transcriptase (RT) reaction with primer #41 (5’-
GGACGAATTCGGGCTGCATTTCTGCAATGTTCC-3’) and 2ml (10%) of total RNA obtained
from protoplast. The RT products were amplified using PCR with primers #41 (5’-
G G A C G A A T T C G G C T G C A T T T C T G C A A T G T T C C - 3 ’ )  a n d  # 4 0  ( 5 ’ -
GGACAAGCTTGCGCTACCGTTGCTTTGC-3’). The RT-PCR products were digested with
XbaI and EcoRI, gel isolated and ligated into similarly treated pUC19 vector. The clones for
sequencing were selected after restriction digestion with XbaI and EcoRI. The sequencing was
done using primer #157 (5’-GGGCTGCATTTCTGCAATGTTCC-3’). Note that cDNA clones
with identical recombination junction sites were counted only once if they were derived from the
same protoplast samples.
To generate full-length cDNA clones for selected recombinant DI RNAs (see control
experiment in Figure 3.6), selected partial cDNA clones, which were used for sequencing, were
digested with XbaI and XhoI. This is followed by gel purification of the appropriate fragments
and cloning into similarly treated DI-2323 (Figure 3.1A).
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Preparation of RNA transcripts
To generate RNA transcripts, all pK2M5 and DI-72XPXN-derived plasmids were
digested with SmaI, and they were used in an in vitro transcription reaction with T7 RNA
polymerase (Nagy et al., 1999). The obtained DI RNA transcripts used in recombination studies
were gel purified from 1% agarose gel, followed by phenol/chloroform extraction, precipitation
in 95% ethanol and three times repeated wash with 70% ethanol to remove residual salts. For the
rest of the in vitro RNA transcripts, DNA templates were removed by DNase I treatment,
followed by phenol/chloroform extraction, precipitation and washing as described above. The
RNA transcripts were electrophoresed on 1% agarose gels and quantified  by UV
spectrophotometer (Beckman).
Preparation and electroporation of protoplasts
N. benthamiana protoplasts were prepared as described Panaviene et al., 2003 (Chapter
2). At the end of the procedure, we resuspended 5¥105 protoplasts in the electroporation buffer
(10 mM HEPES, 10 mM NaCl, 120 mM KCl, 4 mM CaCl2, 200 mM mannitol). For
electroporation, we used the following amounts of RNA transcripts: 2 µg gCNV RNA and 1 µg
gel-purified DI RNAs (unless specified otherwise in the figure legends); After electroporation,
the samples were incubated in 2 ml of protoplast culture medium (Kong et al., 1997) in the dark
for 24-48h at 22 0C.
Total RNA extraction from protoplasts and RNA analysis
Total RNA was extracted from protoplast using a standard phenol/chloroform method
(Kong et al., 1997; Nagy et al., 2001). Aliquots of total RNA were analyzed on 1 or 1.2%
agarose or 4% polyacrylamide/8M urea gels. RNA samples were treated with formamide at 85
0C right before loading on the gels. For Northern blot analysis, the RNA was transferred from the
gels to Hybond XL membrane (Amersham-Pharmacia) by electrotransfer and hybridized with
DI-72 (+) or DI-72 (-) specific probes (Panaviene et al., 2003; chapter 2). Hybridization was
done in ULTRAhyb hybridization buffer at 680C using supplier (Ambion) recommended
conditions. The probes were made in an in vitro transcription reaction with T7 RNA polymerase
in the presence of a [a-32P] UTP and DNA templates representing the 169 bp RI (Figure 3.1A).
These templates were generated by PCR using primers #15 (5’-
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GTAATACGACTCACTATAGGGCATGTCGCTTGTTTGTTG-3’) and #20 (5’-GGAAATT
CTCCAGGATTTCTC-3’) for detection of (+) strands, and primers #31 (5’-
GTAATACGACTCACTATAGGAAATTCTCCAGGATTTC-3’) and #678 (5’-
GGGCTGCATTTCTGCAATGGTCGCTTGTTTGTTGGA-3’) for (-) strand detection.
Results
Rationale: To study the role of replicase proteins in RNA recombination in
tombusviruses, first I developed an efficient recombination system based on a prototypical DI
RNA (i.e., DI-72 that is derived from TBSV via three deletions, Figure 3.1A). Since I wanted to
test the effect of the RNA-binding domains of the replicase proteins on recombination, we chose
DI RNA sequences, namely, region II [RII, (Shapka and Nagy, 2004)] and region III [RIII,
Panavas and Nagy, unpublished], which, as minus-stranded sequences, are known to bind to the
replicase proteins with high affinity in vitro. While the function of RII(-) is currently unknown,
RIII(-) has recently been defined as a strong replication enhancer (Panavas and Nagy, 2003a;
Ray and White, 1999; Ray and White, 2003). It has also been demonstrated recently that RIII(-)
promotes template switching by the CNV RdRp preparation in vitro (Cheng and Nagy, 2003).
Interestingly, RIII(-) served both as a donor and acceptor sites during the recombination events
in vitro. Therefore, I reasoned that due to their binding to the viral replicase proteins, RIII(-) and
possibly RII(-) sequences might constitute recombination hot spots in vivo as well. This
hypothesis was tested in protoplasts below.
Replication and recombination of TBSV DI RNAs carrying duplicated RII and RIII
sequences.
To test the effect of RII and RIII sequences on the ability of DI RNA to replicate and to
recombine, I made four constructs as shown in Figure 3.1A. Namely, DI-33 and DI-333 carried
two and three copies of RIII sequences, while constructs DI-2233 contained two copies of RII
and RIII sequences. The fourth construct, DI-2323 carried a tandem repeat of RII and RIII
(Figure 3.1A).
Each of the gel-isolated TBSV DI RNA transcripts obtained after T7 RNA polymerase
transcription was co-electroporated with genomic CNV RNAs (gCNV) into N. benthamiana
protoplasts as described earlier (Panaviene et al., 2003; chapter 2). I used the heterologous
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gCNV, which is closely related to TBSV, as the helper virus to exclude those DI RNAs that
might be generated spontaneously from the helper RNA during infection, a process known as de
novo DI RNA formation (White and Morris, 1999). I followed the accumulation of plus- and
minus-stranded DI RNAs by using Northern blotting with a DI RNA-specific probe [RI(+) or
RI(-), Figure 3.1B-C]. These experiments detected only the parental (input)-sized (+) and (-) DI
RNAs even after 48 hours of incubation (termed zero passage), suggesting that (i) these DI
RNAs can replicate in protoplasts; and (ii) they do not support recombinant
formation/accumulation at a detectable extent (Figure 3.1B). Interestingly, none of the DI RNAs
with repeated RII or RIII sequences replicated as efficiently as the wt DI RNA (lowest and the
highest accumulation was ~25 and 60% of wt for DI-333 and DI-33, respectively, Figure 3.1B).
Also, the amounts of plus-strands were decreased significantly more than the amounts of minus-
strands for all four constructs tested (Figure 3.1B-C, especially at the 24 hr time point).
It is possible that the lack of recombinant accumulation with these mutants in the zero
passage protoplasts is due to the limited time available for replication of the putative
recombinants after their formation during protoplast incubation (viability of the protoplast cells
sharply declined after 48 hours under the test conditions, not shown). Therefore, to increase the
chance for the formation/accumulation of recombinants, I made a passage with the total RNA
obtained after 48 hours of incubation in protoplasts via electroporation into a new batch of
protoplasts (termed first passage). Then the total RNA from the first passage (after incubation for
48 hours) was used for electroporation into yet another batch of protoplasts (termed second
passage) and so on (Figure 3.2). Northern blot analysis of the total RNA extracts obtained from
the various protoplast samples after the 1st passage revealed the occurrence of novel, ~100-250
bp shorter than input, recombinant-like RNAs for constructs DI-33, DI-333 and DI-2233 in
addition to the parental-sized DI RNAs (Figure 3.2A, 1st passage). Interestingly, many of the
samples contained at least two different-sized recombinant-like DI RNAs, suggesting that more
than one recombination events took place in cells. Total RNA from the 2nd passage showed
similar pattern to that from the 1st passage, except the input-sized DI RNAs became hardly
detectable (Figure 3.2A). Overall, recombinant-like DI RNAs were observed in 100% of the
protoplasts experiments (1st and 2nd passages) with constructs DI-33, DI-333 and DI-2233, based
on Northern blot (Figure 3.2A) and RT-PCR (Figure 3.2B) analyses.
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In contrast to the above three constructs, DI-2323 supported recombinant
formation/accumulation less efficiently. The first recombinants were observed (at hardly
detectable level) in 50% of the samples after the second passage (Figure 3.2A). Half of the
samples still did not contain recombinants after the third passage, suggesting that this construct
could support recombinant formation/accumulation relatively inefficiently.
The observed novel DI RNAs in protoplasts appear to be true recombinants, since they
can be detected in the total RNA extracts using either ethidium bromide-stained gels (not
shown), Northern blotting (Figure 3.2A), or RT-PCR analysis (Figue 3.2B). Control RT-PCR
reactions performed on gel isolated DI RNAs (the same preparations that were used for
electroporation to protoplasts) did not detect recombinant-sized DI RNAs for DI-33 and DI-333
constructs (Figure 3.2B). In contrast, recombinant-sized RT-PCR products were observed in the
control RT-PCR reactions in case of DI-2233 and DI-2323, because of the presence of the 239 nt
RII repeat in these constructs. These were precise recombinants between the duplicated RII
sequences (leading to deletion of one of the duplicated copies, not shown), and we did not count
them in our analysis (Figure 3.3). Nevertheless, DI-2233 and DI-2323 generated unique-sized
recombinants that were not present in the control RT-PCR reactions. These recombinants were
imprecise and they were included in our analysis (see below).
Cloning and sequencing of the above putative recombinants demonstrated that (i) they
were indeed recombinants, derived from the input DI RNAs via single deletions; and (ii) the
recombination junction sites were varied in the recombinants (imprecise recombination) (Figure
3.3). The fact that many of the recombinants obtained with DI-33 and DI-333 had unique and
imprecise junction sites (Figure 3.3A-B) shows the genome plasticity of the DI RNA. The
occurrence of precise recombinants obtained with DI-33 and the lack of these recombinants for
DI-333 indicates that the same sequences might support different recombinants depending on the
neighboring sequences. Many recombinants obtained with constructs DI-2323 and DI-2233 had
the junction sites within the first copy of RII and the second copy of RIII, albeit other
recombinants still carried portions of duplicated sequences (Figure 3.3C-D). Note that I did not
study precise recombination with constructs DI-2323 and DI-2233 due the artifactual products in
the control RT-PCR reactions (see above and Figure 3.2B). Overall, I found that the majority of
the recombinants lacked most of the inserted (duplicated) sequences, and they frequently
contained further deletions in RII and RIII. The observed variability among the obtained DI
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RNA recombinants (Figure 3.3) in junction site pattern is similar to previous findings with de
novo generated recombinants in tombusvirus populations, which also contained unique deletion
sites (White and Morris, 1999).
Testing DI RNA replication and recombination supported by CNV with mutations in the
RPR motif of the replicase proteins
I have previously tested 19 RPR motif mutants that contained either deletions, insertions
of extra arginines or substitutions (arginine/proline to alanine or lysine) in protoplasts (Panaviene
et al., 2003, chapter 2). Among these mutants, 14 supported gCNV and DI-72 accumulation at
detectable levels (Panaviene et al., 2003, chapter 2). To increase the number of viable mutants
with possibly altered properties in replication/recombination, we generated a new set of RPR
motif mutants (total of nine) that had arginine to histidine, lysine, glutamine or alanine changes
(Table 3.2, single and double mutants, R637-K, R637-H, R637-Q, R637-A/R643-H, R637-A/R646-H,
R637-A/R649-H). Additional mutants carried proline to glycine or tyrosine mutations (Table 3.2,
constructs P640-Y, P652-Y, P640-652-G). Testing the ability of these mutants to support DI-333
RNA replication in protoplasts revealed that seven of them were 75-95% as efficient as the wt
CNV (Figure 3.4 and Table 3.2). Two double mutants, namely R637-A/R643-H, R637-A/R646-H,
which carried arginine to histidine mutations, were able to support DI RNA replication only
inefficiently (1-2% of wt level, Table 3.2).
To test the ability of the RPR motif mutants to support recombination in protoplast, I
used a total of 17 mutants and the wt virus in a recombination assay with DI-333. When tested
after the first passage, ten of the RPR motif mutants supported the formation/accumulation of
recombinant DI RNAs with comparable efficiency to the wt CNV (Figure 3.5A). Five mutants,
P640-A, P640-Y, P652-A, and P652-Y and P640-A/P652-A, however, supported the
formation/accumulation of recombinant DI RNAs inefficiently (~15-40% of that of wt, Figure
3.5B). I found that the low recombination efficiency for the above proline mutants was
repeatable in three separate experiments (not shown). In those samples, which accumulated
recombinant DI RNAs, the relative level of DI RNA accumulation (compared to the level of the
parental DI-333 RNA) was low (~5%). These observations suggest that the recombinant DI
RNAs are formed inefficiently or their formation is greatly delayed in the presence of the helper
virus carrying the above proline mutations in the RPR motif (“slow mutants”).
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On the contrary, two RPR motif mutants (R646-A and R643+R) accumulated recombinant
DI RNAs apparently faster than the wt helper did when tested with DI-333 RNA (not shown). To
further test this observation, I used DI-2323, which can support recombination less efficiently
than DI-333 in the presence of the wt helper (Figure 3.2A). I found that in the presence of
mutants R646-A or R643+R, DI-2323 RNA supported recombinant DI RNA accumulation in 82-
100% of samples, while the corresponding value is ~18% in the presence of the wt helper
(Figure 3.5C) after the second passage. The relative amount of the recombinant DI RNAs (in
comparison with the parental DI-2323 RNA) was also higher in samples obtained with R646-A
and R643+R (“fast mutants”) than with the wt. As an additional control, I also used mutant R643-A
(which supported wt level of recombination with DI-333, Figure 3.5A) in combination with DI-
2323. Importantly, I found that R643-A supported low, (~17%) wt-level of recombination with
DI-2323 after the second passage (Figure 3.5C). These observations suggest that the recombinant
DI RNAs might be formed more efficiently and/or earlier during infections in the presence of the
helper virus carrying the R646-A and R643+R mutations than in the presence of wt or R643-A.
The observed differences among the wt gCNV and several mutants in supporting the
occurrence of novel recombinant DI RNAs might be due to (i) differences in the frequency of
recombinant generation. In other words, it is possible that the mutated replicases might have
reduced or increased capacity to generate recombinants (i.e., slow or fast mutants, Figure 3.5B-
C). (ii) It is also possible that there are differences in replication levels of the new recombinants
and the parental DI RNAs (i.e., the difference is at the level of post-recombinational
amplification). To test if those RPR motif mutants, which generated recombinants slower than wt
(e.g., P640-A, P640-Y, P652-A, P652-Y and P640-A/P652-A), might show reduced relative replication
levels for the recombinant DI RNAs (compared to the parental DI RNAs), I performed template
competition experiments between the parental DI-333 RNA and two different recombinant DI
RNAs (derived from experiments shown in Figures 3.2-3.3) in the presence of wt gCNV or the
above mutants. One recombinant, namely #13, had the larger deletion that extended 51 nt into
RII in DI-333 (Figure 3.3B), while recombinant #6 had only 6 nt deleted from RII and it
contained a 5 nt stretch of the marker sequence (Figure 3.3B). I found that after 48 hours of
incubation, both recombinant DI RNAs replicated ~15 to 22-fold better than the parental DI-333
RNA in the template competition experiments. More importantly, these recombinant DI RNAs
showed comparable level of advantage over the parental DI RNA regardless of wt or mutant
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gCNV background (Figue 3.6A-B). These data argue that, after their formation, the recombinant
DI RNAs should be replicated by either the wt or the mutant gCNV to levels higher than that of
the parental DI-333. Since I detected the parental DI RNAs readily, but not the recombinants
(Figure 3.5B), in the presence of slow mutants (i.e., P640-A, P640-Y, P652-A, P652-Y and P640-
A/P652-A), it is unlikely that the differences between the wt and the slow mutants are due to
differences in supporting the accumulation of recombinant DI RNAs over the parental DI RNA.
Instead, it is more likely that the difference is due to the altered efficiency of generation of
recombinant DI RNAs by the wt and the selected mutants (see Discussion).
I also tested the relative accumulation levels of recombinant DI RNAs in a competition
assay with DI-2323 parental RNA for the “fast” mutants and the wt (Figure 3.6C). Similar to the
above observations, the two fast mutants tested (Figure 3.6C, R646-A and R643+R) as well as wt
gCNV supported the recombinant DI RNAs at comparable relative levels in the competition
assay after 48 hours of incubation (Figure 3.6C). Based on this data, I conclude that the “fast”
mutants do not support the recombinant DI RNAs over the parental DI RNA better than the wt
gCNV. This observation further supports that the observed differences in frequency of
recombinant DI RNA occurrence are unlikely due to differences between the wt and the mutants
in post-recombinational selection of recombinant DI RNAs over the parental DI RNAs (see
Discussion).
To test if the mutations in the replicase genes of the tested mutants were stably
maintained during infection, I RT-PCR amplified, cloned and sequenced the replicase genes
from total RNA extracts derived either from the first (for constructs P640-A, P652-A, R637-A, R649-
A and R649-K) or the second passage (R643+R, R646-A, R643-A and R643-K) as described earlier
(Panaviene et al, 2003, chapter 2). I found that the site-specific mutations were stably maintained
in the replicase genes of all these mutants (not shown). This indicates that the mutated replicase
proteins were present in protoplasts at the end of the experiments.
Mutations within the RPR motif of p33 affect RNA recombination
Due to the overlapping expression strategy of p33/p92 genes in tombusviruses, the RPR
motif is present in both replicase proteins. Therefore, it is possible that the observed differences
among the RPR motif mutants in supporting formation of DI RNAs were influenced by
mutations present in both replicase proteins. To test the involvement of these proteins in RNA
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recombination separately, I have developed a three-component, complementation-based system,
based on expression of the p33 protein from a DI RNA (DI-p33, Fig. 7A, Oster et al., 1998;
Panaviene et al., 2003) and the p92 from the mutated gCNV RNA that carries a tyrosine
mutation eliminating the p33 stop codon (construct gCNV-Y, Figure 3.7A, Panaviene et al.,
2003, chapter 2). The third component was DI-333, which can be replicated in trans by p33 and
p92 expressed separately from DI-p33 and gCNV-Y (not shown).
To test the role of the RPR motif mutations in p33 on RNA recombination, I constructed
four DI-p33 mutants, namely P640-A, P640-Y, P652-A, and P652-Y, which can express the p33
protein with the given RPR motif mutation. I co-electroporated N. benthamiana protoplasts with
one of the DI-p33 mutants, the unmodified gCNV-Y and DI-333, followed by passaging the total
RNA extracts obtained after 24 hours incubation to new batch of protoplasts as described in the
Materials and Methods. Total RNA extracts from the samples of the first passage were analyzed
by Northern blotting to detect putative DI-333-derived recombinants (Figure 3.7B). The control
three-component system that included the wt p33 (expressed from WT DI-p33, Figure 3.7B)
supported formation of DI RNA recombinants efficiently (85% of samples contained
recombinants), demonstrating that the three-component system is suitable for recombination
studies. Similar experiments, which included one of the mutated DI-p33, instead of the wt DI-
p33, in the three-component system, gave lower frequency level of DI recombinant formation:
45% for P640-A, 31% for P640-Y, 47% for P652-A, and 29% for P652-Y (Figure 3.7B). Moreover,
the relative levels of DI recombinants were significantly lower than those observed in case of the
wt p33 (Figure 3.7B). This data suggests that mutations within the RPR motif in p33 can affect
RNA recombination (see Discussion).
Mutations within the RPR motif of p92 have no major effect on RNA recombination
To test the role of the RPR motif mutations in p92 on RNA recombination, I constructed
four gCNV-Y mutants, namely P640-A, P640-Y, P652-A, and P652-Y, which can express the p92Y
protein with the given RPR motif mutation, and used them in the three-component RNA
recombination assay described above (the other components were wt DI-p33 and DI-333).
Interestingly, all four gCNV-Y mutants supported DI recombination as efficiently as the wt
gCNV-Y did in protoplasts when tested after the first passage (Figure 3.7C). The relative
amounts of recombinant versus parental DI-333 were also comparable for these gCNV-Y
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mutants and the wt gCNV-Y (Figure 3.7B). Based on these results, I propose that the RPR motif
in p92 (at least the particular mutations tested) might have lesser effect on RNA recombination
than the corresponding mutations in p33.
Discussion
The RPR motif in the p33 replicase protein is involved in RNA recombination
The most popular models of viral RNA recombination predict a close relationship
between replication and recombination. This is because recombination is thought to be an error
made by the viral replicase during the replication process. Therefore, it is possible that
replication and recombination might share the same viral replicase complex and the viral RNA
templates, although the final RNA products generated by replication and recombination could be
different. Indeed, there is a unique template switching step performed by the viral replicase
during recombination that is not needed (based on current models) during replication. The
template switching is proposed to occur from the donor to the acceptor RNAs during
complementary RNA synthesis on the donor template (or from the donor site to the acceptor sites
if they are on the same RNA molecule). Accordingly, in vitro experiments with the Qb phage
(Biebricher and Luce, 1992), poliovirus (Arnold et al., 1999; Tang et al., 1997), Brome mosaic
virus (BMV) (Dzianott et al., 2001; Kim and Kao, 2001), Bovine viral diarrhea virus (Kim and
Kao, 2001), Turnip crinkle virus (TCV) (Nagy et al., 1998) and CNV RdRps (Cheng and Nagy,
2003) demonstrated that template switching by these enzymes is possible and it occurs at a high
frequency. If template switching also takes place in vivo, then mutations in the viral replicase
proteins should affect not only replication, but recombination as well in in vivo experiments.
Indeed, the data obtained in this work demonstrates that several mutations within the RPR motif
of p33/p92 replicase proteins affected RNA recombination. For example, a group of p33/p92
mutants of CNV that carried alterations of either or both prolines in the RPR motif (e.g., P640-A,
P640-Y, P652-A, P652-Y and P640-A/P652-A), supported recombination at reduced efficiency
(frequency) when compared to wt (Figure 3.5B). On the contrary, two of the arginine mutants
(e.g., R646-A and R643+R, Figure 3.5C) supported recombinant formation more efficiently than wt
did. The observed differences among the RPR motif mutants and wt are likely due to altered
efficiency in recombinant formation (frequency of recombination) driven by the mutated
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replicase proteins. This is because these RPR motif mutants supported replication of selected
recombinants at relative levels (when compared to the level of replication of the parental DI
RNA) similar to that observed with wt CNV helper virus in a template competition experiment in
protoplasts (Figure 3.6). In other words, the above template competition experiments suggest
that, after the RNA recombination step, a particular recombinant (such as the recombinants
shown in Figure 3.6) is predicted to have comparable chance to out compete the parental DI
RNA in both the mutant and wt p33/p92 background in protoplasts. Therefore, I suggest that the
p33/p92 replicase proteins of CNV are directly involved in recombination. The direct
involvement of the replicase proteins in recombination is also supported by in vitro data that
demonstrated the ability of a partially-purified CNV RdRp preparation to support recombinant
formation (Cheng and Nagy, 2003).
Interestingly, previous works with the BMV (which belongs to a different supergroup
than Tombusviruses) 1a and 2a proteins also suggested the role of the viral replicase proteins in
recombination (Figlerowicz et al., 1997; Figlerowicz et al., 1998; Nagy et al., 1995). Also, the
polymerase acidic protein subunit, a possible elongation factor, of the RdRp of influenza A virus
has been proposed to affect DI RNA formation (Fodor et al., 2003). These findings are in
agreement with the template switching based recombination models.
Development of a three-component complementation-based recombination system that
contained tombusvirus RNAs expressing p33 and p92 proteins separately allowed us to study the
role of the RPR motif mutations in p33 and p92 independently. I found that selected RPR motif
mutations, which affected recombination frequency in the two-component system where both
p33 and p92 were simultaneously mutated, were capable of affecting RNA recombination when
present in p33 alone. On the contrary, their effects were less obvious on DI RNA recombination
when present in p92. This data indicates that the RPR motif in p33 is involved in recombinant
formation. This further supports the model that RNA replication and RNA recombination might
depend on similar factors and elements (also, see below the discussion on the role of the RNA
template). The actual function of p33 in tombusvirus replication/recombination will need further
studies.
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Is there a relationship between recombination, replication or subgenomic RNA synthesis?
Comparison of the abilities of the RPR motif mutants to support replication and
recombination revealed the lack of correlation between the extent of replication and the
efficiency of recombination. For example, mutants R646-A and R643+R supported replication
poorly (Table 3.2), but they showed accelerated rate of recombination (Figure 3.5C). On the
other hand, mutants P640-A, P640-Y, P652-A, and P652-Y, which supported recombination
inefficiently (Figure 3.5B), were capable of supporting replication at levels (58-87%) similar to
that obtained with mutants R637-K, R637-Q, P640-652-G, and R637-A/ R649-H, etc. (Table 3.2), which
could support ~wt-level of recombinants. The difference in the effect of particular mutant on the
efficiency of replication and recombination suggests that the RPR motif in p33 (and possibly in
p92) plays different functions during replication and template switching. Similar observation was
also made for BMV 2a mutants that affected the levels of replication and recombination
differently (Figlerowicz et al., 1997; Figlerowicz et al., 1998). These observations are not
surprising in that sense that protein factors and RNA elements (see below), which are involved in
replication and recombination, are likely utilized somewhat differently by the replicase proteins.
One of the surprising observations of this work is that the two RPR motif mutants,
namely R646-A and R643+R (Figure 3.5C), which accelerated RNA recombination, also increased
the relative amount of subgenomic RNAs (by ~2-20-fold when the levels of subgenomic RNAs
were compared to the level of genomic RNA) in protoplast (Panaviene et al., 2003, chapter 2).
This observation suggests that there might be a common step in RNA recombination and
subgenomic RNA synthesis (such as termination of RNA synthesis?), which is stimulated by
these RPR motif mutants. Future experiments will address this possibility.
The role of cis-acting elements in tombusvirus recombination
Based on in vitro studies with the partially purified CNV RdRp, we predicted that the
RIII sequence, which has been shown to be a strong replication enhancer in vitro (Panavas and
Nagy, 2003a) and in vivo (Ray and White, 1999a; Ray and White, 2003a), should be active in
promoting RNA recombination. Accordingly, I found that DI RNAs carrying two or three copies
of RIII recombined rapidly in protoplasts. Although the recombination junctions were mainly
imprecise, they clustered within the RIII sequence, suggesting that RIII is a recombination hot
spot sequence. I show similar data for RII (construct DI-2233 and DI-2323 in Figure 3.3C-D),
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which is a putative cis-acting element (albeit its function is currently unknown, (Shapka and
Nagy, 2004) ) that can bind to the replicase proteins in vitro. It has been shown previously that
insertions of short sequences (~110-150 nt) derived from GFP or barstar genes into DI RNA did
not promote recombination (Shapka and Nagy, 2004) under the same conditions used in this
work.
Interestingly, multiple copies of regions II and III elements have not increased the
replication potential of the prototypical DI RNA. Instead, I observed (i) a moderate level of
interference with replication (Figure 3.1); and (ii) reduced competition against the recombinant
DI RNAs (Figure 3.6). The interference might take place during plus-strand synthesis since the
amounts of plus-strands for DI RNAs with multiple copies of regions II and III decreased
significantly more (at the 24 hours time point) than the amount of minus-strands for all four
constructs. Note that, similar to our observation, Ray and White (1999) also observed the lack of
additional stimulation of DI RNA replication due to the duplicated RIII replication enhancer
sequence in the presence of the TBSV helper virus. Also, a duplicated copy of the motif1
replication enhancer of satC, a satellite (chimeric) RNA associated with TCV infections (Nagy et
al., 1999; Nagy et al., 2001) did not further enhance the replication of satC RNA when compared
to satC carrying a single motif1 replication enhancer. It is possible that one copy of the
replication enhancer is optimal for replication and additional copies might only disturb the
replication process, thus leading to replicase errors, such as RNA recombination.
In summary, this is the first report on the role of a tombusvirus replicase protein (namely
p33) in RNA recombination. This and a previous work (Panaviene et al., 2003, chapter 2) firmly
establish that the RNA-binding domains in the replicase proteins are involved in RNA
replication, subgenomic RNA synthesis and RNA recombination. Additional structure/function
studies will be helpful in understanding the mechanism of these processes that are vital for
tombusvirus infection and evolution.
(Reprinted from “Virology”, Vol.317, Zivile Panaviene and Peter D. Nagy, “Mutations in the RNA -binding
domains of tombusvirus replicase proteins affect RNA recombination in vivo”, pages 359-372, 2003, with
permission from Elsevier).
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Table 3.1: List of primers used for site-directed mutagenesis of CNV (pK2M5)
Mutant Primer pair       Sequencea Positionb
R637-K 832 ATTGCGTCCACAGGAAAGCCTCGCAGAAGACCT 622-654
833 AGGTCTTCTGCGAGGCTTTCCTGTGGACGCAAT 654-622
R637-H 834 ATTGCGTCCACAGGACATCCTCGCAGAAGACCT 622-654
835 AGGTCTTCTGCGAGGATGTCCTGTGGACGCAAT 654-622
R637-Q 836 ATTGCGTCCACAGGACAACCTCGCAGAAGACCT 622-654
837 AGGTCTTCTGCGAGGTTGTCCTGTGGACGCAAT 654-622
P640-Y 840 GCGTCCACAGGACGCTAT CGCAGAAGACCTTATG 625-658
841 CATAAGGTCTTCTGCGATAGCGTCCTGTGGACGC 658-625
P652-Y 842 CGC CCTCGCAGAAGATATTATGCAGCTAAGATTG 637-668
843 CAATCTTAGCTGCATAATATCTTCTGCGAGGGCG 668-637
P640-652-G 848 CGTCCACAGGACGCGGGCGCAGAAGAGGGTATG 626-670
              CAGCTAAGATTG
849 CAATCTTAGCTGCATACCCTCTTCTGCGCCCGCGTC 670-626
CTGTGGACG
R637-A/ R643-H 850 TCCACAGGAGCGCCTCACAGAAGACCTTATGCA 628-660
851 TGCATAAGGTCTTCTGTGAGG CGC TCCTGTGGA 660-628
R637-A/ R646-H 852 ACAGGAGCGCCTCGCCACAGACCTTATGCAGCT 631-663
853 AGCTGCATAAGGTCTGTGGCGAGGCGCTCCTGT 663-631
R637-A/ R649-H 854 GGAGCGCCTCGCAGACACCCTTATGCAGCTAAG 634-666
855 CTTAGCTGCATAAGGGTGTCTGCGAGGCGCTCC 666-634
_____________________________________________________________________________________
a The mutated sequences are underlined.
b The nucleotide positions within the p33/p92 ORF of CNV are indicated (Rochon and Johnston, 1991).
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Table 3.2: The level of accumulation of DI RNAs in the presence of gCNV carrying mutations in
the RPR motif
Mutants RPR motif  DI-RNA
replication(%)
24h 48h
WT 100 100
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Figure 3.1: Replication of DI RNAs carrying duplicated copies of known and putative cis-acting
elements in protoplasts. (A) Schematic representation of TBSV genomic and DI RNAs used in
these experiments. The genomic RNA is shown at the top with five genes (indicated with white
and black boxes), which include the p33 and p92 replicase proteins (they overlap in sequence
within the p33 gene). Note that CNV has similar replicase genes to those of TBSV. The
prototypical DI RNA, DI-72, contains four conserved segments derived from the TBSV genomic
RNA, termed RI to RIV, shown as grey boxes. The shown DI RNA constructs carry one or two
copies of the 82 nt RIII, a known replication enhancer. In addition, DI-2323 and DI-2233 also
contain two copies of the 239 nt RII sequence (as shown, framed boxes represent inserted copies
of RII and/or RIII), which is a putative cis-acting replication element. Note that TBSV DI RNAs
can only replicate in the presence of a helper virus, such as TBSV or the closely related CNV
(not shown). (B) Accumulation of (+)-strands of DI-72 RNA and its derivatives in N.
benthamiana protoplast in the presence CNV helper RNA. DI RNAs (1mg) were co-
electroporated with CNV RNA (2mg) into protoplasts (5¥ 105 cells per experiment). The names
of the DI RNA constructs are shown on the top. Samples were taken 24 (top) and 48 (bottom)
hours after electroporation. DI RNAs were detected using 32P-labeled RNA specific for RI(+).
Ethidium bromide-stained ribosomal RNA represents loading control. The relative accumulation
of DI RNAs, compared with DI-72 RNA, is shown based on quantification of Northern blots
with a phosphorimager. The data was adjusted according to loading control. Gray bars represent
samples after 24h and black bars represent samples taken after 48h. The experiments were
repeated four times. (C) Accumulation of (-) strands of DI-72 DI-RNA and its derivatives in
protoplasts. The same total RNA samples were analyzed as in panel B. The total RNA was
electrophorized in 4% denaturing acrylamide gel before transfer to the membrane. The labeled
RNA probe was specific for RI(-). See other details in panel B.
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Figure 3.2: Generation of DI RNA recombinants in N. benthamiana protoplasts. (A) Northern
blot analysis of DI RNAs accumulating in protoplasts that were co-electroporated with the
shown DI RNAs and gCNV helper as described in Fig. 1B. Note that the DI RNA transcripts
(1mg) were gel isolated prior to electroporation into zero passage (primary-infected) protoplasts.
Comparable amounts of the total RNA extracts from the zero passage protoplasts were used for
electroporation to a new batch of protoplasts (first passage), and so on. Names of DI RNAs are
shown on the top. An arrow points to the input-sized DI RNA (also marked with an asterisk since
the sizes are variable based on the DI constructs), while the recombinant-like DI RNAs are
bracketed. (B) Agarose gel analysis of RT-PCR products (using primers specific for the 5’ and 3
ends of DI-72 RNA and its derivatives) obtained from total RNA (first or third passage as
shown). The RT-PCR products obtained with four independent samples are marked as R1 to R4.
Letter C (control) represents the RT-PCR products obtained using the gel purified in vitro
transcripts of the corresponding DI RNAs. Note that, in case of DI-2233 and DI-2323, the RT-
PCR resulted in recombinant products, which were precise (homologous) based on sequence
determination (not shown). These artifactual products were excluded from analysis (Figure 3.3).
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a
   GUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUU//GAGAACUGCAGGGCCCAGAAAGCGAGUAAGACAGACUCUU/     /UCUGGAGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGACUCUU//GUAAAUCUGGCAUAGC
   *
1  GUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUU//GAGAACUGCAGGGCCCAGAAAGCGAGUAA                                                                        AAUCUGGCAUAGC 1/16
2  GUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUU//GAGAACUGCAGGGCCC                                                                         GACUCUU//GUAAAUCUGGCAUAGC 1/16
3  GUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUU//GAGA                                                                                 GACAGACUCUU//GUAAAUCUGGCAUAGC 1/16
4  GUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCA                                                                                 AGCGAGUAAGACAGACUCUU//GUAAAUCUGGCAUAGC 1/16
5  GUCUGCAUAUCA                                                                                                                  AGACAGACUCUU//GUAAAUCUGGCAUAGC 1/16
6  GUCUGCAUAU                                                                                                                AGUAAGACAGACUCUU//GUAAAUCUGGCAUAGC 1/16
7  GUCUGCAUA                                                                                     AGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGACUCUU//GUAAAUCUGGCAUAGC 1/16
8  GUCUGCAUA                                                                                                  CGCGUCUGCAGAGCGAGUAAGACAGACUCUU//GUAAAUCUGGCAUAGC 1/16
9  GUCUGCAU                                                                                                              AGCGAGUAAGACAGACUCUU//GUAAAUCUGGCAUAGC 1/16
10 GUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUU//GAGAACUGCAGGGCCCAGAAA                                                       AGCGAGUAAGACAGACUCUU//GUAAAUCUGGCAUAGC 7/16
RII RIII1 RIII2
(62) (25)
   GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGGCCCAGAAAGCGAGUAAGACAGACUCUUCAGUC//GUUACUCUUGUUGGGUUCUGGAGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGAC
   *
1  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGGCCCAGAAAGCGAGUAAGACAGACUCUUCAG                                    CACGCGUCUGCAGAGCGAGUAAGACAGAC 1/21
2  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGGCCCAGAAAGCG                                                           CGUCUGCAGAGCGAGUAAGACAGAC 1/21
3  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGGCCCAGAAAGCG                                                    CCCCACGCGUCUGCAGAGCGAGUAAGACAGAC 1/21
4  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGGCCCAGAAAGC                        GUUACUCUUGUUGGGUUCUGGAGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGAC 1/21
5  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGGCCCAGAAA                                    UUGGGUUCUGGAGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGAC 1/21
6  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGC                                                                                        UGCAGAGCGAGUAAGACAGAC 1/21
7  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUA                                                                                       CGCGUCUGCAGAGCGAGUAAGACAGAC 1/21
8  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCAC                                                                                                                 AGCGAGUAAGACAGAC 1/21
9  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGU                                                                                                                             GACAGAC 1/21
10 GAGAGUCUGCAUAUCACACCUGUCUCCG                                                                                                                              GAGCGAGUAAGACAGAC 1/21
11 GAGAGUCUGCAUAUCACACCUGUCUCCG                                                                                                 UUCUGGAGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGAC 1/21
12 GAGAGUCUGCAUAUCACACC                                                                                                                               GUCUGCAGAGCGAGUAAGACAGAC 1/21
13 GAGAGUCUGCAUAUCAC                                                                                                                                             GAGUAAGACAGAC 1/21
14 GAGAGUCUGCAUAUCA                                                                                                                                                         AC 1/21
15 GAGAGUCUGCAUAUC                                                                                                                            CCCCACGCGUCUGCAGAGCGAGUAAGACAGAC 1/21
16 GAGAGUCUGCAUA                                                                                                                                                      AGACAGAC 1/21
17 GAGAGUCUGCAU                                                                                                                                                GCGAGUAAGACAGAC 1/21
18 GAGAGUCUGCAU                                                                                                                                                        GACAGAC 1/21
19 GAGAGUCUGCA                                                                                                                                                       AAGACAGAC 1/21
20 GAGAGUCUGC                                                                                                                                            UGCAGAGCGAGUAAGACAGAC 1/21
21 GA                                                                                                                                                 GUCUGCAGAGCGAGUAAGACAGAC 1/21
RII RIII1 RIII3RIII2
(163)
   GCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGGCCCAUCGAUAGAAA // UACAGGUUACUCUUGUUGGGUUCUGGAGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGACUCUUCAG
   *
1  GCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGGCCCAUCGAUAG                      UUGGGUUCUGGAGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGACUCUUCAG 1/23
2  GCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGGCCCAUCGAU                                                  CGUCUGCAGAGCGAGUAAGACAGACUCUUCAG 2/23
3  GCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGGCCC                                               CGCCCCACGCGUCUGCAGAGCGAGUAAGACAGACUCUUCAG 1/23
4  GCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAG                                                                      AGCGAGUAAGACAGACUCUUCAG 1/23
5  GCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAA                                                                              CGAGUAAGACAGACUCUUCAG 1/23
6  GCAUAUCACACCUGUCUCCGAGAGGGA                                                                                    GAGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGACUCUUCAG 1/23
7  GCAUAUCACACCUGUCUCC                                                                                                         ACGCGUCUGCAGAGCGAGUAAGACAGACUCUUCAG 1/23
8  GCAUAUCACACCUG                                                                                                                       CAGAGCGAGUAAGACAGACUCUUCAG 1/23
9  GCAUAUCA                                                                                                                         UCUGCAGAGCGAGUAAGACAGACUCUUCAG 1/23
10 GCAUAUCA                                                                                                                                            AGACUCUUCAG 2/23
11 GCAUAU                                                                                                                     CACGCGUCUGCAGAGCGAGUAAGACAGACUCUUCAG 3/23
12 GCAUAU                                                                                                                                   GCGAGUAAGACAGACUCUUCAG 1/23
13 GCAUA                                                                                                                                      GAGUAAGACAGACUCUUCAG 1/23
14 GCAUA                                                                                                                                            GACAGACUCUUCAG 1/23
15 GCAU                                                                                                                    CCCCACGCGUCUGCAGAGCGAGUAAGACAGACUCUUCAG 1/23
16 GCAU                                                                                                                       CACGCGUCUGCAGAGCGAGUAAGACAGACUCUUCAG 1/23
17 GCAU                                                                                                                                         GUAAGACAGACUCUUCAG 1/23
18 GCAUAUCACACCUGUGCAUA //UCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAA    //  UACAGGUUACUCUUGUUGGGUUCUGGAGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGACUCUUCAG 1/23
19 GCAUAUCACACCUGUGCAUA //UCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAA                      GGUUACUCUUGUUGGGUUCUGGAGAUCUCGCCCCACGCGUCUGCAGAGCGAGUAAGACAGACUCUUCAG 1/23
 RII2 RIII2RIII1 RII1
RIII2RIII1 RII2 RII1
(309)
(74)
   GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAGGG//GAGCCUUUGGACGUCUUUCCCCGUUCAGGAAAGCGGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA
   *
1  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAACUGCAG                                      GGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 1/20
2  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAGAA                                   CAGGAAAGCGGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 1/20
3  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAGCAGAG                                                                 CAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 2/20
4  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACCUUCGUAAAAG                                             GAAAGCGGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 1/20
5  GAGAGUCUGCAUAUCACACCUGUCUCCGAGAGGGAUAGUCACUUGACUACC                                                   UCAGGAAAGCGGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 1/20
6  GAGAGUCUGCAUAUCACACCUGUCUCCGAGA                                                            UCUUUCCCCGUUCAGGAAAGCGGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 1/20
7  GAGAGUCUGCAUAUCACAC                                                                                    CAGGAAAGCGGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 1/20
8  GAGAGUCUGCAUAUC                                                                                                                                                 CAUA 1/20
9  GAGAGUCUGCAUAU                                                                                                                             GUAAGACAGACU//AAUCUGGCAUA 1/20
10 GAGAGUCUGCAUA                                                                                                                                    CAGACU//AAUCUGGCAUA 1/20
11 GAGAGUCUGCAU                                                                                                                                  AGACAGACU//AAUCUGGCAUA 1/20
12 GAGAGUCUGCAU                                                                                                                                   GACAGACU//AAUCUGGCAUA 1/20
13 GAGAGUCUGCAU                                                                                     CCCGUUCAGGAAAGCGGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 1/20
14 GAGAGUCUGCAU                                                                                                                                 AAGACAGACU//AAUCUGGCAUA 1/20
15 GAGAGUCUGCAU                                                                                                                            CGAGUAAGACAGACU//AAUCUGGCAUA 1/20
16 GAGAGUCUGCA                                                                                              GGAAAGCGGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 1/20
17 GAGAGUCUGCA                                                                                                                                    GACAGACU//AAUCUGGCAUA 1/20
18 GAGAGUCUGC                                                                                                                                     GACAGACU//AAUCUGGCAUA 1/20
29 GAGAGUCU                                                                            UUGGACGUCUUUCCCCGUUCAGGAAAGCGGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 1/20
20 GAGAG                                                                         GAGCCUUUGGACGUCUUUCCCCGUUCAGGAAAGCGGUUUGUG//ACGCGUCUGCAGAGCGAGUAAGACAGACU//AAUCUGGCAUA 1/20
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(241)
Figure 3.3: Distribution of recombination sites in DI RNAs. (A-D) The sequences around the
recombination junctions are shown in plus-strand orientation with 5’ sequences on the left.
Various regions of the parental DI RNAs (see Figure 3.1A for the schematic representation of the
full-length constructs) are shown on the top, while the marker mutations between the regions are
underlined. The sequences above and below the asterisk represent the parental and the
recombinant sequences, respectively. Nucleotides that are deleted in the recombinants are
indicated with blank spaces corresponding to the parental sequence. Not shown sequences are
indicated with //, and their length is specified in parenthesis. The frequency (number of
recombinant/total number of sequenced recombinants) is shown on the right. Note that due to
sequence identity in the duplicated regions, the actual recombination sites cannot be determined
in the precise recombinants (the crossover region is boxed).
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Figure 3.4: Effect of mutations in the RPR motif on the accumulation of DI-333 RNA in
protoplasts. (A) Schematic representation of the location of the RPR motif (a grey box) in gCNV
and in the p33 and p92 proteins. The actual amino acids and their positions in the p33/p92 gene
are specified. (B) Northern blot analysis of total RNA extracts obtained with DI-333 in the
presence of either wild type gCNV or one of the RPR motif mutants in protoplasts. Further
details are as shown in the legend to Figure 3.1.
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Figure 3.5: Effect of RPR motif mutations on recombination frequency of DI RNAs. (A-B)
Northern blot analysis of total RNA extracts (first passage) obtained from protoplasts that
contained DI-333 and either wt gCNV or one of the RPR motif mutants. Protoplasts (zero
passage) were co-electroporated with 1mg of gCNV (carrying wt or mutated RPR motif) and 0.15
mg of gel purified DI-333 transcript. For “passaging” the viral RNA, protoplasts were co-
electroporated with the same amounts (5ml each) of total RNA extracts obtained from zero
passage protoplast 48h after electroporation. The frequency of recombinant DI RNA
accumulation (number of recombinants/total number of first passage protoplast samples) is
shown on the bottom. Further details are as shown in the legend to Figure 3.1. (C) RPR motif
mutants that increased recombination frequency in the initial tests (performed with DI-333, not
shown) were tested in the presence of DI-2323 that recombines inefficiently (Figure 3.2).
Protoplasts (zero passage) were co-electroporated with 0.4mg of wt gCNV and 1mg of gel
purified in vitro transcript of DI-2323 RNA or 5mg of the given RPR motif mutant RNA and 2mg
of DI-2323 RNA, respectively. The higher amounts of RNA were used for the mutants because
of the low replication level of DI RNAs when these mutants were used as helpers (Table 3.1, and
Panaviene et al., 2003, chapter 2). For “passaging” the viral RNA, protoplasts were co-
electroporated with the same amounts (5ml each) of total RNA extracts obtained from zero
passage protoplast 48h after electroporation, plus additional 0.4 mg wt or 5 mg of the given RPR
motif mutant gCNV transcripts. Total RNA extract after the second passage was analyzed by
Northern blot as described in panel A. The bottom panel includes an additional control, mutant
R643-A, which supports wt level recombination with both DI-2323 and with DI-333 (see panel
B). Note that the amount and conditions for R643-A was the same as for R646-A.
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Figure 3.6: Similar levels of competitiveness of recombinant DI RNAs for replication in mutant and
wt p33/p92 backgrounds in vivo. (A) Replication of two of the cloned recombinant DI RNAs
(recombinant #13, Figure 3.3B and recombinant #6, Figure 3.3B) were tested in the presence of DI-
333 and wt or mutated gCNV (as shown). Protoplasts were co-electroporated with 1mg of wt or
mutated gCNV, 0.5mg of recombinant DI RNA transcripts and 1mg of DI-333 RNA transcripts. Total
RNA extracts (48h after electroporation) were analyzed by Northern blot as shown in Figure 3.1.
The input- and recombinant-sized RNAs are depicted with arrowheads. (B). The relative
accumulation level of the two recombinant DI RNAs (compared to the level of DI-333 RNA in each
sample) in the presence of wt or mutated CNV, as shown. Light grey and dark grey bars represent
the data obtained with recombinant #13 and #6 DI RNA (Figure 3.3D), respectively. Experiments
were repeated four times. (C) Left and right panels: Competition experiments between recombinant
#29 (Figure 3.3D) and DI-2323 RNA in the wt or P646-A gCNV background; and between
recombinant #12 (Fig. 3D) and DI-2323 RNA in the wt or P643+R gCNV background, respectively.
Relative accumulation levels of recombinant DI RNAs (recombinant/DI-2323) are shown at the
bottom. Experiments were repeated four times.
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Figure 3.7: Characterization of the role of the RPR motifs in p33 and p92 proteins in DI RNA
recombination. (A) Schematic representation of the complementation-based, three-component
system. The p33 stop codon in gCNV has been changed to tyrosine to express only the p92
protein from gCNV-Y. The p33 protein was expressed from a translation competent DI RNA,
termed DI-p33. The RPR motif is shown as a grey box in both constructs. Note that the RPR
motif mutations were introduced separately into either gCNV-Y or DI-p33. The third component
is DI-333 (Figure 3.1A), which is expected to support recombination, as shown in Fig. 2.  (B)
Northern blot analysis of total RNA extracts obtained from the first passage with RPR motif
mutations present in p33 only (as indicated). Protoplasts were co-electroporated with 5mg gCNV-
Y, 2mg wt or RPR motif mutants of DI-p33 and 1mg of gel purified DI-333 RNA. The total RNA
(5 ml, obtained 24h after electroporation of protoplasts) was used for the passage in addition to
5mg of gCNV-Y and 2mg of wt or RPR motif mutant DI-p33 (the extra amount was needed since
gCNV-Y and the mutated DI-p33 replicated inefficiently, but they were needed for DI-333
replication/recombination to supply the replicase proteins in trans). See further details in the
legend to Figure 3.5. (C) These experiments were performed with the p92 RPR motif mutants
using the conditions described in panel B.
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Chapter Four
Purification of the Cucumber necrosis virus replicase from yeast: The role of
co-expressed viral RNA in stimulation of replicase activity
Introduction
Plus-stranded RNA viruses, which constitute the largest group among plant and animal
viruses, replicate in the infected cells by using the viral replicase complex. The replicase
complex consists of viral-coded proteins, such as the RNA-dependent RNA polymerase (RdRp),
auxiliary proteins and possibly host-derived proteins and the RNA template (Ahlquist et al.,
2003; Buck, 1996; Buck, 1999; Kao et al., 1999; Osman and Buck, 1997). To study the
mechanism of viral RNA replication, functional replicases are purified from virus-infected hosts
(Bates et al., 1995; Cheng et al., 2001; Gal-On et al., 2000; Hayes and Buck, 1990; Nagy and
Pogany, 2000; Osman and Buck, 1996; Plante et al., 2000; Quadt and Jaspars, 1990; Quadt et al.,
1991; Song and Simon, 1994; Watanabe et al., 1999) or from heterologous systems, including E.
coli (Hong and Hunt, 1996; Kao et al., 1999; Lai et al., 1999; Neufeld et al., 1991a; Rajendran et
al., 2002; Ranjith-Kumar et al., 2003), yeast (Quadt et al., 1995), insect (Lohmann et al., 1997;
Neufeld et al., 1991; You and Padmanabhan, 1999), Xenopus (Gamarnik and Andino, 1996), and
mammalian cells (Gosert et al., 2003; Neufeld et al., 1991). The advantage of the heterologous
systems is that expression of the replicase proteins can be achieved without the dependence on
virus replication, thus facilitating mutational analysis of the replicase genes. In summary, viral
replicase systems, which are very useful to dissect the protein (trans-acting) and RNA (cis-
acting) factors that control virus replication, have only been developed for a limited number of
plus-stranded RNA viruses.
Tombusviruses are small plus-stranded viruses that belong to supergroup 2 viruses, such
as Hepatitis C virus, flaviviruses and pestiviruses, based on the similarity among their RdRp
sequences (O'Reilly and Kao, 1998; Russo et al., 1994). The genome of Tombusviruses codes for
five genes: involved in replication (termed p33 and p92, Figure 4.1), cell-to-cell movement
(p22), encapsidation (p41) and suppression of gene silencing (p19, Figure 4.1A, reviewed in
(Russo et al., 1994) and in White and Nagy (in press). The two overlapping replicase genes are
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essential for replication of the genomic (g)RNA in plant cells (Oster et al., 1998; Panaviene et
al., 2003; Scholthof et al., 1995d). While the p92 has the RdRp signature motifs in its unique C-
terminus, the function(s) of p33 is currently unknown. Mutagenesis of the RNA-binding site (an
arginine-proline-rich motif, termed RPR-motif (Rajendran and Nagy, 2003)) in p33 was found to
affect gRNA replication (Panaviene et al., 2003, chapter 2), subgenomic (sg)RNA synthesis and
RNA recombination (Panaviene and Nagy, 2003, chapter 3), suggesting that p33 is a
multifunctional protein. Similar mutations within the RPR-motif in p92 also affected RNA
replication, suggesting that the overlapping (pre-readthrough) domain in p92 is essential for its
function in infected cells (Panaviene et al., 2003).    
Tombusviruses are popular model viruses to study virus replication due to the presence of
small defective interfering (DI) RNAs, which are deletion derivatives of the viral gRNA (Figure
4.1A). These DI RNAs do not code for essential genes, allowing for convenient testing of the
role of essential and/or regulatory cis-acting elements, such as promoters (Havelda and Burgyan,
1995; Panavas et al., 2002a; Panavas et al., 2002b) replication enhancers (Panavas and Nagy,
2003a; Panavas et al., 2003; Ray and White, 2003) and a replication silencer (Pogany et al.,
2003).
Efficient assays based on partially-purified RdRp have been developed for TBSV and
CNV, which were obtained from infected plants (Nagy and Pogany, 2000).  These preparations
were then used to confirm the role of cis-acting sequences and structures in  TBSV DI RNA
replication   and   recombination   in  vitro  (Cheng and Nagy, 2003; Panavas and Nagy, 2003a;
Panavas et al., 2003; Panavas et al., 2002a; Panavas et al., 2002b; Pogany et al., 2003).   The
disadvantage   of   the   above   preparations   is   that replication of Tombusviruses   is
necessary   to   obtain   enough   RdRp   activity   for biochemical characterization.
The possibilities to use tombusvirus in broader replication studies increased with
development of  DI  RNA  replication  systems  in  yeast for TBSV and CIRV DI RNAs
(Panavas  and  Nagy, 2003b;  Pantaleo et al., 2003).  For  example,   expression  of  CNV
replicase  proteins  was  achieved  from  separate  plasmids  under  control of constitutive ADH1
promoter, while DI RNAs were expresse via galactose inducible (Gal 1) promoter.This study
showed that in the presence of replicase proteins TBSV DI RNA replicated in yeast cells
(Panavas and Nagy, 2003b). The replication of DI RNA was confirmed by: 1) detection of (-)
strand DI RNA, 2) accumulation of (+) strand DI RNA   over period of time, 3) generation of the
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5’and 3’ ends  that  are  found in DI RNA replicating in plants and protoplasts, 4) dependence of
DI 72 replication on the presence of cis acting element (RIII (-)  enhancer   for  TBSV  DI RNA ;
5)   generation  of  dimer RNAs  that   suggests possible recombination events during DI RNA
replication in yeast, 6) recovery  of  CNV replicase activity from yeast cells,which replicated DI
RNA (Panavas and Nagy, 2003b).
In    addition     to    studies of DI RNA  replication  in vivo,  development   of   a
heterologous   system   to   express  and  purify  highly  active   recombinant  tombusvirus
replicase would be useful to define the role of the replication proteins and RNA templates in
replication.
To obtain such a system, in this study, I used yeast cells, which co-expressed p33 and
p92, as well as the DI RNA template from plasmids (modified system described in Panavas and
Nagy (2003b). Characterization of the obtained CNV replicase preparation from yeast revealed
that it had similar properties when compared with the plant-derived preparation. The yeast-
derived preparation was capable of de novo initiation on exogenous plus- and minus-stranded DI
RNA templates.
The   previous   studies of replicase activity in vitro suggested that there were differences
in  viral  components  required  for replicase activity in vitro.  It was reported that   the RdRp of
several viruses, including Turnip crinkle virus, Tobacco etch virus, Bamboo mosaic virus,
Hepatitis C virus,   Bovine viral diarrhea virus   (Hong and Hunt, 1996;   Kao  et  al.,  1999;
Kao  et  al.,  2001;  Lai  et  al.,  1999;  Lohmann  et  al.,  1997; Rajendran et al., 2002; Ranjith-
Kumar et  al., 2003),  are  active  when  expressed without other  viral-coded  auxiliary  proteins.
On the contrary, RdRps for several other viruses, such as Brome mosaic virus  (BMV)  and
Alfalfa  mosaic  virus  (AMV),  required  the presence of several factors, such as the RdRp, a
viral auxiliary protein and the viral RNA in order to be functional in vitro (Quadt et al., 1995;
Vlot et al., 2001). It was established that 3’UTR and intracistronic region in RNA3 are required
for active BMV replicase formation. The study showed that there was correlation between
amount of (-) strand RNA3 and purified BMV replicase activity in vitro. The similar
requirements for 3’UTR were reported for AMV replicase activity in vitro.
 My experiments with CNV replicase purified from yeast showed that the generation of
highly active replicase in yeast required the co-expression of a DI RNA template together with
the essential p33 and p92 replicase proteins. The more detailed studies of DI RNA elements
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revealed that strong hairpin in RII (RIISL) and ~80 3’nt of RIV were required for active CNV
replicase formation in yeast cells.
Materials and methods
Construction of expression plasmids in yeast
 To express the CNV p92 gene with an N-terminal 6xHis-tag, we generated pGAD-
His92(Figure 4.1B).This was done by: (i)eliminating the HindIII site in pGADT7 (position 2280,
BD Biosciences) by partial digestion with HindIII, blunting the ends   with  Klenow polymerase
and religation. This modification yielded pGAD(H-) vector.  (ii)  The   CNV   p92    gene   was
amplified   by   PCR    using    primers     #424     (5’-
C G A C G G A T C C G A T A C C A T C A A G A G G A T G C T G T G )  a n d  # 9 5 2  ( 5 ’ -
CCCGCTCGAGTCATGCTACGGCGGAGTCAAGGA) from p92Y, in which stop codon of the
p33 gene was replaced with a tyrosine codon (Oster et al., 1998; Scholthof et al., 1995d). The
obtained 2.5 kb PCR fragment was digested with BamHI and XhoI. (iii) In addition, we
generated the 116 bp HindIII–BamHI fragment encoding a 6x His tag at the 5’ end (the actual
s e q u e n c e  i s :  5 ’ -
CTGGTGGACAGCAAATGGGTCGGGATCTGTACGACGATGACGATAAGGTACCCGGA
TCC) from pYES2/NT-C vector (Invitrogen).  (iv) Finally, the 2.5 kb and the 116 bp fragments
were cloned simultaneously into HindIII-XhoI digested pGAD(H-) vector to generate pGAD-
His92.
For the construction of pGBK-His33 (Figure 4.1B) to express the CNV p33 gene with an
N-terminal 6xHis-tag, we gel isolated the 1.5 kb HindIII (position 6544) – HindIII (position 738)
fragment from HindIII digested pGBKT7 plasmid (BD Biosciences). The CNV p33 sequence
was ampli f ied with  PCR using pr imers  #424 and #992B (5’-
GAGCTGCAGCTATTTCACACCAAGGGA). The obtained 0.9 kb PCR fragment was digested
with BamHI and PstI and gel isolated. In addition, the 116 bp HindIII-BamHI encoding a 6xHis
tag fragment was obtained as described above. The generated 1.5 kb, 0.9 kb and 116 bp
fragments were ligated together, followed by re-amplification of the ligated product with PCR
using primers #953 (5’-GATCCTTTTGTTGTTTCCGGGTGTACAATA) and #992B.  The
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obtained PCR product was digested with Bsp1407I and PstI and inserted into Bsp1407I and PstI
digested pGBKT7 vector.
To   modify the  original  RNA  transcription  vector  (Panavas and Nagy, 2003)  that
produced  yDI-72  RNA  with  a ~120  nucleotide  5’ leader, which is plasmid-borne nonviral
sequence,   we   constructed   a   new   expression   vector  based  on  the  high  copy  number
pYES2/NT-A   plasmid   carrying  a  URA3  selectable  marker  (Invitrogen)  and  the  GAL1
promoter.  First, pYC2/CT plasmid (Invitrogen), which was originally used to express yDI-72
RNA in yeast (Panavas and Nagy, 2003), was modified to remove most of the plasmid-borne
leader sequence, leaving only 4 bp between the start site of transcription and a HindIII site  in
pYC2/CTm.This was done using primers #1080
5’CAGGCAAGCGATCCGTCCGCCGGCGAACGT) and #1145 (5’-
CCCGAAGCTTACTTTTATTACATTTGAATAAGAAGTAAT)  in  a  PCR  reaction  in  the
presence  of  pYC2/CT  template. The obtained PCR product was digested with NaeI and HindIII
enzymes, gel purified and ligated into pYC2/CT between NaeI (position 4479) and HindIII
(position 501) sites, resulting in the pYC2/CTm plasmid. After the above modification of the
expression vector, we inserted DI-72 sequence in order to  facilitate  the  expression of plus  and
minus-stranded  DI-72 RNA. This was made   by a   two - step PCR reaction.  First, I used
primers    #542    (5’-GCCCGAAGCTTGGAAATTCTCCAGGATTTC) and     #157     (5’-
GGGCTGCATTTCTGCAATGTTCC)  for    plus  -  stranded  DI-72, and   primers #719     (5’-
GCCCGAAGCTTGGGCTGCATTTCTGCAATGTTC)      and       #20        (5’-
GGAAATTCTCCAGGATTTCTC) for minus-stranded DI-72 in the presence   of   DI-72SXP
template   (White  and  Morris, 1994b).  The   obtained    PCR products were separately gel
isolated and ligated with  gel  isolated   PCR   products   that   included the ribozyme sequence
from the minus-stranded satellite   of  Tobacco   ringspot   virus (TRSV) (Buzayan et al., 1988;
Buzayan  et  al.,  1986)    obtained     with    primers  #1067   (5’-
AGTCCTGTTTCTTGCCAAACAGAGAAGGGCACCAGAGAAA)      and     #1068      (5’-
GGTAATATACCACAACGTGTGTTTCTCTGGTGCCCTTCTC).     The   ligation    products
were     PCR          amplified          with         primers        #542       and       #1069  (5’-
CCGGTCGAGCTCTACCAGGTAATATACCACAACGTGTGT) for plus-stranded DI-72, and
with #719 and #1069 for minus-stranded  DI-72. The obtained PCR products were digested with
HindIII and SacI enzymes, gel isolated and ligated into the similarly – treated  pYC2/Ctm
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plasmid. Finally, to transfer  the  cloned plus-and minus- stranded DI-72 sequences to the high
copy plasmid  pYES/NT-A,  I  treated  the  above  plasmids with NgoMIV  and  EcoRI  and  then
the  gel  isolated  fragments  were inserted into NgoMIV and EcoRI-treated pYES/NT-A
plasmid. The obtained plasmids were termed as pYES-DI-72(+)Rz (Fig. 1B) and pYES-DI-72(-
)Rz.
DI-72 region deletion derivatives were obtained using PCR with following primer pairs
and templates: for RII/IV primers   #709    (5’- GCCCGAAGCTT AGAAACGGGAAGCTCGC)
and #157  with templast DI-72 XPXN DRIII ; for RI/II/III primers  #542  and  #454A  (5’-
GACCCAACAAGAGTAACCTGTATGCTATGC) with template  DI-72 SXP;  for RI/II/IV  and
RI/III/IV  primers  #542   and  #157  with  DI-72 XPXN DRIII and DI-72 XPXN DRII,
respectively; for RII/III/IV  primers #709  and #157 with  template  DI-72SXP. The PCR
products  were  gel  isolated, ligated to ribozyme as described   above,   and   secondary   PCR
was  performed  using  forward  primers  #542 (RI/II/III,  RI/II/IV,  RI/III/IV)  and  #709
(RII/II/III, RII/IV)  with  reverse primer #1069 using  as  templates  ligation  products.  The
obtained PCR products were  cloned  into pYES/NT-A, using the same procedure as described
for pYES-DI-72(+)Rz.
Construction   of RII/IV deletion  mutants are    described     below.   RII/gPR   was made
first     amplifying    RII    by    PCR    with    primers    #709    and    #1314    (5’-
CCCGGCATGCTTCTCTGCTTTTACGAAGGTAG) and    gPR    with   ribozyme   sequence
using    primers   #1317  (5’- CCCGGCATGCCATTGCAGAAATGCAGCCC) and   #1069
(template was RII/IV construct), followed by SphI digestion,  gel isolation, ligation  and   2nd
PCR   with   primers   #709 and #1069.  The   obtained   PCR   product was digested with
HindIII  and   SacI,  gel  isolated  and  ligated  into   similarly  treated pYES-DI-72 (+) Rz that
was  used  as   the  vector. RII/RIVDss4 was made ligating RII   PCR   product   as   for RII/gPR
construct    and      PCR     product      obtained      with     primers        #1318      (5’-
CCCGGCATGCGACACGGTTGATCTCACCCTTC) and    #1069  (template RII/IV), digested
with   SphI, followed by cloning steps used for   RII/gPR construction. The first step in
RIIDSL/RIV construction was making two PCR products: (1)- primers    #709   and     #1315
(5’-CCCGGGATCCGCTTTCCTGAACGGGGAAAG);   (2)- primers   #1316  (5’-
CCCGGGATCCGTGGAGAGTCTGCATATCACAC) and   #1314   using as  template RII/RIV
construct.  These PCR products were digested with BamHI, gel isolated, ligated and used in the
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2nd PCR reaction with primers  #709 and #1314. The RIV with ribozyme sequence was amplified
using primer #1309   (5’- CCCGGCATGCATTCCTGTTTACGAAAGTTAGG) and   #1069
from   RII/IV construct. Then   both   PCR   products were  digested  with SphI  and  following
cloning  steps   were   the  same  as  for  RII/gPR.  To make RIISL/RIVDss4 construct, first I
amplified from RII/IV construct RIISL sequence by PCR using primers #709 and  # 1308   (5’-
CCCGGCATGCGGCTCGTGTGTAAGTACGG),  digested   PCR   product   with HindIII  and
SphI  enzymes,  gel  isolated  and  ligated  into  RII/RIVDss4  replacing  RII sequence in this
plasmid. For construction of RII/RIV∆SL3 we did PCR using template RII/IV and
primers #709 and  #1319 (5’- CCCGGCATGCGTGTCTGGGTCCGCTTCCAC) for 5’ fragment
and   #1320   (5’-CCCGGCATGCAAGCACTACCGGACAACCGG) and #1069 for 3’fragment.
The PCR products were digested with SphI, gel purified, ligated and amplified with primers #709
and  #1069 and cloned into pYES/NT-A as described above. For construct RII/IV∆SL2 I used
similar approach, amplifying  5’end  fragment  with  primers  #709  and #1321 (5’-
CCCGGCATGCTAGTGCTTCCAGCGATCTCTA)    and    3’end    fragment    with  primers
#1317 and #1069, then following procedure as for construct RII/IV∆SL3.
Yeast transformation and growth
S. cerevisiae strain INVSc1 (Invitrogen) was used in these studies (Panavas and Nagy,
2003b). The yeast cells were co-transformed with all three plasmids (i.e., pGAD-His92, pGBK-
His33 and pYES-DI-72(+)Rz) using the LiAc/ssDNA/PEG method (Panavas and Nagy, 2003b).
In control experiments, we replaced one of the three plasmids with the original plasmid lacking
viral sequences. After transformation, yeast cells were plated on selective SC medium without
uracil, leucine and tryptophan (SC-ULT `).
For CNV replicase studies, yeast was grown in SC-ULT ` medium containing 2%
galactose for 24 h at 30°C. Then the cultures were diluted 10-fold with fresh SC-ULT ` medium
with 2% galactose and grown under the same condition until 0.6-0.7 OD600 (approximately 24 h).
Yeast cells were then harvested by centrifugation at 1100g for 5 min, followed by washing the
pellet with 20mM Tris- HCl, pH 8.0 and centrifugation (same as above). The pelleted cells were
re-suspended in a small amount (~1-2ml) of fresh buffer (20mM Tris-HCl, pH 8.0), aliquoted,
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followed by centrifugation at 21,000g for 1 min and storage of the pellet at –80°C until further
use.
For obtaining the enriched membrane fraction, yeast was grown at 30°C in SC-ULT `
with 2% glucose for 24 h, followed by dilution to 0.1 OD600 in SC-ULT ` with 2% galactose.
After further incubation at 23°C, yeast samples were taken at time points described in legend to
Figure 4.2.
Purification of the CNV replicase from S. cerevisiae cells co-expressing the replicase
proteins and DI RNA
 Frozen yeast cells were homogenized in liquid nitrogen by grinding in a mortar,
followed by transferring the obtained powder to a tube containing the extraction buffer (200mM
sorbitol, 50mM Tris-HCl, pH7.5, 15mM MgCl2, 10mM KCl, 10mM b-mercaptoethanol, yeast
protease inhibitor mix, Sigma), which was applied in 10-fold excess over the fresh weight of
yeast cells. Unbroken cells were removed by centrifugation at 100g for 1.5 min at 4°C.
Supernatant was then transferred to a new tube and the enriched membrane fraction was pelleted
via centrifugation at 21,000g for 15 min at 4°C. The obtained fraction was considered “enriched
membrane fraction”, which was re-suspended in the extraction buffer and used in the in vitro
replicase reactions as described below.
To further purify the CNV replicase preparation, the enriched membrane fraction was re-
suspended in the extraction buffer containing 1.2M NaCl, followed by gentle rotation for 20 min
at 4°C and centrifugation at 21,000g for 15 min at 4°C. The obtained pellet was re-suspended in
the extraction buffer containing 1% Triton X-100 and 5% SB3-10 (caprylyl sulfobetaine)
(Sigma) by gentle rotation for 1h at 4 °C, followed by centrifugation at 21,000g for 15 min at
4°C. The obtained supernatant was considered the “solubilized membrane fraction”. This
preparation was tested in the in vitro replicase assay as described below.
To prepare the samples for the His-tag-based metal-affinity purification, I solubilized the
enriched membrane fraction in the solubilization buffer (extraction buffer plus 1% Triton X-100,
5% SB3-10 and 0.5M KCl) as described above. After centrifugation, the supernatant was applied
to a column containing ProBond resin (Invitrogen) equilibrated with the solubilization buffer.
Then the column was rotated for 1 h, followed by washing with two column volumes of the
solubilization buffer, followed by washing with the extraction buffer containing 1% Triton X-
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100, 5% SB3-10, then a second wash with the extraction buffer containing 1% Triton-100, 5%
SB3-10 and 2mM imidazole. The recombinant proteins were recovered from the column in the
extraction buffer containing 150mM imidazole, 1% SB3-10 and 0.1% Triton X-100 in two-step
elution (each in a half column volume). The purity of the obtained recombinant protein-
containing preparations was tested with SDS-PAGE (Sambrook et al., 1989), while the amount
of the recombinant proteins in various samples was compared by using Western blotting with
monoclonal anti-His-tag antibody (Amersham).
In vitro CNV replicase assay
To test the activity of various preparations, I performed two types of assays. One tested the
endogenous template activity present within the CNV replicase preparation, whereas the other
assay examined the ability of the CNV replicase preparation to accept exogenous templates. The
only difference between the two assays is whether extra templates were added to the reaction or
not.
I used 0.5 mg RNA templates for the CNV replicase reactions. The reactions contained either
25 ml of recombinant or 25 ml of plant – derived CNV replicase as described previously (Nagy
and Pogany, 2000). Briefly, RdRp reactions were done in the buffer containing 50mM Tris-HCl,
pH8.2, 15m MgCl2, 10mM dithiothreitol, 20mM potassium glutamate, 1.0mM  each  ATP,  GTP,
CTP  and  0.01mM UTP, 0.3ml [a-32P] UTP,  4.8 U  RNAse  inhibitor  (Pharmacia).  Samples
were kept at 25°C for 2h. After phenol : chlorophorm   extraction   RdRp  products  were
precipitated  with  ammonium-acetated - isopropanol  mixture  and  washed  with  70%  ethanol.
Following heating with formamide at 85°C for 5 min. half of the RdRp products were analyzed
under denaturing conditions (i. e., 5% PAGE containing 8M urea) (Nagy and Pogany, 2000).
Preparation of protoplast membrane fraction for in vitro RdRp assay
 Nicotiana benthamiana protoplasts were prepared and electroporated as described
(Panaviene et al., 2003, chapter 2). The enriched membrane fraction and the solubilized
membrane fraction were prepared from pelleted protoplast cells using the method described
earlier (Nagy and Pogany, 2000): to each protoplasts sample  was added 500 ml of buffer A
(50mM Tris-HCl, pH 8.0, 15mM MgCl2 , 10mM KCl, 2mM EDTA, 20% (v/v) glycerol, 10mM
b-mercaptoethanol and 1x protease inhibitor (Sigma). Samples were shaken at 4°C for 10min,
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and spun down at 1000 rpm for 1.5 min. Supernatant was transferred to the fresh eppendorf tubes
and spun at 21,000g, for 10min at 4°C. The pelleted membrane fraction was resuspended in 100
ml of buffer B (50mM Tris-HCl, pH 8.0, 10mM MgCl2, 1mM EDTA, 6% (v/v) glycerol, 10mM
b-mercaptoethanol and 1x protease inhibitor).
Preparation of RNA transcripts
RNA transcripts for the replicase assays and protoplasts experiments were prepared using
standard in vitro T7 transcription reaction with various DNA templates as described (Panaviene
et al., 2003). The DNA templates used in this work were prepared as described in (Panavas and
Nagy, 2003a; Panavas et al., 2002b; Panavas et al., 2002d). Following the T7 RNA polymerase
reaction, the RNA transcripts were isolated from 1% agarose gel for the RNA blot, followed by
phenol/chloroform extraction, and precipitation in 95% ethanol. The RNA transcripts were
dissolved in water.
Total RNA extraction from yeast cells and RNA blot analysis
To extract total RNA from yeast, equal volumes of buffer (50mM sodium acetate, pH 5.2,
10mM EDTA, 1% SDS) and water-saturated phenol were added to the pelleted cells (Panavas
and Nagy, 2003b). Samples were vortexed, incubated for 4 min at 65°C, followed by incubation
for 2min on ice and cetrifugation at 21,000g for 5 min at room temperature. Total RNA was
precipitated from the aqueous phase by adding 3 volumes of 95% ethanol with 0.1 volume of 3M
sodium acetate, pH 5.2, and washed with 70% ethanol. RNA was dissolved in TE buffer and
formamide (in 1:1 ratio). Total yeast RNA samples were heated for 5 min at 85°C,
electrophoresed in 1% agarose gels, and transferred to Hybond XL membrane (Amersham). In
vitro made RNA transcripts, following 5 min preincubation with formamide at 85°C, were
pipetted to the Hybond XL membrane and crosslinked with UV (BioRad). Hybridization was
done using ULTRAhyb solution (Ambion) at 68°C according to the supplier’s instructions. The
32P-labeled replicase products were used as probes for hybridization.
Western blot
Aliquots of replicase proteins purified from yeast cells using Nickel-chelating affinity
columns were mixed in 1:1 ratio with SDS-PAGE sample loading buffer (Sambrook et al.,
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1989), heated for 5min at 85°C, electrophoresed in 8% SDS-PAGE gels and electrotransfered to
a PVDF membrane (BioRad). Non-specific binding sites on the membranes were blocked using
5% non-fat dry milk solution in TBS buffer (Sambrook et al., 1989) also containing 0.1% Tween
20, and the membranes were washed three times with TBS-Tween buffer and incubated with
monoclonal anti-His antibodies (Amersham) for 1h at room temperature. Following three 10-min
washes with TBS-Tween buffer, membranes were incubated for 1 h at room temperature with
secondary alkaline phosphatase-conjugated antibody (Sigma). After three washes of membranes
with TTBS, protein bands were developed using BCIP and NBT (Sigma).
Results
Comparison of CNV replicase activity of the enriched membrane fraction obtained from
yeast and plant protoplasts
To facilitate the detection and purification of CNV replicase proteins from yeast, I
modified the yeast expression system described earlier (Panavas and Nagy, 2003b). Briefly, we
added an N-terminal 6xHis-tag to both the p33 and p92 proteins, which were expressed
constitutively from high copy number plasmids (Figure 4.1B). Co-expression of the p33 and p92
proteins together with the DI-72 RNA replicon, which is obtained from the galactose-inducible
GAL1 promoter (Figure 4.1B), results in robust DI-72 RNA replication in yeast cells. The
presence of His-tags in p33 and p92 does not appear to inhibit DI-72 RNA replication, because
the amount of DI-72 plus-strand can reach ribosomal RNA levels in yeast, similar to that in plant
cells (see below).
Enriched membrane preparations were obtained from yeast co-expressing p33, p92 and
DI-72 as described in Materials and Methods. Briefly, yeast was grown on selective medium in
the presence of galactose for 12 to 30 hours (in a time course experiment, Figure 4.2), followed
by disruption of cells and differential centrifugation to obtain the crude, enriched membrane
fraction. For comparison, I used N. benthamiana protoplasts electroporated with CNV gRNA
transcripts (note that we did not use DI RNA template here, because the super-competitive DI-72
RNA would reduce gCNV replication, thus resulting in reduced amount of replicase in plant
cells), followed by harvesting of cells at various time points (Figure 4.2A). Then the enriched
membrane preparations were obtained from the CNV gRNA-transfected protoplasts using the
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method described in (Nagy and Pogany, 2000). Subsequently, the obtained enriched membrane
preparations from yeast and from plant protoplasts were tested in the presence of four
ribonucleotides, including 32P-labeled UTP. Under these conditions, the CNV replicase complex
is expected to complete RNA synthesis on the endogenous templates (i.e., the viral RNA that
was co-purified with the replicase), which are part of the actively synthesizing replicase complex
in cells. Since the replicase products became 32P-labeled during the in vitro reaction, they were
analyzed in denaturing gels (Figure 4.2A-B). These experiments demonstrated that both the
yeast- and plant protoplasts-derived CNV replicase complexes synthesized 32P-labeled products,
which were either DI-72 RNA-sized (in yeast, Figure 4.2A) or gRNA-, sgRNA1- and sgRNA2-
sized (in plant protoplast, Figure 4.2A). The amounts of these products increased over time in
both hosts, suggesting that more replicase complexes were formed in the cells during longer
incubation times. Accordingly, the amount of p33 increased continuously during incubation up to
24 hours in N. benthamiana protoplasts (not shown).
To test the nature of the in vitro synthesized replicase products, I recovered the 32P-
labeled RNAs after the in vitro replicase reaction, and used them as probes in RNA blotting. I
applied the same amounts of denatured plus- and minus-stranded DI-72 RNA for yeast samples
and CNV gRNA for protoplast samples as target RNAs, which were fixed on nylon membranes
(Figure 4.2C). After hybridization of the membranes with the 32P-labeled RNAs obtained from
the in vitro replicase reactions, I measured the ratio of plus- versus minus-strand-specific signals
on the RNA blots using a Phosphorimager (Nagy and Pogany, 2000). These experiments
demonstrated that the enriched membrane preparations containing the CNV replicase from both
yeast and plant protoplasts synthesized more minus-stranded than plus-stranded RNAs at the
early time point, while the synthesis was gradually shifted toward plus-strands at later time
points (Figure 4.2D, left panel). This finding was expected based on detection of more abundant
plus-strands than minus-strands in plant protoplasts at late time points (Ray and White, 2003).
Interestingly, I observed new minus-strand synthesis by the CNV replicase even at late time
points in both preparations (Figure 4.2D, right panel), suggesting that the minus-strand synthesis
had not been “shut down” in order to favor plus-strand synthesis (see Discussion).
86
Solubilized CNV replicase preparation from yeast is capable of using exogenous templates
in vitro
 Because the CNV replicase present in either the crude yeast extract or the enriched
membrane fraction was unable to utilize exogenous template (i.e., template added for the in vitro
reaction) (Figure 4.3A), I tried various detergents to solubilize the replicase complex from
membranes (not shown). I found that after treatment with either 1% Triton X-100, the replicase
complex remained active, because it could synthesize 32P-labeled RNA product using the
endogenous template (see Figure 4.3A, lane 9). The same preparation, however, was also capable
of complementary RNA synthesis on added (exogenous) template as well (Figure 4.3A, lane 9).
In summary, I conclude that the solubilized preparation contains a highly active CNV replicase
that can be programmed by added templates.
Affinity-based purification of CNV replicase from yeast
To purify the recombinant CNV replicase from the solubilized preparation, I utilized the
engineered 6xHis-tag present at the N-termini of p33 and p92 for nickel-chelating affinity
purification as described in Materials and Methods. Analysis of crude yeast proteins, and
proteins eluted from the column samples on SDS/PAGE gel showed amount of p33 protein in
comparison to yeast proteins. As a control were used proteins purified from yeast cells that did
not express p33 protein (Figure 4.3, B). I found that the obtained purified CNV replicase
preparation showed high polymerase activity (Figure 4.3A, lane 10). Characterization of the
replicase product by PAGE analysis revealed that the recombinant CNV replicase was able to
synthesize complementary RNA on added RI/III(-) template, which contains minus-stranded
sequence of region I and region III of DI-72 (Figure 4.1A), in the presence of ribonucleotides
and 32P-labeled UTP. Next, I wanted to know if the properties of the purified recombinant CNV
replicase was comparable with that of the partially-purified CNV replicase (RdRp) preparation
obtained from infected N. benthamiana plants (Nagy and Pogany, 2000). First, I tested plus- and
minus-stranded DI-73 RNA templates in vitro. DI-73 RNA contains the same sequence as DI-72
(Figure 4.1A), plus a 167 nt long sequence between RIII and RIV, which is missing in DI-72
RNA (White and Morris, 1994b). Importantly, the larger size of DI-73 than that of DI-72
allowed me to distinguish between the added exogenous DI-73 RNA and the co-purified
endogenous DI-72 templates after the in vitro reaction. I found that the yeast-derived
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recombinant and the plant-derived CNV replicase produced comparable products with DI-73(+)
and (-) templates (Figure 4.4, lanes 1-4). For example, both preparations used the minus-stranded
template more efficiently than the plus-stranded DI-73. In addition, both replicase preparations
synthesized three different types of RNA products on DI-73(-), such as (i) template-sized
complementary RNA obtained by de novo initiation from the 3’-terminal promoter, (ii) several
shorter-than-template-sized products, which were due to de novo initiation at internal positions
(resembling promoter-like sequences (Panavas et al., 2002b)), and (iii) a longer-than-template-
sized product, which was the result of primer extension from the 3’ end of the template (self-
priming reaction). All these in vitro replicase products were characterized in detail before using
the plant-derived preparation (Nagy and Pogany, 2000; Panavas et al., 2002a; Panavas et al.,
2002b).
Additional templates tested in the recombinant CNV replicase assay were the CNV-
derived DI-42, the related Turnip crinkle virus (TCV)-associated satD and satC (Song and
Simon, 1994), the Q beta-associated satellite RNA (termed MDV,(Axelrod et al., 1991)) and
yeast tRNA (Figure 4.4). All these viruses belong to “supergroup 2”, though TCV and CNV are
more closely related (they belong to Tombusviridae family) than Q beta bacteriophage. The
recombinant and the plant-derived CNV replicases were found to use DI-42(-) (lanes 15-16) and
satC(-) (lanes 11-12)  templates efficiently, while DI-42(+)(lanes 13-14), satC(+) (lanes 9-10),
satD(+) (lanes 5-6)  and satD(-) (lanes 7-8) RNAs were less efficient templates in vitro (Figure
4.4). In contrast, MDV(-) (lanes 17-18) and the yeast tRNA(lanes 23-24) were not recognized by
the CNV replicase as templates (Figure 4.4). Overall, the template specificities of the
recombinant and the plant-derived CNV replicases were very similar.
To test if the recombinant CNV replicase can recognize properly TBSV and CNV-
derived cis-acting sequences, such as minus- or plus-strand initiation promoters, I used
constructs MDV(-)/gPR and MDV(-)/cPR, which carried either the gPR promoter (i.e., the
minimal minus-strand initiation sequence in TBSV and CNV, (Panavas et al., 2002a; Panavas et
al., 2002b)) or the cPR promoter (i.e., the minimal plus-strand initiation sequence (Panavas et al.,
2002a)) in addition to the MDV(-) sequences at the 5’ end. Analysis of the in vitro replicase
products revealed that the recombinant yeast derived CNV replicase, similar to the plant-derived
preparation, recognized these minimal promoter sequences correctly and efficiently (Figure 4.4,
lanes 19-22).
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Isolation of highly active CNV replicase complex requires co-expression of template RNA
in yeast
To take advantage of the heterologous CNV replicase system, I co-expressed various
combinations of p33, p92 and DI-72 RNA in yeast, followed by testing the replicase activity of
the purified preparations in the presence of an added RNA template [RI/III(-)] as shown in
Figure 4.5. These experiments demonstrated that neither p33 nor p92, when expressed separately
in yeast, had detectable levels of replicase activity in vitro (Figure 4.5, lanes 1-2). Co-expression
of p33 and p92 in the same yeast cells, however, resulted in detectable, albeit very low, level of
replicase activity on the added template in vitro (Figure 4.5, lane 3).  The observed polymerase
activity seems to come from the CNV replicase, because it was capable of producing full-length
products, which were single-strand-specific RNase-resistant (not shown), and these products
were similar to those observed with the plant-derived CNV replicase preparation (Figure 4.3,
lane 11).
Co-expression of p33, p92 and DI-72(+) RNA in the same yeast cells, however, led to the
isolation of a CNV replicase preparation with the highest activity as shown in Figure 4.5 (lane 5).
These observations suggest that the RNA template stimulates significantly (~40-fold increase)
the formation of stable CNV replicase complex in vivo (see Discussion). In contrast, co-
expression of DI-72(-) template with p33 and p92 resulted in basal level of CNV replicase
activity (Figure 4.5, lane 4), suggesting that the minus-stranded RNA cannot stimulate the
formation of the CNV replicase in vivo. Western-blot analysis of levels of p33 and the less
abundant p92 in the purified replicase preparations revealed that the protein levels were
comparable in the active (Figure 4.5C, lane 5), less active (lanes 3-4), and inactive preparations
(lanes 1-2), suggesting that there is no correlation between the amount of the individual replicase
proteins and the activity of the purified CNV replicase in vitro.
To examine if active CNV replicase can be assembled in vitro from separately expressed
components, I used three types of mix-and-match experiments. In one type, I mixed in 1:1 ratio
two separate enriched membrane fractions obtained from two yeast strains, which co-expressed
p92/DI-72 RNA and p33/DI-72 RNA separately, prior to the replicase assay (Figure 4.6, lane 3).
I did not observe endogenous (32P-labeled) DI-72 RNA product in this mix-and-match assay in
contrast to the high template activity obtained with similar extract derived from yeast co-
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expressing p33/p92/DI-72 RNA (Figure 4.6, lane 1). The second type of assay included the
mixture of purified p33 and p92 components (expressed separately in two yeast strains) and
exogenous RI/III(-) template obtained by in vitro transcription. Again, I did not observe
detectable level of replicase activity in this in vitro mix-and-match experiment (Figure 4.6, lane
6). The control experiment, which included affinity-purified preparation obtained from yeast co-
expressing p33/p92/DI-72 RNA, resulted in 32P-labeled products from the endogenous and
exogenous templates (Figure 4.6, lane 10).
Because it is possible that I might have lost one or more host-derived components from
the CNV replicase during purification, thus resulting in inactive replicase in the above mix-and-
match experiment, I also used non-purified solubilized membrane fractions for in vitro studies
(Figure 4.6, lanes 11-17). However, mixing (prior to the replicase assay) solubilized membrane
fractions obtained from two separate yeast strains, which co-expressed either p92/DI-72 or
p33/DI-72, in 1:1 (Figure 4.6, lane 14) and 1:4 ratio (Figure 4.6, lane 15), respectively, did not
give the predicted 32P-labeled products in the in vitro assays. Based on these mix-and-match
experiments with (i) the enriched membrane fractions, (ii) the solubilized membrane fractions, or
(iii) the affinity-purified replicase proteins and RNA transcripts, I conclude that the in vitro
conditions used did not favor the assembly of functional CNV replicase complex. This result is
in contrast with the in vivo conditions in yeast co-expressing p33/p92/DI-72 RNA, which gave
functional CNV replicase. Future studies will be aimed to test if cellular membranes or host
factors, which might be missing in the above preparations, are needed for the assembly of the
CNV replicase complex.
Identification of DI RNA elements required for active CNV replicase assembly in vivo
To identify DI RNA elements necessary for active CNV replicase formation in yeast
cells, I made a series of DI RNA deletion constructs (Figure 4.7A) that were individually co-
expressed with p92 and p33 proteins. Expression of the above deletion mutants of DI RNA was
achieved by growing yeast cells in galactose containing media. The CNV replicase was isolated
as described above and its activity was tested in in vitro reaction using exogenous template RI/III
(-) (Figure 4.7B). The results of this experiment showed that when yeast cells co-expressed
p92/p33 and one of DI RNA deletion mutants: namely RI/II/IV, RII/III/IV, RII/IV (Figure 4.7A),
the activity of the purified CNV replicase was comparable to activity of replicase purified from
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cells co-expressing full length DI-72 and replicase proteins (Figure 4.7B lanes 1, 2, 5 and 6).
These results suggested that both RII and RIV are necessary for replicase activation. The
requirement of RII/IV for active replicase formation in vivo was supported by experiments
performed with DI RNA deletion mutants lacking one of these regions (Figure 4.7A, constructs
RI/II/III and RI/III/IV). CNV replicase purified from yeast cells co-expressing one of these
constructs and p92/p33 proteins had only basal level of activity (Figure 4.7B, lanes 3 and 4).
 The total yeast RNA analysis by Northern blot using as a probe RI/III/IV (-) RNA
showed that most of the DI RNA deletion mutants did not replicate at all or replicated very little
(Figure 4.7C), with exception of construct RI/II/IV (Figure 4.7C, lane 6).  I have not observed
correlation between DI RNA replication in yeast cells and the activity of the purified replicase in
vitro (constructs RII/III/IV and RI/II/IV (Figure 4.7B-C, lanes 5 and 6)). Both these constructs
stimulated replicase activity, albeit construct RI/II/IV RNA is more abundant than RII/III/IV
(Figure 4.7B-C, lanes 5 and 6).  These results suggest that very limited amount of certain viral
RNA sequences is sufficient for active replicase formation.
The aim of the next set of experiments was to identify RNA elements within RII/IV RNA
that are required for CNV replicase activation. I made separate deletions in RII and RIV,
eliminating predicted RNA structures (Figure 4.8A). These constructs were co-expressed with
p92 and p33 in yeast cells, followed by replicase purification and in vitro reaction with
exogenous template RI/III(-). The results showed that deletion of RII SL (Figure 4.8A, construct
2) resulted in low replicase activity (Figure 4.8B, lane 2). Combination of (-) strand initiation
promoter (gPR) and RII (Figure 4.8A, construct 3) did not increase replicase activity (Figure
4.8B, lane 3). This observation suggested that RII is not sufficient for assembly of the active
replicase, even in the presence of promoter. Separate deletions of SL3, SL2 and gPR in construct
RII/IV resulted in reduced CNV replicase activity suggesting that each of these sequences is
important in CNV replicase assembly (Figure 4.8A, constructs 5, 6, 7. In contrast, deletion of
single stranded (ss) region from 5’end in RIV (Figure 4.8A, construct 4) did not affect replicase
activity when compared to RII/IV (Figure 4.8B, lane 4 and 1).  Additional experiments defined
that RIISL/RIVDss4 (Figure 4.8A, construct 8) is the minimal construct, which still support
efficient replicase assembly.
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The future studies should further define structures and nucleotides within RIISL/RIVDss4
RNA that are critical for stimulation of CNV replicase and possibly will lead to better
understanding the role of the viral RNA role in replicase assembly.
Discussion
TBSV and CNV replicases obtained from infected plants have been used extensively to
characterize viral RNA elements that affect plus- and minus-strand synthesis, including promoter
(initiation) elements (Panavas et al., 2002a; Panavas et al., 2002b), replication enhancers
(Panavas and Nagy, 2003a; Panavas et al., 2003) and a replication silencer element (Pogany et
al., 2003), and template-switching in vitro (Cheng and Nagy, 2003; Cheng et al., 2002). These
processes are important for replication and recombination (including DI RNA formation) of
Tombusviruses. In spite of the usefulness of the above plant-derived CNV replicase preparations
in providing in vitro data that complement the wealth of in vivo data on Tombusviruses (Fabian
et al., 2003; Havelda and Burgyan, 1995; Park et al., 2002; Ray and White, 1999; Ray and
White, 2003; Ray et al., 2003), there is one major drawback in obtaining such preparations: the
production of the replicase proteins depends on virus replication. Therefore, the effect of
detrimental mutations within the viral RNA or the replicase proteins on replication is difficult to
study in the plant-derived in vitro CNV replicase assay. The development of a heterologous
expression system for the CNV replicase genes in yeast should however circumvent this
problem. This is because the recombinant replicase proteins are produced from expression
plasmids in yeast even in the absence of viral replication (Figure 4.5D). Accordingly, I
succeeded to purify active CNV replicase complex from yeast in the absence of replicating CNV
gRNA (Figure 4.5A). This recombinant preparation will complement the traditional plant-based
CNV replicase assay.
Comparison of the recombinant CNV replicase from yeast and the partially-purified CNV
replicase preparation from plants revealed that both were capable of complementary RNA
synthesis on added templates. I observed three different types of replicase products when minus-
stranded DI-72 RNA was used as a template: (i) production of full-length complementary RNA
product (via de novo initiation from the 3’-terminal cPR promoter (Panavas et al., 2002a)); (ii)
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internal initiation from promoter-like sequences (also via de novo initiation (Panavas et al.,
2002b)); and (iii) primer-based initiation (self-priming from the 3’ end) of complementary RNA
synthesis (Cheng et al., 2002). In contrast to the minus-stranded templates, the plus-stranded DI-
72 RNA was used inefficiently by both replicase preparations (Figure 4.4). Thus, in spite of (i)
the different expression strategies for p33 and p92 in plant (CNV-infection-based) and in yeast
(plasmid-based), (ii) the different purification methods (i.e., affinity-based purification from
yeast and purification via chromatography from plants), and (iii) the different N-terminal
sequences in p33 and p92 (i.e., wt p33/p92 in the plant-expressed and His-tagged p33/p92 in the
yeast-expressed preparations), the properties of the purified recombinant CNV replicase
preparations and the plant-derived preparations are comparable under the in vitro conditions
used.
The results shown in this study confirm that the functional CNV replicase complex
contains both p33 and p92 replicase proteins (Figure 4.5). This has been predicted earlier based
on data obtained from biochemical and genetic experiments (Nagy and Pogany, 2000; Oster et
al., 1998; Panaviene et al., 2003; Scholthof et al., 1995d). Yet, it is somewhat surprising that the
purified recombinant p92, when expressed alone in yeast, was not a functional polymerase
(RdRp) in vitro (Figure 4.5). This is because p92 contains the same sequence as p33 in its N-
terminal overlapping (pre-readthrough) domain (Figure 4.1A). Apparently, the N-terminal region
in p92 cannot fulfill the function(s) provided by the “free” p33 in the CNV replicase complex. In
contrast to the CNV p92, which requires p33 in the functional CNV replicase, the similar TCV
p88 RdRp protein or its N-terminally truncated version (when purified from E. coli) are highly
active polymerases in vitro in the absence of the smaller replicase protein (i.e., p28 (Rajendran et
al., 2002)). It is currently not known what is the reason for this difference between the CNV and
TCV RdRp proteins in the requirement for the auxiliary viral protein.
In addition to the p33 and p92 replicase proteins, the endogenous DI RNA is also an
important factor in the CNV replicase complex. Although the purified CNV replicase containing
p92 and p33 was active in the in vitro assay, co-expression of DI-72 RNA in the same yeast cells
resulted in a CNV replicase preparation with ~40-fold enhanced activity (Figure 4.5A). By using
Western blotting, I excluded the possibility that the increase in replicase activity is due to
increased amounts of the replicase proteins in the purified preparations obtained from yeast
lacking or co-expressing DI-72 RNA (Figure 4.5D). I also demonstrated that the enhanced CNV
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replicase activity requires the plus-stranded DI-72 RNA, while the minus-stranded DI-72 failed
to achieve the same effect (Figure 4.5). The more detailed studies of DI RNA elements revealed
that strong hairpin in RII (RIISL) and ~80 3’nt of RIV were required for active CNV replicase
formation in yeast cells (Figure 4.8). Based on these observations, I propose that the role of the
plus-stranded RNA template is to promote the assembly of the functional replicase in cells by
possibly providing an “assembly platform”. A similar model on the “nontemplate” role of the
RNA has also been proposed for the BMV and the Alfalfa mosaic virus (AMV) replicases, which
are related to each other, but only very distantly related to the CNV replicase (Quadt et al., 1995;
Vlot et al., 2001). A seemingly important difference between the BMV and AMV replicases
versus the CNV replicase is that the latter is functional, albeit at a low level, in the absence of the
RNA template (Figure 4.5).
Although the co-expression of DI-72 RNA is important for isolation of highly active
CNV replicase from yeast, I found that, after purification of the replicase complex, the template
RNA can be removed partially without the loss or large reduction in the activity of the CNV
replicase (based on exogenous templates, Figure 4.4). This suggests that the CNV replicase, once
it has been formed in cells, is a stable complex even in the absence (or in the presence of minute
amount) of RNA.
The actual role(s) of the RNA template during the assembly of the CNV replicase
complex or during other processes, such as recruitment of replicase proteins to the membranous
structures (the proposed sites of Tombusvirus replication (Pantaleo et al., 2003; Rubino and
Russo, 1998)), is currently unknown. My effort to assemble the CNV replicase in vitro from
either purified components (p33/p92 and DI-72 RNA) or by mixing enriched or solubilized
membrane fractions failed to yield functional preparation (Figure 4.6). It is possible that our in
vitro preparations lacked host factors and/or particular membrane surface, which might be
essential for the assembly of the functional CNV replicase complex in vivo.
Time-course experiments (Figure 4.2A-D) revealed that the CNV replicase present in the
enriched membrane fractions obtained from yeast and N. benthamiana protoplasts synthesized
both plus and minus-stranded products in vitro. As expected, the CNV replicase synthesized
more plus-stranded products at the late time points than at the early time point (Figure 4.2D, left
panel). However, we also observed new minus-strand synthesis taking place even at the late time
points in the enriched membrane preparations obtained from yeast and plant protoplasts. Based
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on this observation, I propose that the CNV replicase is involved in minus-strand synthesis
during the entire replication process, thus there is no “shut down” of minus-strand synthesis in
cells, a process that would favor plus-strand synthesis at the late time points, as suggested for the
unrelated Tobacco mosaic virus (Ishikawa et al., 1991). This observation seems to be valid for
both the yeast-based infection-independent and the protoplast-based infection-dependent systems
(Figure 4.2C). I interpret these results that new CNV replicase complexes, which first synthesize
minus-stranded RNA products, are continuously being formed in yeast cells and in plant
protoplasts, even at the late time points. In agreement with this model, the amounts of plus- and
minus-stranded TBSV (Ray and White, 2003) and CNV RNAs (not shown), both gRNA and DI
RNA, increase continuously over 24-30 hours of infection in cucumber and N. benthamiana
protoplasts. Also, I found that the amount of p33 increases over time (up to 24 hours) in plant
protoplasts (not shown), which suggests continuous production of p33, and possibly p92,
replicase protein in these cells.
The above model is based on the assumption that the obtained CNV replicase
preparations can only complete RNA synthesis on the endogenous templates, thus the new 32P-
labeled in vitro replicase products would only consist of the complementary strands of the co-
purified RNAs. However, it is also possible that the CNV replicase present in the enriched
membrane fraction can perform sequential plus- and minus-strand synthesis from the
endogenous templates. This complete in vitro replication would result in new 32P-labeled
replicase products consisting of both strands, even if the co-purified RNA was consisted of one
strand. Although I cannot exclude this model at this time, I do not have any evidence supporting
complete replication in our CNV replicase assays (based on either endogenous or exogenous
templates). Future experiments will address this possibility.
In summary, in this work, I have developed three new in vitro assays with the
recombinant CNV replicase. One assay is based on obtaining an enriched-membrane fraction, the
second on solubilized membrane preparation, and the third on affinity-purified replicase
preparation, which will be useful to further study the mechanism of Tombusvirus replication and
recombination. In addition, I have demonstrated that the CNV replicase complex contains both
p33 and p92 replicase proteins. Also, the activity of the CNV replicase obtained from yeast is
greatly enhanced by co-expression of DI-72(+)-strand, in particular RNA elements located in RII
and RIV, suggesting that the viral RNA plays a role in assembly of the CNV replicase.
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Figure 4.1: Expression of CNV replicase proteins in yeast. (A) Genome organization of CNV
and the closely related TBSV RNA encoding five open reading frames, and TBSV-derived DI-72
RNA. The p33 and p92 replicase genes are shown as white boxes (“STOP” sign represents
translational termination codon at the end of p33) and remaining three genes are shown as black
boxes. Regions of TBSV present in DI-72 RNA are marked on the gRNA. (B) Plasmids used to
express the CNV p33 and p92 replicase proteins and DI-72 RNA in yeast cells. pGBK- His33
and pGAD-His92 have constitutive PADH promoter, and DI-72 RNA is expressed from galactose
inducible (PGAL1) promoter. Black boxes in pGBK-His33 and pGAD-His92 constructs represent
the 6¥His tag. The translation termination codon of p33 was replaced with a tyrosine (Y) codon
allowing p92 expression from pGAD-His92 plasmid. There is a satTRSV(-) ribozyme (Rz sat) at
the 3’end of DI-72.
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Figure 4.2: Characterization of CNV replicase activity in enriched membrane fractions derived
from yeast or N. benthamiana protoplasts. (A) PAGE analysis of the (32P-labeled) in vitro
replicase products on the endogenous templates, which are present in the enriched membrane
fractions, obtained from yeast (top) and from protoplasts (bottom). Time of incubation, shown on
the top of the gel in the time-course experiments, started after the addition of galactose to the
media for yeast or with the addition of incubation media after electroporation for N. benthamiana
protoplasts. Arrows indicate the bands that correspond to products obtained on the various
endogenous RNAs. (B) Relative RdRp activity of enriched membrane fractions. Circles and
triangles represent data obtained with CNV replicase derived from protoplasts and yeast,
respectively. The CNV replicase activity at the 30 hr time point corresponds to 100%. (C) RNA
blot showing (+) and (-) strand levels in the in vitro CNV replicase products on endogenous
templates. Unlabeled in vitro transcripts of DI-72(+) and DI-72(-) (400 ng each) for yeast and
gCNV(+) and gCNV(-) for protoplasts-derived samples were blotted on the membrane as shown
below the blots. Time points for harvesting the yeast and protoplast samples for isolation of
membrane fractions are shown on the top. The blotted RNAs were hybridized with denatured
32P-labeled RNA probes, which were generated by the CNV replicase in vitro on the endogenous
templates present in the enriched membrane fractions from yeast or protoplast (see panel A). (D)
Relative amounts of plus- and minus-stranded RNAs in the in vitro replicase products. Total
replicase products at each time point were taken as 100% (left panel), or the amount of plus-
stranded replicase product at the 30 hr time point was taken as 100% (right panel). Solid and
dotted lines represent plus- and minus-stranded products, while circles and triangles represent
data obtained with preparations from protoplasts and yeast, respectively.
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Figure 4.3:  Activity of CNV replicase in different preparations obtained from yeast. (A) Each
preparation,  as  shown  on the  top,  was  tested  in  the  absence  or  presence  of exogenous
RI/III(-) template, which contains the minus-stranded regions I and III of DI-72 (Figure 4.1A)
in  a  standard  CNV  replicase  assay.  The positions of the exogenous RI/III (-), the
endogenous  DI-72  (for  the  yeast - derived  samples),  genomic (g)  and subgenomic (sg1 and
sg2) templates (plant), are shown by arrows and bracketed lines on the  side of the gel. The
internal initiation products and the primer extension product are shown   with  a  bracket   and
an   asterisk,  respectively.  “Sol” represents  “solubilized membrane fraction”, while “Pur”
indicates  affinity-purified CNV replicase from yeast, while   “Nb”   represents   the   partially -
purified   CNV   replicase   obtained  from   N. benthamiana  plants.  The  replicase  products
obtained  from the endogenous templates representing  gCNV,  sgRNA1  and  sgRNA2  are
indicated  as  “g,  sg1  and  sg2”.
(B) Silver stained SDS-PAGE gel of protein samples from indicated replicase preprations used in
(A).
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Figure 4.4: Comparison of template usage by the CNV replicases obtained from yeast and plant
in vitro. Radiolabeled replicase products were analyzed on denaturing 5% PAGE/8M urea gels.
The exogenous RNA templates used in the in vitro replicase reaction are shown on the top of the
gel. The products of the CNV replicase purified from yeast (odd lane numbers) and from plants
(even lane numbers) are shown. RNA size markers obtained by T7 transcription with [a-32P]
UTP are shown on the left side of the gel. Template-sized products are marked with arrowheads,
while the primer extension and internal initiation products are marked with asterisks and
bracketed lines, respectively. The replicase products obtained from the endogenous templates
representing gCNV, sgRNA1 and sgRNA2 are indicated as “g, sg1 and sg2”.
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Figure 4.5: Co-expression of DI-72 RNA in yeast stimulates the activity of the purified CNV
replicase. (A) 32P-labeled RNA products obtained in the in vitro CNV replicase assay with
exogenous template [RI/III(-)] were analyzed on 5% PAGE/8M urea gel. The co-expressed p33,
p92 and DI-72(+) or (-) RNAs in yeast cells are shown on the top as “+”, while yeast lacking one
of these components is marked as “-“. See additional symbols in the legend to Fig. 4. (B)
Northern blot of total yeast RNA (top) and corresponding ethidium-bromide stained agarose gel
(bottom). The total RNA was extracted from the yeast cells co-expressing various components as
shown in panel (A), analyzed in 1% agarose gel (bottom) and with Northern blotting (top) using
32P-labeled RI/III/IV(-) RNA probe. Transcripts of yDI-72-(before ribozyme cleavage) and DI-
72-sized bands are indicated by arrows. (C). Western blot analysis of p33 and p92 proteins,
which were affinity-purified from yeast cells co-expressing the shown viral components (see
panel A), with anti-His antibodies.
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Figure 4.6: Mix-and-match in  vitro  replicase  assays. The CNV replicase preparations represent
enriched membrane fractions (lanes 1-5), affinity purified proteins (lanes 6-10), solubilized
membrane  fractions  (lanes 11 - 17)  obtained  from  yeast,  except  lane  16 contains   products,
which   were   generated   by   CNV   replicase   obtained   from   N. benthamiana plants. The
CNV replicase assay in lanes 6-17 included exogenous RI/III(-) templates. The co-expressed
p33, p92 and DI-72 (+) RNA in yeast cells are shown on the top as “+”, while yeast lacking one
of  these  components  is marked as “-“. The boxed lanes represent the mixed preparations as
follows: preparations containing either p33 or p92 (co-expressed with DI-72 RNA) were
obtained from separate yeast lines, which were mixed in  1:1  ratio  prior  to  the CNV replicase
reaction (replicase products in lanes 3, 6 and  14-15  are from mixing preparations corresponding
to yeast lines shown in lanes 4-5; 7-8 and 12-13,  respectively). Note that the  CNV  replicase
preparation  in  lane 15 was obtained  by  mixing  p92  and  p33 preparations in 1:4 ratio. The
CNV replicase products generated   on endogenous DI-72 or  exogenous  RI/III(-)  templates  are
marked.  Lane marked as  “Nb” represents the replicase  product obtained with the plant-derived
CNV replicase preparation.
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Figure 4.7: DI-72 regions necessary for purified CNV replicase activity stimulation. (A)
Schematic representation of DI-72 deletion  derivatives  used  in  (B) and (C) analysis. Boxes
represent DI-72  regions  present  in the construct (numbers indicated inside box), while thin bent
lines show deleted regions. (B) 32P-labeled RNA products obtained in the in vitro CNV replicase
assay with exogenous template [RI/III(-)] were analyzed on 5% PAGE/8M  urea  gel. The co-
expressed with p33 and p92 DI-72 deletion derivatives are indicated by numbers on the  top  of
the  gel. Template-sized products are marked with arrowheads, while the primer extension and
internal initiation products are marked with asterisks and bracketed lines, respectively. (C)
Northern blot  of total  yeast RNA. The total RNA was extracted from the yeast cells co-
expressing various components as shown in panel (B), analyzed with Northern blotting using
32P-labeled RI/III/IV(-) RNA probe. Transcripts of yDI-72 constructs -(before ribozyme
cleavage) and DI-72 constructs-sized bands are indicated by arrows.
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Figure 4.8: Defining DI-72 regions  II/IV  (RII/IV)  motifs  involved  in  purified  CNV replicase
activity stimulation. (A) Schematic representation of RII/IV constructs used in (B). Boxes
represent  RII/IV  motifs  present  in  the construct (names marked inside box) and bent lines
indicated deleted part of the region. RIISL-region II stem -loop; ss4- single stranded 4; SL3 -
stem -loop 3 (includes silencer);   SL2 - stem- loop 2;   gPR - genomic promoter ((-) strand
initiation promoter). (B) 32P-labeled RNA products obtained in the in vitro CNV replicase assay
with  exogenous  template  [RI/III(-)]  were  analyzed on 5% PAGE/8M  urea  gel.  The co-
expressed with p33 and p92 RII/IV deletion derivatives are indicated by numbers on the  top  of
the  gel. Template-sized products are marked with arrowheads, while the primer extension and
internal initiation products are marked with asterisks and bracketed lines, respectively.
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Chapter Five
Summary
Tombusviruses are small positive -strand RNA viruses of plants. They are excellent
model system that can help us understand replication and recombination of RNA viruses in
general. Tombusviruses use only two viral coded proteins p33 and p92 for replication.
The purpose of this work was to study in detail the role of the common arginine/proline
rich (RPR) RNA binding motif of p33 and p92 (Rajendran and Nagy, 2003) in tombusvirus
replication, recombination and sgRNA synthesis. The first part of the study showed that RPR
motif is critical for RNA binding and, thus, for replication. Mutational analysis revealed that the
second and third arginines residues within the RPR (sequence RPRRRP) motif were required for
virus replication in cis (gRNA) and in trans (DI RNA), and they are likely involved in RNA
binding. I also showed that addition of one more arginine within the RPR motif increased
sgRNA2 accumulation about 20 fold, compared to gRNA, while mutations of proline to alanines
decreased sg RNA2 accumulation by ~ 40%. Separately introduced mutations to p33 or p92
showed that the third arginine mutations were critical for p33 function, while they had smaller
effect when present in p92 for virus replication. This finding suggests that RPR motif might be
more critical for function of p33 than for p92. This effect could be related to the requirement of
higher concentration of p33 than p92, or RPR is required for p33, but is less important for p92
due to the presence of two more RNA binding motifs in p92 protein.
The second part of my study focused on the effects of RPR mutations on DI RNA based
recombination. We developed a DI RNA based system that allowed us to test how RPR
mutations in replicase proteins influenced recombination. I found that various DI RNAs
replicated and recombined differently in the presence of wt replicase proteins, pointing to the
role of RNA elements in recombination. The effects on recombination by introduction of the
second copy of regions RII and RIII depended on their order in the DI RNA. Addition of one or
two copies of RIII to DI-72 (DI-33, DI-333), or two RII copies in tandem followed by two copies
of RIII (DI-2233) led to more efficient recombination compare to DI-2323 where RII and RIII
were duplicated in head-to-tail position.  It is possible that by changing the order of regions, I
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created less optimal arrangement for cis- acting sequences that resulted in enchanced
recombination.
The RPR motif studies showed that the most of the mutations did not affect
recombination, but proline mutations to alanine in replicase proteins slowed down recombinant
DI RNA appearance, while additional arginine (the same mutation that increased sgRNA2
accumulation), or mutation of central arginine to alanine led to rapid recombination. The
experiments with mutations introduced separately into p33 and p92 showed that RPR motif in
p33 was important for DI RNA recombination. This finding suggests that the binding of p33 to
viral RNA is a critical factor in recombination.
In the third part of the thesis I developed CNV replicase purification method from yeast
cells.  The data showed that expression of only p33 and p92 in the yeast cells led only to very
low replicase activity. But co-expression of (+) strand DI RNA increased the replicase activity
by ~ 40 fold (Panaviene et al., in press). In the next set of experiments we identified that co-
expression of stem-loop (SL) structure in RII and SL3, SL2 and gPR ((-) strand initiation
promoter) in RIV, were all necessary to obtain highly active CNV replicase. Taken together
these findings suggest that viral replicase proteins p33 and p92, as well as certain viral RNA
elements are required for active replicase formation.
Based on my results presented in this thesis, I would like to propose the following model
to explain tombusvirus replicase assembly, virus replication and recombination.
When tombusvirus gRNA enters the cell, first replicase proteins are translated. When p33
is made, it binds to viral RNA via its RNA binding motif. The recent data suggest that p33 binds
with high specificity to SL structure in region II (+) (Pogany and Nagy, unpublished data). This
structure is present in p92 ORF as well. It is known that p33 binds to tombusvirus RNA in
cooperative manner, possibly via its protein- protein interaction domain (Rajendra and Nagy, in
press). It means that a few p33 molecules can bind to viral RNA, coat it and possibly interfere
with ribosome movement and translation. The RNA binding motifs and protein-protein
interaction domain are also present in p92 that functions as RdRp. Since p33 can interact with
p92 (Rajendran and Nagy, in press), it is possible that p33 facilitates p92 targeting to replication
site on the membrane. On the other hand, it is possible that p92 (it also has membrane
localization domain) with or without RNA finds its way to the replication site, and interaction
with p33 occurs later.
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The studies of replicase purified from yeast suggest that p33 and p92 without viral RNA
can form replicase only with limited activity. It means that viral RNA likely serves not only as
the genetic material, but it is also involved in the active replicase formation.  It could be that
binding to viral RNA sequences could lead to conformational changes in p33 and p92 that
possibly would affect their interaction and/ or attraction of host factors leading to active replicase
formation.
The results showing that only RII SL (is bound specifically by p33 (Pogany and Nagy,
unpublished), SL3 (silencer), SL2 and gPR ((-) strand initiation promoter) from RIV  (about
200nt in total) are necessary for active CNV replicase formation in yeast cells, suggest that these
motifs have essential roles in replicase assembly. The finding that RII with gPR, is not sufficient
to form active replicase, points to the conclusion, that having RII SL, involved in recruitment
(Pogany and Nagy, unpublished), and promoter is not enough for replicase activation. It is likely
that replicase formation is a more complex process. The requirement of RII SL and SL3, SL2
and gPR, suggests a possibility that these components can interact between themselves and form
certain structures that in return would influence activity of replicase proteins.
It could be that binding of p33 to certain viral RNA structures ensures RNA specificity
and integrity and then it can direct p92 for RNA synthesis. It is possible that p92 could only
initiate RNA synthesis process, after p33 binds to gPR and destroys interaction between silencer
and promoter. The finding that mutations in the RNA binding motif of p33 had stronger effect on
virus replication and recombination than the same changes in p92, support the above idea.
It is also possible that p33 binding to tombusvirus RNA is important for later steps of
replication (e.g.anchoring RNA in replication site) and sgRNA synthesis. There is a possibility
that p33 could bind to secondary structures in the viral RNA that lead to termination of (-) strand
synthesis by RdRp and production of sgRNA. Increased viral RNA binding by addition of
arginine to RPR motif could make p33 an “obstacle” for RdRp leading to more frequent
termination at the (-) strand synthesis step. Proline mutation might have an opposite effect that
would allow RdRp to finish gRNA (-) strand synthesis without termination more frequently than
in wt situation and reduce production of sgRNAs.
The observed effect of RPR motif mutations in p33 and p92 on tombusvirus
recombination suggests that p33 binding to RNA is critical for recombinant RNA formation. The
role of p33 in recombination might be similar to the one in sgRNA synthesis: p33 binds stronger
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(for example, arginine mutations) or weaker (proline mutations) to viral RNA and interferes or
makes it easier for RdRp to synthesize full length RNA. It is possible that RNA elements in DI
RNA influence where p33 binds and where the recombination sites will be.
The experiments described in this study imply that all three viral components, p92, p33
and viral RNA, are critical for virus replicase assembly, replication and recombination. The RNA
in these processes is an important factor influencing replicase assembly by “attracting”, changing
not only replicase proteins but possibly host factors as well. The requirement of RNA binding
motif of replicase proteins for p33 function in virus replication and recombination suggests that
tombusvirus auxiliary protein and RNA interactions plays essential role in viral infection and
evolution.
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